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Abstract 
The delivery of poorly water-soluble drugs represents one of the main challenges to the 
pharmaceutical formulation field. In this regard solid dispersion formulations have emerged 
as an effective approach for improving poorly water-soluble drug dissolution rates and 
bioavailability. Despite this, the uncertain physical stability and the unclear dissolution 
mechanism of solid dispersions have strongly limited their application in the pharmaceutical 
market to date. Significant efforts have been made to improve solid dispersion formulation 
physical stability, but the mechanism of dissolution is still debated in the literature. This 
project was designed to better clarify the dissolution mechanism of solid dispersion 
formulations in media simulating the intestinal environment, with particular consideration of 
the possible interaction between polymeric carriers and the biosurfactants present in 
intestinal media. Spray dried solid dispersions were prepared using 4 polymeric matrices and 
three different model drugs. Solid-state characterisation of the obtained solid dispersion 
formulations was performed by the use of SEM, ATR-FTIR spectroscopy, PXRD, DSC and 
TGA techniques, which revealed drug partial amorphisation for all of the formulations. 
Biorelevant dissolution media FaSSIF and FeSSIF were employed, with and without the 
presence of lecithin, to assess drugs apparent solubility and spray dried solid dispersions 
dissolution profiles. In order to investigate the occurrence of interaction between polymeric 
carriers and bile salts, NMR and surface tension experiments were performed. Polymer/bile 
salts aggregates were characterized by using light and neutron scattering techniques and 
cryo-TEM. The possible impact of polymer-surfactant interaction on drug uptake in the 
intestinal tract was studied by the use of CaCO-2 cell model. Several key achievements were 
obtained across the project. The occurrence of polymeric carrier/bile salts aggregation was 
confirmed and aggregate characterization, together with steady state solubility and 
dissolution results, suggested possible involvement of polymer/bile salts aggregates in drug 
solubilisation. Finally drug uptake studies revealed a significant increase in the drug 
absorption in FaSSIF and FeSSIF media in the presence of the polymeric carriers in 
comparison to simple buffer media. The obtained results highlighted the possible role of 
polymeric carrier/intestinal fluids components interaction in the drug solubilisation and 
absorption in the intestinal tract. The achievements of this project are expected to provide 
insight into the mechanisms of drug solubilisation and stabilisation in the gastrointestinal 
tract after oral administration of solid dispersion formulations. In particular a better 
understanding of polymeric carriers behavior in the intestinal fluids during dissolution and 
of their interaction with intestinal fluids components can have an impact on the development 
of new solid dispersion formulations and on the design of new pharmaceutical polymers.  
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Chapter 1. Introduction   
1.1Background of the project 
There is a general consensus that lipophilic drug candidates are emerging often from 
drug discovery. 1,2 Oral delivery of poorly water-soluble drugs still represents a challenge for 
formulation scientists. 3 The absorption of such compounds in the gastrointestinal tract (GIT) 
is strongly influenced by their solubility in the gastrointestinal media and by their ability to 
permeate GIT membranes. The Biopharmaceutics Classification System (BCS), introduced 
to the pharmaceutical industry in the 90s, divided active pharmaceutical ingredients (APIs) 
into four groups based on their aqueous solubility and permeability. BCS II and IV (poor 
permeability) APIs are classified with poor aqueous solubility and their bioavailability can 
potentially be improved through formulation strategies. 4 Different approaches have been 
studied to formulate poorly-water soluble drugs in order to enhance their solubility and 
bioavailability. These include particle size reduction, salt formation, lipid based drug 
delivery systems, pro-drug formation, complex formation, self-emulsifying drug delivery 
systems and solid dispersions. 5–11  
Formation of solid dispersions has been proved to be an effective approach to 
increase the dissolution rate of poorly water-soluble drugs and potentially improve their 
bioavailability. 12–14 In order to achieve good in vivo-in vitro correlation and accurately 
predict the in vivo performance of a solid dispersion using in vitro data, increasing attention 
has been paid to the in vitro dissolution media employed to study drug dissolution from solid 
dispersions formulations and the importance of the dissolution media composition has been 
highlighted by many recent studies. 15–17 The mimicking of human gastro-intestinal fluids 
composition is crucial to accurately predict APIs dissolution behavior and assess the 
effectiveness of solid dispersion on the drug solubility enhancement. The composition of 
human gastrointestinal fluids is extremely complex and many components may influence the 
solubilisation of a poorly soluble drug. 18–20 Furthermore dissolution fluids components can 
also influence the behavior of the drug carrier and impact on the drug release from the 
formulation. 21 To date there is a lack of knowledge about the possible interaction between 
the polymeric carriers commonly used in the solid dispersions formulations and gastro-
intestinal fluids components and its possible influence on the drug solubilisation and 
subsequent oral absorption. Such mechanimistic study is extremely challenging due to the 
complex environment of human GIT. However, it can dramatically improve the 
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predictability of the in vitro dissolution tests and provide useful guidance for the formulation 
optimization. The focus of this project was to characterise solid dispersion polymeric 
carriers/bile salts interactions and identify the possible roles of these interactions in poorly 
water-soluble drug solubilisation and absorption. Different dissolution media with increasing 
complexity were employed and the molecular level interactions between the polymer and the 
media were studied using a wide range of characterisation techniques. The macroscale 
physico-chemical behaviour of freshly spray dried solid dispersions in these dissolution 
media was analysed and used to facilitate the interpretation of the potential roles of the 
identified interactions in the dissolution and drug release process of the drug from a solid 
dispersion formulation.    
 
1.2 Solid dispersions 
1.2.1 General introduction to solid dispersions 
The initial definition of solid dispersion given by Chiou was “the dispersion of one 
or more active ingredients in an inert carrier or matrix in solid state prepared by melting 
“fusion”, solvent or melting solvent method”. 22 Solid dispersion can be described as a 
processed mixture of a drug in a solid inert matrix, where the drug can be dispersed in 
different states depending on the material matrix used and the preparation method employed. 
23 The physical forms of the drug can either exist as crystalline particles, as amorphous drug 
rich domains or being molecularly dispersed in the carrier polymer. 24 
In comparison to other formulation strategies employed for increasing the 
bioavailability of lipophilic APIs, such as pro-drug formulation and self-emulsifying drug 
delivery system for enhanced dissolution and absorption, solid dispersion offers different 
advantages. The production of solid dispersions is normally low-cost and scalable. 
Furthermore solid dispersion formulations can widely be applied to various drugs with 
different physical properties for both solubility enhancement and controlled release purposes. 
11 Another advantage offered by solid dispersion technology is the possibility of obtaining 
and maintaining supersaturation of the drug in the dissolution media, which is gaining 
increasing interest as a possible tool to improve drug bioavailability. 25 Therefore, the solid 
dispersion technology represents a promising formulation strategy that is increasingly being 
remarked by the pharmaceutical industry.  
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Despite the advantages mentioned above, the use of solid dispersion in clinic is still 
very limited and only around 10 solid dispersion based products are currently on the 
pharmaceutical market. Fuller understanding of the relationship between the physical 
properties and in vivo behavior of solid dispersions are needed to more rationalised 
formulation design of solid dispersions. 
1.2.2 Classification of solid dispersions 
According to the physical states of the drug in the polymer matrices, solid dispersion 
can be classified into two main types, phase separated solid dispersion containing crystalline 
drug, and amorphous solid dispersions (solid solution) in which the drug is ideally 
molecularly dispersed in the polymer network, but often could be in the form of drug rich 
domains. In this study, the behaviour of solid dispersions containing crystalline drug and 
molecular dispersions were studied. The chemical, physical and pharmaceutical features of 
the two classes are described in the following sections. 
1.2.2.1 Solid dispersion containing crystalline drug 
The crystalline state of material is characterised by three long-range order symmetry 
operators including translational, orientational and conformational. 26 The presence of such 
symmetry confers high physical stability to crystalline materials. Therefore the main 
advantage of using solid dispersion containing crystalline drug is the stability of the drug in 
the system. 27 The first reported solid dispersion containing crystalline drug was a simple 
eutectic mixture. Eutectic mixtures consist of two components that are miscible in the liquid 
state but only partially miscible in the solid state. Solid eutectic mixtures are commonly 
obtained by rapid cooling of a co-melt of the two components, in order to obtain physical 
mixtures of the two compounds fine crystals. 28,29 The release of fine drug crystals once the 
eutectic mixture is in contact with the dissolution medium can lead to an increase in the drug 
dissolution rate, which is mainly due to the significantly increased surface area of the 
systems. Schematic representation of a solid dispersion containing crystalline drug is shown 
in Figure 1.1. 
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Figure 1.1: Schematic representation of solid dispersion containing crystalline drug 
 
Together with eutectic mixtures other solid dispersion formulations containing 
crystalline drug have been reported in literature. The proposed solid dispersion systems have 
been shown to be able to increase drug dissolution rate despite its crystalline form. Such 
effect has mainly been related to the presence of the hydrophilic carrier which covering the 
crystalline drug particles promoted their solubilisation. 30,31 
1.2.2.2 Amorphous solid dispersions (solid solutions) 
Amorphous solid dispersions are composed of drug molecularly dispersed in the 
formulation matrix. Amorphous state of a material is characterised by the absence of the 
long-range order within the structure. 32 The lack of long-range order results in a relative 
random position of the molecules one to each other and only short-range orientation is 
present.33 This results in thermodynamic instability of amorphous materials, due to the 
higher energy level in comparison to their crystalline counterparts. The properties of 
amorphous materials made them attractive for solubility enhancement, 34 as they can yield 
solution concentrations many times higher than their crystalline counterparts. 35–37 The 
molecular dispersion state of a drug in solid dispersion facilitates the drug solubilisation in 
the dissolution media, reducing the barrier to solubility presented by solute-solute molecular 
interactions in the crystalline state. 38 On the other hand the physical instability of 
amorphous solid dispersion can result in drug recrystallization during the storage. 39–41   
Amorphous solid dispersions are normally obtained by dispersing the drug in an 
amorphous polymer, which can prevent the drug crystallization in the formulation. 42 They 
can be characterized by rich drug domains or by a molecular dispersion of the drug in the 
matrix (Figure 1.2). The latest represents the ideal solid dispersion as higher dissolution rate 
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is expected when the drug is molecularly dispersed in the inert matrix. 43 Further 
recrystallisation of drug from drug-rich domains in an amorphous solid dispersion can be 
characterised by partially crystalline and partially amorphous drug in the dispersions. 44  
 
 
Figure 1.2: Schematic representation of amorphous solid dispersion characterized by 
amorphous drug rich domains and molecularly dispersed drug. 
 
 
1.2.3 Preparation of solid dispersions 
Processing methods for solid dispersion preparation can be divided into two main 
classes: solvent evaporation and non-solvent based methods. Classical solvent evaporation 
methods include spray drying, film casting and co-precipitation. More recently spin coating, 
electrospinning and electrospraying techniques have also been remarked for their potential 
applications for pharmaceutical solid dispersions preparation.  Non-solvent based methods 
include melting based methods, such as hot melt extrusion, and milling. The different 
methodologies are briefly described in following sections 1.2.3.1 and 1.2.3.2. 
1.2.3.1 Solvent based methods 
The most widely used solvent evaporation method for preparation of solid 
dispersion is spray drying. Spray drying is a process of the transformation a liquid feed into 
dried particles by spraying the feed into a heated drying gas (air or nitrogen). 45 Many spray 
dried solid dispersions have been reported in literature. Most of them demonstrated good 
ability to increase dissolution rate and solubilise poorly water-soluble drugs in vitro. 46 More 
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recently spray drying technique has found applications in the field of biological therapies, 
such as spray drying of proteins, viable organisms and plant extracts. 47 Technical and 
processing aspects of spray drying are described in details in Chapter 2 (Section 2.3.1).  
Film casting is based on the pre-dissolution of the drug and polymer in a suitable 
solvent and casting the obtained solution on a chosen surface under ambient condition or 
low vacuum. Different works in literature described the possible applications of film casting 
technique for solid dispersions preparation. 48,49 An essential prerequisite for solid dispersion 
preparation through film casting methods is the choice of a solvent or a mixture of solvents 
that allow simultaneous solubilisation of the drug and the polymeric carrier.  The choice of 
appropriate solvent or solvent mixture represents a major limitation for the film casting 
methodology application.    
Spin coating technique is based on the production of films with micron to nanometer 
thickness on a chosen substrate. Spin coating has widely been used in the semiconductor 
industry and more recently has been remarked as possible processing method for solid 
dispersions preparation. 50,51 As for film-casting drug and polymer are pre-dissolved in a 
solvent or mixture of solvents, but differently from the common film-casting technique, 
ultra-fast solvent evaporation occurs under fast spinning during spin-coating process. Spin 
coating technique offers the advantages of high reproducibility and fast preparation. Due to 
the more intimate mixing through dissolving in a solvent and ultra-fast solvent evaporation 
which gives the material a quenching effect, spin coated solid dispersions have been shown 
to more effectively stabilize amorphous drugs in the carrier matrix in comparison to other 
methods, such as hot melt extrusion. 51 
Co-precipitation method consists in the simultaneous dissolution of the drug and the 
carrier in a solvent and the subsequent addition of an anti-solvent. The difference in polarity 
between solvent and anti-solvent causes the precipitation of the polymer and the drug 
leading to the formation of a solid dispersion. Usually polar solvent and non-polar anti-
solvent are employed and high difference in polarity is necessary to promote the formation 
of solid dispersion. 52 After precipitation completion, filtration or solvent evaporation are 
performed to obtain the solid dispersion. 53 Solid dispersions obtained by co-precipitation 
method are normally composed of porous particles, having large surface to volume ratios. 
The surface to volume ratio and the porosity of the co-precipitated solid dispersion particles 
may potentially improve dissolution rate of poorly water-soluble drugs. 54 However, due to 
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the complexity of solvent and anti-solvent selection, the application of co-precipitation for 
the preparation of solid dispersion has been to date quite limited. 
1.2.3.2 Non-solvent based methods 
The use of organic solvents in the preparation of solid dispersions may represent a 
limitation for this strategy formulation, due to both environmental and cost concerns. For 
this reason non-solvent based methods for solid dispersions preparation have attracted 
increasing interest in pharmaceutical industry. In this regard hot melt extrusion (HME), a 
technique widely employed in the plastic industry, 55 represents a possible process for the 
production of solid dispersion formulation. During a HME process, the raw materials are fed 
into the extruding system, where a rotating screw extrudes the heated material through 
different zones (for mixing and transporting purposes). The material exits the extruder 
through a die and solidifies either under ambient or additional cooling conditions (Fig. 1.3). 
56 HME has advantages over other methods such us easy scaling-up, and the efficiency of 
being a one-step processing. However thermal degradation of heat-sensitive drugs and 
polymers in preparation restricts the selection of drugs and polymers can be processed by 
HME. 57 
 
Figure 1.3: Schematic diagram of a hot melt extrusion system 58 
 
Milling processing allows particle size reduction, conversion of crystalline materials 
in their amorphous counterparts and formation of co-crystals. Milling technique has been 
shown to be an effective method to obtaine solid dispersion. 24,59 It can be performed with 
(wet milling) and without (dry milling) the presence of wetting agents. Wet milling has been 
employed for the preparation of nano-suspensions, whereby drug and matrix were mixed 
together in a surfactant solution. Such methodology allowed the reducing of particle size to 
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the nano-scale, 60 leading to an increase in the drug dissolution rate. For the preparation of 
solid dispersions through wet milling method the wetting agent removal by lyophilisation is 
required during downstream processing. 61,62 Dry milling was shown to favor crystalline 
drug conversion in their amorphous state, facilitating drug dissolution. Despite the reported 
increase in drug solubilisation obtained by using wet and dry milling, milling techniques 
presents few disadvantages. Firstly only a certain range of particle size reduction can be 
achieved depending on the properties of drugs and polymers. Second, milling processing can 
be time-consuming as hours or days milling periods are required to produce amorphous solid 
dispersion. 63 
 
1.2.4 Limitations of solid dispersions 
Despite the high number of studies carried out and the significant amount of 
scientific contributions published in the field of solid dispersions, their commercialization is 
still limited. A summary of the pharmaceutical products based on solid dispersion 
technology currently available in the market can be found in Table 1.1. 43,64 
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Table 1.1: Summary of marketed pharamecutical products prepared using solid dispersion 
approach. 
Product Company API Polymer Year of 
approval 
Preparation 
method 
GrisPEG Pedinal 
Pharm Inc. 
Griseofulvin PVP 1975 Melt process 
Cesamet Eli Lilly Nabilone PVP 1985 Unknown 
Sporanox J&J Itraconazole HPMC 1992 Spray drying 
Prograf Astellas 
Pharma 
SpA 
Tacrolimus HPMC 1994 Spray drying 
Kaletra Abbott Lopinavir/Rit
onavir 
PVP-VA 2005 Melt extrusion 
Intelence Tibotec Etravine HPMC 2008 Spray drying 
Zotress Novartis Everolimus HPMC 2010 Spray drying 
Norvir AbbVie Ritonavir PVP-VA 2010 Melt extrusion 
Onmel Merz 
Pharma 
Itaconazole HPMC-AS 2010 Melt extrusion 
Incivek Vertex Telaprevir HPMC-AS 2011 Spray drying 
Zelboraf Roche Vemurafenib HPMC-AS 2011 Co-
precipitation 
Kalydeco Vertex Ivacaftor HPMC-AS 2012 Spray drying 
 
  In formulation science many efforts have been made to address how the drug is 
dispersed in the inert matrix in the solid state and optimisation of solid dispersion physical 
stability. 36,50,65,66 However the mechanism of how solid dispersions facilitate the dissolution 
and absorption of poorly soluble drugs in vivo is not clarified. This lack of knowledge 
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represents a barrier for the solid dispersion in vivo performance prediction and consequently 
for their optimisation. Indeed, a clearer mechanistic understanding of solid dispersion 
behaviour in the biological fluids would provide guide for the polymeric carriers selection 
and facilitate the development of new solid dispersions formulation, opening up more 
possibilities for the commercialisation and use in the clinic. 
 
1.3 In-vitro dissolution assessment for solid dispersion  
In vitro dissolution test is widely used as a tool to assess the dissolution performance 
of pharmaceutical formulation. The study of the in vitro dissolution of a drug provides useful 
information in different drug development stages and can potentially predict the drug 
solubilisation in vivo and consequently its bioavailability. 67 The dissolution behaviour of 
solid dispersion has received significant attention in literature and few possible dissolution 
mechanisms have been proposed. Proposed dissolution mechanisms and dissolution media 
are described in Sections 1.3.1 and 1.3.2. 
1.3.1 Solid dispersions dissolution 
Drug dissolution process has been theoretically described by the Noyes-Whitney 
equation 
                                               𝑑𝑊 𝑑𝑡⁄ = 𝐷𝐴(𝐶𝑆−𝐶)
𝐿
                                              Eq 1.1 
where dW / dt is the dissolution rate, A is the surface area, C is the concentration of the drug 
in the bulk media, Cs is the solubility of the drug in the media and L is the diffusion layer 
thickness. 68 Each parameter of the equation can be strongly influenced by the drug 
formulation in solid dispersion, as besides the possible change in the physical state of the 
drug obtained by the solid dispersion preparation, the carrier matrix surface, area and 
thickness are key parameters for the drug dissolution rate.  The drug release and dissolution 
mechanism from solid dispersion formulations is still not clearly understood. Craig proposed 
two possible models, which are schematically represented in Figure 1.4. A carrier-controlled 
dissolution model, which proposed the drug dissolution into the concentrated carrier layer 
prior to release, and drug-controlled dissolution mechanism whereby the un-dissolved drug 
is released intact into the dissolution medium. 69 
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Figure 1.4: Schematic representation of carrier controlled (a) and drug controlled (b) solid 
dispersion dissolution mechanisms proposed by Craig. 69 
 
Despite the indications provided in literature on the possible solid dispersion 
dissolution media, the role of gastro-intestinal fluids components in the dissolution 
mechanism of dispersions has not been considered. Recently the key role of mimicking the 
gastro-intestinal fluids for in vitro dissolution studies has been highlighted by many works. 
15,20,70,71 The following section reviewed the variety of bio-relevant media compositions have 
been used in the literature.  
1.3.2 Biorelevant dissolution media 
Mimicking of biological conditions in the study of formulations dissolution profile 
is essential for more accurate analysis of the in vitro and in vivo correlation which will be 
used for predicting in vivo therapeutic outcome 18. As widely described in literature the 
presence of amphiphilic molecule species in the intestinal fluids plays a major role in the 
drug solubilisation in the GIT. 70 In the last few decades intestinal fluids have been 
intensively studied and the key features of intestinal fluids are reviewed in Table 1.1. 
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Table 1.2: Summary of Intestinal fluids composition. 70 
 
Table 1.2 gives indication of how pH, osmolality, surface tension, bile salts and 
phospholipid content change in the absence (fasted state) and in the presence of (fed state) 
food in the GIT, and how all these parameters vary in the different regions of the human 
intestinal tract. For in vitro studies performance, an effective simulation of the human 
intestinal fluids is essential for producing good in vivo-in vitro correlation data. Dressman et 
al proposed biorelevant media that could mimick the average fasted and fed upper small 
intestinal fluid (composition shown in Table 1.2). 67 Although fasted state simulated 
intestinal fluid (FaSSIF) and fed state simulated intestinal fluid (FeSSIF) only contain a 
simplified combination of the actual lumenal composition, they have been shown to be 
capable to closely predict the in-vivo dissolution process. 15 For this reason they have been 
widely used to assess the dissolution of poorly soluble, lipophilic weak acids, weak bases 
and non-ionisable compounds. 72–74 
As shown by Table 1.2 sodium taurocholate (NaTC) is employed in FaSSIF and 
FeSSIF to represent bile salts in the intestinal fluids. NaTC is the most often used model bile 
salt in the biorelevant media. Together with glycocholate, it is the most abundant bile salt in 
human bile. The pKa of NaTC is 1.5, thus it is ionized in the pH range of the small intestine. 
75 The increased knowledge about intestinal fluid composition has lead to an improvement of 
the biorelevant media used in pharmaceutical studies for assessing drug dissolution behavior 
and solubility in simulated intestinal fluids. FaSSIF and FeSSIF have recently been revised, 
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according to the new knowledge about human intestinal fluids composition. This brought to 
the preparation of new updated simulated intestinal fluids named FaSSIF-V2 and FeSSIF-V2 
(see Table 1.3). 76  
In FaSSIF-V2, the phospholipid concentrations were decreased, causing the bile 
salts/phospholipid (BS/PL) ratio to increase from 5 to 15. The buffering species were 
changed from phosphate to maleate and the osmolality decreased from 270 (for FaSSIF) to 
180 (for FaSSIF-v2) mOsm/kg. In FeSSIF-V2 the buffering species were also changed to 
maleate and the BS/PL ratio changed from 4 to 5. Furthermore lipolysis products were added, 
but in smaller amounts compared with the human intestinal fluids and the obtained oleic 
acid/monoolein (OA/MO) ratio of 0.16 is still not representative of the intestinal 
physiological condition. Osmolality was decreased to a level matching the osmolarity of 
human instestinal media. More recently further modification of fasted and fed states were 
investigated and Copenhagen fasted and fed states were studied. In this case bile 
salts/phospholipids or monoolein/oleic acid ratios were increased and adjustment of the ratio 
is required for each individual drug.70  
 
Table 1.3: Summary of Simulating intestinal fluids composition. 70 
 
Recently the use of phosphate buffer for in vitro dissolution studies has also been 
questioned. Indeed phosphate buffer ions do not relate to the gastrointestinal fluids. To 
overcome this limitation “physiological” bicarbonate buffers mimicking the gastrointestinal 
fluids in terms of ions content and buffer capacity have been developed. 77 The new buffered 
system was developed by modification of pH 7.4 Hanks balanced salt solution to obtain a 
pH 6.8 bicarbonate buffered solution (modified Hanks buffer, mHanks). mHanks system 
was proved to better assess the in vitro dissolution profile of enteric coatings. 78 
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In this study the first version of fasted and fed state prepared by Dressmann et al 
were chosen for all drug and formulation drug solubility and release studies. NaTC was 
therefore used as model bile salt. The reason for not choosing the more recently developed 
but more biorelevant media is that the presence of lipolysis products in the newer media 
would produce high level of interference with the molecular characterization of the specific 
polymer-bile salts aggregates, which is the focus of this study. Thus, the original fed and 
fasted intestinal fluids having the less complex composition were chosen as biorelevant 
media for all tests performed in this study.  
 
1.4 Bile Salts 
Bile salts are bio-surfactants derived from cholesterol metabolism, produced in the 
liver and stored in the gallbladder. Bile salts are secreted in the small intestine in 
concentration ranging from 5 to 25 mM. 79 In the intestinal tract bile salts play a primary role 
in the solubilisation of lipids during the digestion process. Moreover they promote calcium 
absorption, represent a mean of excretion of waste molecules from the blood and have 
regulatory properties influencing the bile acid and cholesterol biosynthesis. 79–82 Bile salts 
are almost quantitatively recoverd in the ileum and transported back to the liver via the 
portal circulation. In the liver they are extracted by hepatocytes from sinusoidal blood and 
subsequently resecreted into the bile.  This enterohepatic circulation allows bile salts to be 
recovered up to 90 %, thus only about 10% of bile salts is eliminated in the feces. 83 
 
1.4.1 Structural features of bile salts 
Bile salts structure differs significantly from the classical surfactant structure. 
Classical detergents present a polar head group and a hydrophobic chain, whereas bile salts 
are based on a rigid tetracyclic steroid ring structure. The hydrophobic surface is the convex 
side of the ring and the hydrophilic surface is the concave side of the molecule, where 
between one and three hydroxyl groups and one acid group are attached (Fig.1.6). Thus, the 
hydrophilic and the hydrophobic portions of the molecule are not clearly separated as in 
classical surfactants. 84,85 
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Fig.1.6: Bile salt chemical structure (A) (From R1 to R3 hydroxyl groups, R4 acidic group), 
three dimensional structure (B) and representation of a dihydro-bile salt (C). 85 
 
 
Table 1.4: Position and orientation of –OH groups in bile salts. 85 
 
 
 
The unique structure of bile salts can significantly impact on their aggregation 
behaviour. Compared to classical ionic surfactant, bile salts present smaller aggregation 
numbers of about one order of magnitude, typically 2<Nagg>15 and the concentration range 
in which the aggregation process occurs is broader with respect to the classical surfactants. 
At 37˚C the critical micellar concentration (CMC) of a bile salts mixture, comparable to the 
one present in the intestinal tract, in a solution containing physiological concentration of 
electrolytes is 1-2 mM. 86 
 
1.4.2 Bile salts micellisation 
The unique structure of bile salts gives rise to peculiar aggregation behaviour of 
these biosurfacants. In particular the hydroxyl groups and the acid group play an important 
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role in the bile salts aggregation. In fact, they create an intermolecular hydrogen-bonding 
network that contributes to the micelles formation and renders micelle aggregates more rigid. 
This aggregation driving force is complementary to the hydrophobic effect, which represents 
the main aggregation driving force. 85,86 
Several association models have been proposed for bile salts.  Small proposed the 
“two step model” with the formation of small primary micelles, resulting from hydrophobic 
interactions between monomers, and the following aggregation of primary micelles in bigger 
secondary micelles through hydrogen bonding of hydroxyl groups. 87 Small’s model for bile 
salts aggregation was also confirmed by simulation and NMR studies. 88–90 According to the 
“disk-like model” bile salts aggregate with their hydrophobic surface oriented towards the 
inner part of the aggregate and the hydrophilic surface toward the solution. The monomers 
have an alternating orientation to reduce electrostatic interaction between charged groups. 91 
Another model was based on the crystalline structure (in solid state) of bile salts rather than 
on their solution state. Such model suggested the arrangement of monomers in helical 
structure, driven by polar interactions. The hydrophobic surfaces of the monomers are 
pointed to the extern, like in inverted micelles, and the inner part of is filled with cations 
surrounded by water molecules.  A schematic representation of the three models is shown in 
Figure 1.7  
 
Fig.1.7: Representation of different models for bile salts micelles structure: A and B different 
primary micelles; B dislike micelle; C helical micelle. 85 
 
The value of bile salts CMC is strictly dependent on the bile salt structure, the 
number, location and orientation of hydroxyl groups. Furthermore, similarly to classical 
surfactants, the CMC value of a bile salt can also be significantly influenced by many 
external factors, such as solution pH, ionic strength and temperature. Normally higher ionic 
strength leads to the screening of charged groups favouring bile salts micellisation and 
therefore resulting in lower CMC values and higher aggregation numbers. 92,93 Bile salts 
monomers electrostatic repulsion can also be reduced by decreasing charges via pH control. 
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The temperature influence of the bile salts CMC value is very limited. Normally bile salts 
CMC shows a minimum value around room temperature and increases above room 
temperature. 85 Finally pH can also influence bile salts aggregation behaviour and CMC 
value. The impact of pH on bile salts association occurs when it impacts bile salts molecules 
ionization state. If the pH value is well above the pKa of the bile salts all the monomers in 
solution are ionized, but pH shift towards the pKa value yields the presence of undissociated 
monomers changing the species involved in the aggregation pattern and therefore impacting 
CMC. 84,94  
 
 
1.5 Impact of bile salts on drug absorption in the GIT    
Bile salts are important components of gastrointestinal fluids. The presence of bile 
salts during the drug release from a solid dispersion system can influence the rate of drug 
release from the formulation and its dissolution. It has been shown that bile salts can 
improve solubilisation of poorly water-soluble drug in the gastro-intestinal tract. 95 The drug 
dissolution rate can be increased either via enhancing of the drug molecules wetting, through 
a decrease of the interfacial energy barrier between the drug molecules and the dissolution 
medium, or via an increase in the drug solubility due to the micellar solubilisation. 95 
Generally the wetting effect predominates for bile salts concentration below the CMC, while 
the micellar solubilisation occurs at concentrations above the CMC. 96 
 
The potential role of bile salts in drug solubilisation in the GIT can also be related to 
their possible interaction with the polymeric carriers employed in pharmaceutical 
formulations. As already mentioned in this Chapter, the presence of polymer and bile salts in 
the dissolution medium can potentially lead to the occurrence of their interaction. Such 
interaction can result in the formation of aggregates that might play a role in the drug 
solubilisation in vivo. Therefore a characterisation of bile salts/polymeric carrier aggregation 
and its possible impact on the drug solubilisation and uptake in the GIT may provide new 
insights into the drug dissolution mechanism in the GIT. 
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1.6 Polymer-surfactant interactions 
Polymer-surfactant interactions have been extensively studied in literature and 
mixture of polymer-surfactants are increasingly being employed in a wide range of 
applications. 97–103 An overview about polymer-surfactant interactions can be found in the 
following sections. 
1.6.1 “Weakly” and “strongly” interacting systems 
The most widely studied polymer-surfactant systems are mixtures of neutral 
polymers and ionic surfactants, which are referred as “weakly interacting” systems. The 
name refers to the weak hydrophobic interactions occurring between the polymer chains and 
the surfactant head groups that represent the predominant interactive forces. Weakly 
interacting systems containing anionic surfactants have been subject of most interest, while 
mixtures containing cationic or non-ionic surfactants and neutral polymers have attracted 
less interest, since they usually do not show the occurrence of significant polymer-surfactant 
interaction. 97 However, cationic micelles formed by cetyltrimethylammonium salts (CTAX) 
associate significantly with sufficiently hydrophobic polymers, like poly-propylene oxide 
(PPO) and poly(vinyl methyl ether) (PVME). 104 Furthermore studies on systems containing 
PPO and the non-ionic surfactant n-octyl β-D-thioglucopyranoside (OTG) have shown the 
occurrence of association between neutral micelles and polymer. 105  
Systems containing charged polymers and oppositely charged surfactants are 
referred as “strongly interacting” systems. In this case the association between mixture 
components is driven by electrostatic interactions. Nevertheless, hydrophobic interactions 
between surfactant and polymer chains are also present and can contribute significantly to 
interactive forces. 106  
The behaviour of polymer-surfactant mixtures is influenced by many factors and is 
strictly dependent on components structural features, such as polymer hydrophobicity, 
polymer molecular weight, surfactant charge, surfactant chain length, but can also be 
influenced by physical and chemical conditions, such pH and ionic strength. 107  
Both bulk solution properties and interfacial aspect of polymer-surfactant system 
have been largely investigated. 99,108 In this study only weakly interacting systems were 
investigated. The interactions between a model anionic surfactant, NaTC, and two neutral 
polymers, hydroxypropyl methylcellulose (HPMC) and polyvinylpyrrolidone (PVP), were 
studied. In most reported studies, polymers and surfactants with high purity and narrow 
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molecular weigh distribution were used. However, this is not the case for this project as its 
goal is to provide better understanding on the interactions of bile salts with pharmaceutical 
grade polymers which are used in oral pharmaceutical product under simulated physiology 
conditions. 
 
1.6.2 Polymer-surfactant complexation 
It is well known that surfactant molecules in aqueous solution aggregate to form 
micelles when their concentration is higher than critical micellar concentration (CMC). The 
dominant force driving for micellization is the gain in entropy attributed to the reduction of 
the contact area between surfactant hydrocarbon chains (hydrophobic surfaces) and water. 
This leads to the aggregation of hydrophobic groups in the interior core of micelles.  109 
When a surfactant is added to a polymer aqueous solution an aggregation process 
starting at a surfactant concentration lower than CMC, usually referred as critical 
aggregation concentration (CAC), can be observed.  Above the CAC the association 
increases up to polymer saturation. As the polymer is saturated with surfactant 
micelles/monomers, free surfactant micelles formation occurs (Fig.1.8). 110 
CAC and CMC surfactants values depend on the nature of polymer and surfactant, 
and are less dependent on molecular weight (MW) of the polymer if the MW is over 4kDa. 
CAC is insensitive to polymer concentration, while CMC increases as polymer 
concentration is increased. It is generally agreed that polymer-surfactant aggregation number 
are smaller than those of pure surfactant micelles. 111–113 
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Fig.1.8: Solution phases in a surfactant-polymer system 114 
 
 
1.6.2.1 Neutral Polymers 
Surfactant-neutral polymer interactions may occur by cooperative binding or 
association of individual surfactant molecules on polymer chains, or by the formation of 
surfactant micelles along the polymer chains. Usually the binding model is preferred for 
polymers with hydrophobic groups, while the later approach is more representative for 
hydrophilic polymers. 110 For polymer-surfactant solutions containing neutral hydrophilic 
polymers, the formation of surfactant-polymer aggregates can be described by the widely 
accepted “pearl-necklace” model (Fig. 1.9). The surfactants form micellar-like clusters (as 
the pearls) along the polymer structure. It seems likely that the micellization process is 
polymer-induced, with the polymer acting as a seed for the aggregation process. 115  
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Fig. 1.9:  Schematic representation of “pearl-necklace” model” of surfactant-polymer 
association. 116 
 
For hydrophobic polymers the association with surfactant is driven by strong 
hydrophobic interaction between individual surfactant molecules and polymer molecules, 
according to the cooperative binding model. Such interactions are particularly strong for 
hydrophobically modified polymers, such as hydrophobically modified non-ionic cellulose 
ester (HM-EHEC), where hydrophobic groups are covalently bonded to the polymer chains. 
110As reported in the review of K.C. Tam and Wyn-Jones, when hydrophobically modified 
polymers are dissolved in water, there is evidence of both intra- and intermolecular 
associations of the hydrophobic groups. With the addition of sodium dodecyl sulphate (SDS) 
the CAC is reached and surfactant micelles are hydrophobically attached to pendant alkyl 
groups. As more SDS is added, alkyl chains cross-link via the micelles bound. Further 
addition of SDS results in the formation of dissociated polymer surfactant complexes. At 
high SDS concentration, in fact, the ratio of bound micelles to pendant chains increases 
causing the network breakdown (Fig. 1.10). 117 
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Fig.1.10: Structures occurring at different stages for hydrophobically modified-polymer-
surfactant aggregation. Rearranged from reference 108.110 
 
1.6.2.2 Charged Polymers 
Usually interactions between polymers and surfactants having similar charges are 
minimal, due to the electrostatic repulsion. 115 In the case of oppositely charged polymer-
surfactant systems, cooperative binding occurs above the CAC. 106 At very low surfactant 
concentration, the solutions are clear, since the polymer-surfactant complex is completely 
soluble. As further surfactant is added, the solution becomes turbid and cloudiness can be 
accompanied by phase separation or precipitation. This is due to the reaching of the charge 
neutralization point, when the concentration of charged surfactant molecules approaches the 
number of charged groups on the polymer chains. As the surfactant concentration is further 
increased, more surfactant molecules are bound to the polymer chains and the excess of 
charge on the complexes promotes solubilisation and the system turns into a single phase. 
Usually higher polymer concentrations promote phase separation or precipitation. 113,118 
Polymer/surfactant systems interaction models illustrated in this and previous 
sections are generally accepted. However, the relationship between the structure of 
surfactant and polymer and their interaction, as well as the interaction driving forces, are still 
argument of debate in literature. Moreover, multiple factors can impact the occurrence and 
the pattern of polymer/surfactant aggregation. The main factors impacting the association 
behaviour of polymer/surfactant systems are reviewed in the following sections. 
1.6.3 Factors influencing polymer-surfactant association 
As already mentioned in this Chapter, the interaction between polymers and 
surfactant is affected by different physical and chemical factors. 107 An overview of the 
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possible factors affecting the occurrence and the features of interactions between polymers 
and surfactants is given in this section. 
1.6.3.1 Polymer Hydrophobicity 
Polymer hydrophobicity influences both neutral and charged polymers-surfactant 
interactions. For example, for non-ionic polymers the interaction with a given anionic 
surfactant progresses according to the order polyvinyl alcohol (PVA) ≤ polyethylene oxide 
(PEO)< methylcellulose (MC) < polyvinyl acetate (PVAc) < polyvinyl pirrolidone (PVP), 
while for cationic surfactant the order is PVP<PEO<PVA<MC<PVAc. 119 In such systems 
the main driving forces for interactions between polymers and surfactants are the 
hydrophobic interaction. Consequently, the more hydrophobic is the polymer, the stronger is 
the association with the surfactant. In the case of ionic polymers, hydrophobic effect may be 
as important as electrostatic attraction. Therefore polymer hydrophobicity can influence the 
polymer/surfactant interactions. 
A rheological study carried out by Thuresson et al investigated the difference 
between ethyl-(hydroxyethyl) cellulose (EHEC) and the hydrophobically modified analogue 
(HM-EHEC) in the interaction with SDS. 120 Rheological results revealed polymer/surfactant 
interactions occurrence for both polymers. However, while HM-EHEC interacted with SDS 
at very low surfactant concentrations, the binding between EHEC and SDS occurred at much 
higher SDS concentrations.  
A series of papers by Anthony and Zana focused on the effect of polymer 
hydrophobicity on polyelectrolyte-oppositely charged surfactant systems. Their study 
showed that the main interaction between hydrophilic polymers and surfactant is 
characterised by electrostatic nature. However, if increasing polymer hydrophobicity by 
changing the number of carbons in the polymer alkyl group, hydrophobic forces contribution 
to the polymer-surfactant interactions became comparable to the electrostatic force one. 121 
The further increase of polymer hydrophobicity resulted in the formation of polyelectrolyte 
hydrophobic micro-domains. In this case the surfactant binding onto the polymer was not 
cooperative. The bound surfactant simply lead to the swelling of pre-existing micro-domains, 
but no formation of new hydrophobic micro-domains was obtained. In the case of weakly 
hydrophobic polyelectrolytes, the binding with the surfactant was still not cooperative, but 
new mixed micro-domains were formed. 122 
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1.6.3.2 Polymer Molecular Weight  
The interaction between polymer and surfactant is significantly influenced by 
polymer molecular weight. The study carried out by Mészáros et al. showed that the PEO-
SDS system behaviour can be divided in three molecular weight (MW) ranges. With MW 
below 1000 Dalton, no complex formation was observed, and the CAC corresponded to the 
CMC. For PEO with molecular weight from 1000 to 8000 Dalton, polymer and surfactant 
interactions occurred and the CAC decreased with increasing the polymer molecular weight. 
When the molecular weigh was higher than 8000 Dalton the interaction between polymer 
and surfactant was not dependent anymore on the polymer molecular weight, and the CAC 
was constant. 123 Thus, it can be argued that a minimum polymer molecular weight is 
possibly required for the polymer-surfactant complexation to occur. However such 
molecular weight dependence of the polymer-surfactant interactions may no longer 
applicable for polymers with extremely high MW values. 
1.6.3.3 Surfactant Charge 
As already described, neutral polymers usually interact more favourably with 
anionic surfactants than with cationic and uncharged surfactants. Nevertheless cationic and 
uncharged surfactants show interactions with hydrophobic polymers, but do not associate 
with hydrophilic polymers. The surfactant head-group charge can influence the interaction 
with the polymer. The study by Brackman and Engberts on the interaction between n-
dodecyldimethylamine oxide (DDAO) and a series of polymers, (poly(vinylmethylether) 
(PVME), poly(propylene oxide) (PPO), and poly(ethy1ene oxide) (PEO)) revealed an 
increase in the micelles stabilization by the polymer when the surfactant average charge was 
increased. This effect was likely due to the reduction of the electrostatic repulsion by the 
polymer association. 124 
The surfactant head-group charge distribution has also been shown to influence 
polymer-surfactant interactions. A study on the interaction between sodium alkyl sulfates 
(CnSO4)/sodium alkyl sulfonates (CnSO3) and PEO showed differences in the interaction of 
the two surfactant with the polymer, as sodium alkyl sulfonates were seen to interact more 
weakly than their sulfate analogs. Such difference was attributed to the different charge 
distribution in the surfactant head-groups. 125 
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1.6.3.4 Surfactant Chain Length 
In homologous series of surfactants the value of CMC decreases with increasing the 
number of carbons in the surfactant chain length. 113 Taylor et al. studied the effects of 
surfactant chain length on polymer-surfactant interaction. In their studies, the interactions of 
sodium poly(styrene sulfonate) (NaPPS) with a series of CnTABs were studied, where n is 
the number of carbons in the hydrocarbon chain. 126 The study showed that, as for CMC, the 
CAC values decrease when the number of carbon in the surfactant chain length increases. A 
similar study was carried out by Wallin and Linse. Their investigation on oppositely charged 
surfactant-polymer mixtures showed higher surfactant chain length results in a decrease of 
both CAC and CMC values, with CAC decreasing faster than CMC. 127 
1.6.3.5 Addition of salts 
The presence of salts in an ionic-surfactant solution causes the reduction of 
electrostatic repulsion between surfactant charged head groups. Such effect promotes the 
micellization and usually leads to decreases on CMC value. 110 Furthermore, the presence of 
salts in a polyelectrolyte solution can influence the polymer behaviour, since counterions can 
neutralise polymer charges. Thus, the addition of salt to a polymer-surfactant solution can 
have strong influence on the aggregation behaviour of the system. 126 
Goddard and Hannan studied the influence of salt addition in the interaction between 
cationic derivative of hydroxyethyl cellulose and a series of anionic surfactants, showing 
that the added salt does not influence significantly the formation of polymer-surfactant 
aggregates and their precipitation. Only when the added salt influences the solubility of one 
of the components involved in the interaction, an effect of the salt addition on the interaction 
occurrence can be observed.  Nevertheless, many surfactant–polymer systems may be 
influenced by salt addition to the solution, but opinions about the salt effect on CAC are 
divided in the literature. 113 
1.6.3.5 pH 
Polyelectrolytes are usually sensitive to pH, as their charge, and consequently their 
solubility and aggregation features, can change according to the solution pH. Thus, in the 
case of polyelectrolyte-surfactant systems, pH represents a crucial factor for the system 
behaviour and for the formation of polyelectrolyte-surfactant aggregates. 113 
The study of the system composed by chitosan, a cationic biopolymer, and SDS, 
showed pH variation effect on the chitosan-SDS interaction. At pH=3, chitosan was highly 
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soluble in aqueous solution, and isothermal titration calorimetry (ITC) measurements 
showed the occurrence of strongly SDS-chitosan interaction. At pH=7, chitosan was not 
soluble and most of its positive charges were neutralised, thus the electrostatic interaction 
with SDS was weaker and no evidence of strongly binding between SDS and chitosan was 
found. 128 
1.7 Characterisation of polymer-surfactant interactions  
This section reviews the experimental techniques that can be used for the 
characterisation of polymer-surfactant systems. These include surface tension measurements, 
nuclear magnetic resonance (NMR), rheology, conductivity measurements, light scattering 
techniques, fluorescence, isothermal titration calorimetry (ITC). Microscopy techniques can 
also be employed to characterise polymer/surfactant aggregates morphology.  
Surface tension measurement is one of the most commonly used technique for the 
study of polymer-surfactant systems, as it provides good indication of the intermolecular 
interactions occurring in the bulk phase. 113 For weakly interacting systems, a typical surface 
tension profile is shown in Figure 1.11. The point T1 corresponds to the onset of the 
interaction between the polymer and the surfactant (CAC).  At T2 the polymer is saturated 
with surfactant. T3 corresponds to the CMC and above this concentration the surfactant 
forms free micelles. 129 In the dilute region (<T1) the surface tension of the 
polymer/surfactant systems is below that of the surfactant solution, indicating higher surface 
activity of the polymer/surfactant systems compared to the surfactant alone. 99 
 
Fig. 1.11: Representation of surface tension profile for polymer-surfactant weakly interacting 
systems. 113 
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In the case of strongly interacting systems, surface tension profiles are more 
complex and cannot be described by the simple model illustrated in Figure 1.11. The 
different nature of the interaction between the polymer and the surfactant influences the 
surface tension profile and can result in the presence of sharp peaks instead of smooth 
transitions as shown in Figure 1.12.  
 
Fig. 1.12: Surface tension profile of the strongly interacting system C14 TAB/NaPSS system. 129 
 
Figure 1.12 represents the surface tension profile of the strongly interacting system 
tetradecyltrimethylammonium bromide (C14 TB) and sodium polystyrene sulfonate (NaPPS). 
In this case a tension peak (T3 in Figure 1.12.) is observable. The point T1 corresponds to the 
polymer-surfactant monomer saturation at the surface, points T2 to the formation of the 
polymer-micelle complex in the bulk, while the peak T3 represents the saturation of the 
polymer-micelle complex. Finally T4 corresponds to the CMC. Each of the critical transition 
points occurs at surfactant concentrations corresponding to a change in the system, and the 
surface tension profile depends on the relative stability of the polymer-micelle complex. 129 
NMR has been widely used for the study of physical chemistry of surfactants and 
polymer-surfactant systems. 130 NMR signal is sensitive to the chemical local environment, 
thus can be used as a probe for the formation of complexes and aggregates study. 131 
Chemical shift measurements provide information about the chemical environment changes 
and have been used to probe surfactant-polymer aggregations.  132,133 Another NMR 
technique widely employable for studying polymer surfactant interaction is NMR self-
diffusion measurements. The reported studies in literature have shown that self-diffusion 
NMR technique represents a powerful tool to investigate the influence of polymer addition 
on surfactant aggregates structure. 134 
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Light scattering techniques can provide useful information firstly about the 
polymer/surfactant interaction occurrence, secondly can be used to characterise the 
polymer/surfactant aggregates features, in particular aggregates size. As reported in literature, 
light scattering techniques have previously been used for the characterisation of 
polymer/surfactant systems, for both weakly and strongly interacting systems. 100,135,136 Light 
scattering techniques are highly sensitive and non-invasive methods. The occurrence of 
scattering by the sample is the indication of the formations of “scattering entities”. 
Furthermore light scattering is sensitive to changes in the conformation of scattering entities 
and can therefore provide information on the occurrence of possible interactions between the 
species present in solution. 136  
Small angle neutron scattering (SANS) has also been shown to be an effective 
approach to investigate the occurrence of polymer/surfactant interaction. 137–140 The first 
neutron studies on polymer/surfactant systems were performed by Cabane et al on 
polyethyloxide (PEO)/SDS systems. The use of SANS allowed the determination of size, 
shape and distribution of the surfactant aggregates within the polymer/surfactant system. 
141,142.  
Imaging techniques such as transmission electron microspcopy (TEM) and 
cryogenic transmission electron microscopy (cryo-TEM) are also routinely used 
characterization method for studying colloidal systems including polymer/surfactant 
aggregates. In cryo-TEM, the samples are vitrified and imaged in the frozen-hydrated state. 
Cryo-TEM represents an effective tool to determine size and shape of colloidal aggregates. 
143 Few studies have been reported in which the used of cryo-TEM technique was aimed to 
clarify the structure of polymer/surfactant aggregates. 144,145 Moreover cryo-TEM has been 
employed for the ex vivo characterization of intermediate phases of human intestinal fluids 
(HIFs) produced during lipid digestion. Cryo-TEM allowed the imaging of micellar and 
vescicles species present in HIF in different stages of lipolysis, highlighting the possible role 
of such colloidal species in lipid digestion and poorly water soluble drug soluble drug 
solubilisation in the GIT.146 Therefore Cryo-TEM technique represents a powerful tool for 
the investigation of intestinal and simulating intestinal colloidal phases.  
In this study surface tension and NMR technique were chosen as the primary 
methods to investigate the occurrence of polymer/NaTC interactions. Light and neutron 
scattering techniques were also used as principle methods to characterise the complexes 
obtained from the aggregations of bile salts and hydroxypropyl methylcellulose (HPMC) and 
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polyvinylpirroldone (PVP), two model polymers used as the matrix materials of the solid 
dispersion formulations. Cryogenic transmission electron microscopy (Cryo-TEM) was also 
used to visualise polymer/NaTC aggregates. The detailed technical information on each 
technique can be found in Chapter 2.  
 
1.8 Polymer-bile salts interaction during the dissolution of solid 
dispersions 
As described by the previous sections of this Chapter, polymer/bile salts systems 
have widely been investigated. This project focused on the study of the interactions of bile 
salts and the polymers used as solid dispersion matrices during the dissolution process of a 
solid dispersion formulation. In particular for two of the four polymeric carriers employed to 
prepare solid dispersion in this study, their possible interactions with bile salts was 
investigated. HPMC and PVP polymers were used as model polymeric carries to study the 
interaction of polymeric carriers with bio-relevant surfactant in simulated intestinal fluids. 
Such polymers were chosen because they are commonly employed in pharmaceutical 
products and in particular in solid dispersions preparation. 147–149 Chemical and physical 
features of HPMC and PVP can be found in Chapter 2 (sections 2.2.1.1 and 2.2.1.2). 
Interactions of HPMC with SDS, cetyltrimethylammonium bromide (C16TAB), 
sodium cholate (NaC), and NaTC were previously investigated. 150 HPMC can form 
polymer/surfactant complexes with the studied surfactants. Also for PVP different studies 
have been performed to determine its ability to interact with surfactants.  In particular 
PVP/SDS system represents one the most studied polymer surfactant systems, with many 
scientific contribution published about this system. 98,112,113,117,119,151,152 The significant impact 
of PVP on the SDS self-assembling pattern was shown in many of the cited studies, and can 
be considered an indication of the occurrence of PVP/SDS interaction.  
 
1.9 Principal aims of the project 
The use of solid dispersions for the delivery of poorly water-soluble drugs has been 
extensively studied, but marketed products using such formulation approach are still very 
limited. In literature, most research efforts were focused mainly on the improvement of solid 
dispersion physical stability and dissolution enhancement. Less attention has been paid to 
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the solid dispersion behaviour in human intestinal fluids and in particular to the possible 
interactions that may occur between the different components of the intestinal fluids and the 
components of the solid dispersion formulation. The main aim of this study was to 
investigate the behaviour of solid dispersions in simulated intestinal fluids, to enrich the 
molecular understanding of the physicochemical interpretation of the behaviour observed 
and to predict the possible significance of such behaviour in drug absorption in GIT. In 
order to mimick the intestinal environment Fed and Fasted state simulated intestinal fluids 
were used in this study. The project was composed of 4 main stages. 
1. Preparation and solid-state characterisation of spray dried solid dispersions by using 
different carriers and model drugs. Dissolution performance of obtained solid 
dispersion was assessed in different media and firstly correlated to the drug physical 
state in the formulation. This part of the project is described in Chapter 3. 
2. In order to correlate the dissolution behaviour of the spray dried solid dispersions to 
the behaviour of the polymeric carriers in the media employed, the possible 
aggregation of the polymeric carrier with model bile salts, sodium taurocholate 
(NaTC), was investigated. The interaction between the polymeric carrier and NaTC 
was studied by NMR and interfacial tension techniques. The obtained data are 
described in Chapter 4. 
3. Polymer-NaTC aggregates obtained in the different media were characterised by the 
use of light and neutron scattering and transmission electron microscopic techniques. 
The studies were carried out also in the presence of drug to investigate the possible 
encapsulation of the drug in polymer-surfactant aggregates and the possible role of 
such complexes in the drug solubilisation. This part of the project is described in 
Chapter 5. 
4. In the final stage of the project the possible impact of polymer-NaTC aggregates on 
the drug absorption in the intestinal tract was evaluated by using Caco-2 cells model. 
Both drug uptake and transport experiments were performed.  The biological part of 
the project is reported in Chapter 6. 
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Chapter 2. Materials and Methods 
2.1 Introduction 
The use of hydrophilic polymers has widely been researched as an approach to 
deliver poorly water-soluble drugs. The choice of the carrier and the preparation method are 
key factors to achieve a successful formulation. Thorough solid-state characterisation is 
essential for predicting the physical states of the drug in the formulation and the physical 
stability of the formulation. 153 
Spray drying technique is one of the commonly applied processing techniques for 
the production of solid dispersion formulations and is the chosen preparation method in this 
project. A wide range of characterisation techniques were used to characterize the spray 
dried solid dispersion formulations, as well as the raw materials used for their production 
and the corresponding polymer-drug physical mixtures. These include scanning electron 
microscopy (SEM), powder X-Ray diffraction (PXRD), differential scanning calorimetry 
(DSC), thermogravimetric analysis (TGA) and Fourier Transform Infrared-Attenuated Total 
Reflectance (ATR-FTIR). The in vitro dissolution behaviour of the obtained spray dried 
formulations and relative physical mixtures were studied under simulated Fed and Fasted 
state intestinal conditions. In order to further understand the mechanisms of the in vitro drug 
release behaviour of the spray dried solid dispersions, the molecular interactions of 
formulation ingredients and the components of the simulated intestinal fluids were 
investigated. Several techniques were employed to investigate the possible occurrence of 
interaction between the polymeric carriers used and the components of the simulating 
intestinal fluids. These include 1H and self-diffusion NMR spectroscopy, surface tension 
measurements, light and neutron scattering techniques and cryogenic electron transmission 
microscopy (cryo-TEM). 
In the last stage of the project, Caco-2 model cells were used to study the impact of 
the polymers used in the solid dispersion formulation and the components in the simulated 
intestinal fluids on the uptake and transport of the model drugs. The key focus of this chapter 
is to lay the therotical foundations of the methodologies used and the background 
information of the materials used in the project.   
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2.2 Materials 
2.2.1 Model drugs 
Slow drug dissolution is the limiting step for BSC class II drug clinical use. 
Therefore BSC class II drugs were chosen in this study with the aim to investigate the effect 
of the formation of solid dispersions on the drug solubilisation. Three different BSC class II 
drugs (poorly soluble and highly permeable) drugs with different log P values, piroxicam, 
fenofibrate and griseofulvin, were used in this study. Piroxicam has been selected for its low 
water solubility (Table 2.1) and its pH sensitivity, in order to investigate the effect on the 
different pH used in the simulated intestinal fluids on ionisable drugs. Chemical structures, 
chemical and physical properties of the model drugs are summarised in Table 2.1. Dose/ 
solubility ratio is referred to an intestinal medium volume of 250 ml (dimensionless).  
 
Table 2.1: Model drugs structure and properties 
 Piroxicam Fenofibrate Griseofulvin 
Structure 
 
 
 
Melting point 
(°C) 
198-200 154 80.2 27 220.4 152 
Water Solubility 
(mg/ml) at 25°C 
0.007 4 0.0001155 0.015 156 
Log P value 1.8 157 5.1158 1.77 159 
Dose (mg) 20 4 200 160 500 4 
Dose/solubility 
ratio (unitless) 
1.14161 8000 133.33 161 
pKa 1,86, 5,46 6 - - 
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2.2.2 Polymeric carriers 
2.2.1.1 Hydroxypropyl methylcellulose (HPMC) 
HPMC, also known as hypromellose, is one of the most used amorphous polymer in 
pharmaceutical formulation. It is a water-soluble cellulose derivative and it can be used as 
film-coating agent, tablet binder, thickening agent and controlled-release matrix. 162 
 
Fig.2.1: Hydroxypropyl methylcellulose chemical structure 162 
The application of HPMC as carrier in drug delivery systems (in most cases 
modified release formulations) is mainly due to its high swellability and the ability to form a 
viscous layer around the drug delivery device, when in contact with aqueous media. 163 The 
drug release mechanism is assumed to be drug diffusion through the hydrated layer for 
soluble drugs and hydrated layer erosion for poorly water-soluble drugs. 164 
In this project HPMC Methocel® K4M was used to prepare spray dried solid 
dispersions. According to the producer nomenclature, K is indicating the HPMC chemistry 
(R group is –OCH3), which is shown in Figure 2.1.  The number 4 identifies the viscosity of 
the polymer in milli-pascal*seconds (mPa*s), measured at 2 % concentration in water at 
20 °C. Physical properties of HPMC K4M are summarised in Table 2.2. 165  
2.2.1.2 Polyvinylpirrolidone (PVP) 
PVP is an amorphous synthetic polymer consisting of 1-vinyl-2-pyrrolidone groups 
(Fig. 2.3).  PVP is highly water soluble and is widely used in biomedical applications, 
personal care products as thickening agent and in formulations as binder in granulation and 
as coating agent. 166 PVP is characterised by high hygroscopicity, which is due to the 
presence of carbonyl group that can form hydrogen bonding with water. 167  
Chapter 2  
 
 42 
 
Fig.2.2: Chemical structure of N-vynilpyrrolidone monomer unit. 
 
The amorphous nature and the high water solubility make PVP a possible candidate 
as polymeric carrier in solid dispersions. In particular it has shown to have the ability to 
increase the apparent solubility of poorly water soluble APIs and to reduce their 
recrystallization tendency in the formulation during storage. 168  
There are different grades of PVP homopolymers which are classified according to 
their viscosity in 1% w/v of PVPs solution by K values via Fikentscher’s equation (Kibbe, 
2002).  A higher K value is related to a higher viscosity of the PVP solution. In this study 
PVP K 30 was used. Its key physical properties are reported in Table 2.2. 166  
 
2.2.1.3 Hydroxypropyl methylcellulose Acetate Succinate (HPMCAS) 
HPMCAS is the partially esterified derivative of HPMC (Fig. 2.3). It has been 
developed as enteric coating material, for both regular enteric coating and sustained release 
formulations. 169 More recently HPMCAS has been studied as possible carrier in solid 
dispersion formulations prepared via spray drying or hot melt extrusion, leading to a 
significant enhancement of the dissolution of poorly water-soluble drugs. 170 Furthermore, 
crystallization inhibition effect on amorphous drugs obtained using HPMCAS has been 
reported to be higher than the ones obtained by using cellulose derivative, suggesting 
HPMCAS being a good solid dispersion formulation carrier. 171 
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Fig.2.3: Chemical structure of HPMC-AS 
According to the substitution ratio of acetyl and succinoyl groups in the polymer, 
HPMCAS is classified in different grades that dissolve at different pH values.  In this study 
HPMCAS LF grade was used. This HPMCAS grade can be easily solubilised at pH values 
higher than 5, such as common buffers and simulated intestinal fluid used in this study (for 
fluids pH and composition refer to Chapter 3, section 3.2.1).  Physical properties of 
HPMCAS LF are shown in Table 2.2. 172 
 
2.2.1.4 Polyvinylpirrolidone-Vinyl Acetate (PVP-VA 64) 
PVP-VA is a copolymer of PVP produced by free-radical polymerization of 6 parts 
of n-vinylpyrrolidone and 4 parts of vinyl acetate, which yields a water-soluble copolymer 
having the structure showed on Figure 2.4. 166 
 
Fig. 2.4: Chemical structure of PVP-VA monomer unit 166 
Similar to the PVP homopolymer, PVP-VA 6:4 is mainly used as a binder in the 
granules and tablets production, as film forming agent for coating and as matrix material for 
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solid formulation. Due to the modification with vinyl acetate groups, PVP-VA is 
characterized by lower hygroscopicity. PVP-VA was chosen for this study to investigate the 
impact of the derivatization with vinyl acetate groups on the polymer behaviour in simulated 
intestinal media. The presence of the functional groups increases the hydrophobicity of the 
polymer, which can impact its interaction with the components of the dissolution media and 
consequently the drug solubilisation and release from the solid dispersion formulation. The 
commercial grade of PVP-VA used in this study is Kollidon® VA 64, where 64 indicates the 
mass ratio of the two monomers, N-vinylpyrrolidone and vinyl acetate. Key physical 
properties of the polymer are provided in Table 2.2. The sourcing of raw materials employed 
in this study is summarised in Table 2.3. 
 
Table2.2 Physical features of polymeric carriers 
 
 
 
                               
 
 
 
 
 
 
 
 
 
 
 
 
Polymeric Carrier Molecular Weight Viscosity , 1%, 20°C, 
mPa*s 
Tg  (°C) 
HPMC 86000 Mn 3000-5000 186 
PVP 44000-54000 Mw 5.5-8.5 168 
HPMC-AS 18000 Mw 3 120 
PVP-VA 15000-20000 Mn ≈2 106 
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Table 2.3:  Sources of materials employed in this study 
                                Material Source 
 
Drugs 
Piroxicam Gattefosse’ 
Griseofluvin Sigma Aldrich 
Fenofibrate Sigma Aldrich 
 
 
Carriers 
HPMC-KM4M Colorcon 
PVP-Kollidon 30 BASF 
HPMC-AS Shin-Etsu Chemical Co, Ltd 
PVP-VA BASF 
 
 
Chemicals for 
buffers 
preparation 
Sodium hydroxide  
 
Sigma Aldrich 
Sodium chloride 
Sodium dihydrogen 
phosphate dihydrate 
Glacial acetic acid 
 
 
Solvents 
Ethanol absolute  
Sigma Aldrich Methylene Chloride 
Methanol 
Acetonitrile HPLC grade Fisher Scientific 
Chemicals for 
simulating 
intestinal 
fluids 
preparation 
Sodium Taurocholate, 99% Prodotti chimici e alimentari SPA 
Lecithin, from egg yolk Acros Organics 
NMR and 
neutron 
experiments 
Deuterium oxide, 99% Apollo Scientific 
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2.3 Experimental methods 
2.3.1 Spray Drying 
Spray drying is the process that transforms a liquid feed into dried particles by 
spraying the feed into a heated drying gas (either being air or nitrogen). Schematic 
representation of the spray drying process is shown in Figure 2.5. The process involves three 
main steps. The first step is the atomization of the liquid feed by a nozzle atomizer. In the 
second step evaporation of solvent from the atomized droplets is achieved by their exposure 
to a drying gas in the drying chamber, under controlled temperature and airflow conditions. 
In the final step the resulting dried particles are separated from the drying gas in the cyclone 
and collected in a receiving vessel. The three phases and the operational parameters in which 
they are performed have significant impacts on the properties of the final product. 45 
 
Fig.2.5: Schematic representation of spray dryer 
The atomization is the most important step of the spray drying process. In order to 
break up the liquid bulk in individual droplets, energy is needed. Depending on the type of 
energy used to achieve atomization, atomizers can be classified in 4 different main 
categories: centrifugal, pressure, kinetic and sonic. 173 According to the mutual orientation of 
the drying air system and the atomizer, it is possible to have three different “air-droplet 
contact systems”: cocurrent dryers, counter-current dryers and mixed flow dryers (Fig 2.6).  
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In the cocurrent systems (most commonly used), the droplets are sprayed in the 
same direction as the heated air. In this kind of dryers the droplets meet the air at the highest 
temperature causing rapid surface evaporation and providing safe conditions for heat-
sensitive materials for the rapid exposure to the heat flow. In the counter-current dryers, the 
atomized droplets and the air pass through the dryer in the opposite direction, as the air is 
supplied from the bottom of the dryer. This system is not suitable for heat-sensitive materials 
as the droplets meet the air stream when it has already passed part of his path loosing part of 
its heat. Thus the wet droplets hit the coldest air, while the drying is finished at the highest 
temperature. In the mixed flow method, the nozzle is positioned at the bottom of the drying 
chamber, forcing the particles to move upwards when the air flow coming from the opposite 
direction overcomes the gravity of the particles. 174   
 
               Fig. 2.6 Typical product-air flow patterns in spray dryers 175 
 
In this study, spray drying technique was applied for the preparation of 
microparticles using a Buchi Mini-Spray dryer B-290 (BUCHI Corporation, New Castle, 
USA) equipped with dehumidifier B-296. The atomization of the feed is obtained using a 
pressure atomizer with nozzle diameter of 0.7mm. A cocurrent product-air flow was applied. 
Details about the experimental parameters are described in Chapter 3 (section 3.2.2). 
 
2.3.2 Scanning Electron Microscopy (SEM) 
SEM is one of the most commonly used electron microscopy technique for studying 
the morphology of the materials. It based on the use of a high energy electron beam that is 
scanned over the specimen surface. 176 The signal generation is a result of the interactions 
between the incident electron beam and the atoms in the sample, which are electronically 
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detected and amplified. The production of the electron beam can be obtained heating a 
metallic filament (normally tungsten) or using cold cathode emitters. Different signals from 
the specimen can be collected such as secondary electrons, backscattered electrons, light 
emission, specimen current, Auger electrons and X-Ray radiations. Each signal is collected 
by a proper detector and can provide different information about the specimen when fed to 
the monitor. The secondary electron signal normally allows the observation of the sample 
topography, while by the use of some of the other signals produced it is possible to obtain 
structural information about the specimen. 177 
SEM represents a powerful tool to image solid dispersions formulations and 
investigate their morphology. 178 In particular for spray dried microparticles it allows the 
study of the particles shape, size and heterogeneity and can also image the presence of drug 
crystals in the formulation. 35 
 
2.3.3 Powder X-Ray Diffraction (PXRD) 
PXRD is a powerful technique for the elucidation of crystals and molecular 
structures. PXRD is commonly applied to characterize pharmaceutical materials in order to 
study their crystal structure, which can be identified from the material diffraction pattern. 179 
The diffraction of X-Ray by a crystalline material is the result of the atom 
periodicity in the crystal lattice, thus every deformation of the crystal lattice, that affects the 
molecular arrangement of the investigated material, causes changes in the XRD pattern. The 
interaction between the incident X-Ray beam and the crystalline structure is defined by 
Bragg`s law                                                                       nλ = 2d sinθ                                                             Eq 2.1 
where λ is the wavelength of the incident X-Ray beam, n is the order of the diffracted beam, 
d is the interplanar distance between diffracting planes or atoms, and  θ is the incident angle 
of the X-Ray beam. The positions of the peaks in the diffraction pattern are defined by the 
interplanar spacing between the set of diffracting planes. The interplanar spacing changes 
are inversely proportional to the changes in sine θ, thus changing θ different d values are 
obtained. The interplanar distance changes affect the peaks position and intensity in the 
XRD pattern (plot of intensities versus the detector angle 2 θ), that is unique for each 
individual crystals. 180 
Normally, the transition from a crystalline to an amorphous solid form can be related 
to the loss of distinct P-XRD peaks in the pattern and the appearance of a “halo” pattern. P-
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XRD can be a useful tool for characterisation of amorphous and non-crystalline solids and 
particularly for the study of the formulation process effect on the raw drug crystallinity in 
the pharmaceutical field. 181 Powder X-Ray Diffraction measurements were performed using 
a Xtra X-Ray diffractometer (Thermo ARL, Thermo Scientific, Waltman, MA). Details 
about experimental parameters are described in Chapter 3 (Section 3.2.5)  
2.3.4 Differential Scanning Calorimetry (DSC) 
Conventional DSC is the most commonly used thermal analysis technique for the 
characterization of pharmaceutical materials. It provides both qualitative and quantitative 
information from energy and temperature associated to the thermal events the sample 
undergoes, when a cooling or heating signal is applied. There are two types of DSC 
instrument, power compensation and heat flux. In power compensation instruments two 
separated furnaces for the sample and the reference are used. The two furnaces are heated 
and the power supplied, to maintain a zero temperature difference between the two furnaces, 
is measured. For heat flux instruments sample and reference are placed in the same furnace 
on to different crucibles. In this case both crucibles are heated from the same source and the 
temperature difference between the sample and the reference is measured. 182 Power 
difference from the sample and reference furnaces can be obtained from the temperature 
difference using the following equation                                                                        𝑑𝑄 𝑑𝑡 = ∆𝑇 𝑅⁄⁄                                                        Eq. 2.2 
where Q is the heat, t is the time, ΔT is the measured temperature difference between the 
sample and the furnace and R is the thermal resistance of the heat path between the furnace 
and the pan. The heat capacity of a material Cp is the quantity of heat required to increase its 
temperature of 1 K                                                                           Cp = dQ/dT                                                          Eq.2.3 
Rearranging this equation with time, the heat flow dQ/dt can be expressed as a 
function of the heating rate as follows                                                                    𝑑𝑄 𝑑𝑡 = 𝐶𝑝  (𝑑𝑇 𝑑𝑡)⁄⁄                                                Eq. 2.4 
where dQ/dt is the  heat flow out of the sample, dT/dt is the heating rate and is Cp heat 
capacity of sample. 
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DSC allows the study of important thermal behaviour of pharmaceutical 
formulations, such as extent of drug crystallization, miscibility between the drug and the 
excipients and glass transition temperatures. 
In this study, thermal behaviour of spray dried solid dispersions and physical 
mixtures was analysed using a Q2000 DSC (TA Instrument, Newcastle, USA). Baseline 
calibration, cell constant calibration and temperature calibration were performed using a 
heating rate of 10 ºC/min. Calibrants used include sapphire disk for the baseline calibration, 
indium for the cell constant calibration, benzoic acid (mp=122.3), tin (mp=231.9) and n-
octadecane (mp=28.24), for the temperature calibration. 183 
 
2.3.5 Thermal Gravimetric Analysis (TGA) 
TGA is a thermal analysis method whereby sample mass change is measured as a 
function of temperature/time. It is often used to investigate chemical or physical processes 
that the sample undergoes upon heating or isotherm at certain temperature. 184 The most 
common use of TGA is studying the thermal degradation behaviour of material. TGA 
instrument includes a suitable analytical microbalance where the pan is attached and a 
furnace where the sample is heated in a controlled atmosphere, while its weight is constantly 
measured. 182 For solid dispersions, TGA is commonly used to quantify the residual solvent 
content of solid dispersions formulation after processing and to study their thermal stability. 
66  
In this study, TGA analysis was performed using a TGA 5000 (TA Instruments, 
Newcastle, USA). To identify water content as measured by weight loss due to sample 
dehydration, samples were heated from room temperature to 250 ºC at a heating rate of 
10 °C/minute.  
2.3.6 Attenuated total reflectance-Fourier transformed Infrared spectroscopy 
(ATR-FTIR) 
Fourier Transformed Infrared Spectroscopy (FTIR) is a spectroscopic technique 
based on the molecular absorption of an electromagnetic wave in the infrared region 
(wavelength between 750nm and 1mm). The electromagnetic wave can induce molecular 
bonds vibrations, such as stretching, bending and rocking motions, at specific frequencies 
for each functional group. Thus, the FTIR spectrum can provide information about 
functional groups and molecular bonds present in the sample. 185 
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It is possible to analyse powder or liquid samples directly using ATR-FTIR, without 
the preparation of KBr/sample disk, which is necessary in the conventional transmission 
mode. For ATR-FTIR experiments, the sample is placed on the high reflective index crystal 
and the incident infrared radiation is partially absorbed by the sample, at the frequencies 
values corresponding to the molecular vibration of the sample material, while the remaining 
light is reflected into a detector. 
FTIR spectroscopy is a powerful tool to investigate possible drug-polymer 
interactions in solid dispersions, 186 such as hydrogen bonding, 168 and possible physical state 
transformation of the drug (from crystalline to amorphous and vice versa). 187 
In this study, ATR-FTIR spectroscopy was performed using a Perkin Elmer 
Spectrum BX-FTIR (Whaltam, Massachussets, USA) spectrometer, equipped with with an 
attenuated total reflectance (ATR) accessory (SPECAC, Orpington, UK). 64 scans were 
collected for each sample, at a resolution value of 2cm-2. Experiments were performed in 
triplicate.  
2.3.8 Nuclear Magnetic Resonance (NMR) 
NMR is a phenomenon occurring when nuclei having a “spin” are immersed in a 
magnetic field. Spin is a fundamental property of nature, it comes in multiples of 1/2 and can 
be + or - (nuclear spin number). The interaction between the electromagnetic field and spin 
active nuclei can result in the absorption of a photon by the nuclei. The frequency, ν, of 
absorption depends on the nuclei gyromagnetic ratio, γ 
                                                                                                                                                                 𝑣 = 𝛾𝐵                                                         Eq.2.5 
where B is the magnetic field strength. Also, when placed in an external magnetic 
field, the spin vector aligns itself with the applied field, and the number of possible 
orientations is given by 2I+1, were I is the spin number. For a nucleus with I=1/2 the spin 
can have two possible orientations associated with two different energy levels. The oriented 
nuclei oscillate around the applied magnetic field B, at a frequency, called Larmor frequency. 
It is proportional to the two levels energy difference. If the frequency of the absorbed photon 
matches the Larmor frequency, the nuclei can undergo an energy transition between the two 
energy states. Irradiation at the Larmor frequency results in the generation of the NMR 
signal. The effective field applied to each nucleus depends on the types of nuclei and bonds 
present in the molecule. In each nucleus the electrons immersed in the magnetic field 
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generate an opposing small magnetic field that affects the effective field for the close nuclei, 
causing a shift of their resonance frequency, 188 process known as “chemical shift”. Thus, 
NMR technique allows the elucidation of molecules structures, as from the chemical shift it 
is possible to have information about the local chemical environment, providing the 
identification of functional groups and chemical bonds with other spectroscopic techniques 
such as IR. 
NMR spectroscopy has found wide applications in pharmaceutical and colloidal 
sciences, as it can be used as a probe of microstructure and dynamics of self-assembly 
systems. 131 In this study two different NMR techniques, 1H proton NMR and diffusion-
ordered spectroscopy (DOSY), were employed. Both experiments have been performed 
using a Bruker Ultrashield Plus 400 MHz Spectrometer (Bruker, BioSpin Corporation, The 
Woodlands, TX). The detailed experimental conditions are described in Chapter 5. 
2.3.7.1 1H proton NMR spectroscopy 
1H proton NMR spectroscopy is the most commonly used NMR technique. It is 
based on the study of 1H nuclei presents in the sample. Chemical shift of 1H can be applied 
to study molecular structure, phase transition, aggregation and many other chemical and 
physical processes. In this study 1H proton NMR was applied to study the aggregation of the 
polymeric carriers with a model intestinal surfactant.  
2.3.7.2 DOSY NMR spectroscopy 
Diffusion NMR is based on the measurement of molecules Brownian motions, 
which are driven by the molecules internal energy. When a homogenous gradient B0 of 
know magnitude is applied to the sample, the Larmor frequency ω0 provides a spatial label 
of the spin, with respect to the direction of the gradient. In normal diffusion experiments the 
gradient is oriented towards the z-axis. When a π/2 rf pulse is applied, the macroscopic 
magnetization rotates from the z-axis to the x-y plane. During the first time period τ, at a 
time t1, a gradient pulsed of duration δ and magnitude g is applied, causing a phase shift of 
each spin. The application of a second rf pulse π at the end of the first period causes the 
reversing of the phase angle. At a time t1+∆ a second pulsed gradient, having same duration 
and magnitude of the first one is applied. If the spins have undergone a translational motion, 
the degree of their dephasing is proportional to their displacement in the direction of the 
gradient (Fig. 2.7). 189                         
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Fig. 2.7: A schematic representation of pulse field gradient sequence and diffusion and flow 
measurements. 189 
 
The molecules displacement during the diffusion time ∆ leads to the NMR signal 
attenuation, which is described by: 
                                                  𝐼 = 𝐼0𝑒−𝐷𝛾2𝑔2𝛿2(Δ−𝛿 3⁄ −𝜏 2⁄ )                                          Eq.2.6 
where I is the observed intensity, I0 is the unattenuated signal intensity, D the diffusion 
coefficient, γ the gyromagnetic ratio, g the gradient strength, δ the length of the gradient, and 
∆ the diffusion time.  
The diffusion coefficient of a molecule D, can be related to the hydrodynamic radius 
of the molecule, as described by the Stokes-Einstein equation                                                              𝐷 = 𝐾𝐵𝑇 6𝜋𝜂𝑟𝑠⁄                                                     Eq.2.7 
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where KB is the Boltzmann constant, T is the temperature, η the viscosity of the medium and 
rs the hydrodynamic radius of the molecule. Any aggregation phenomena that can affect the 
molecules size can be tracked and studied using self-diffusion NMR, as any change in the 
size will affect the self-diffusion coefficient of the studies molecule. 
Self-diffusion NMR technique is well-established method for studying surfactant 
solutions, surfactant self-association equilibria, counterion binding, solubilisation, and 
hydration phenomena. As widely shown in literature self-diffusion NMR can be a useful tool 
to study the aggregation of polymers and surfactant, and for this aim it has been used in this 
study. 103 
 
2.3.9 Pendant Drop Measurements 
Pendant drop technique is used to measure surface/interfacial tension at air/liquid or 
liquid/liquid interfaces, which can be calculated from the size and shape of a sample drop 
hanging from the tip of a syringe. The drop shape can provide information about the drop 
fluid itself or about the surrounding medium. 
Due to surface tension, the liquid hanging from the tip of a capillary tube tends to 
take a spherical shape. In a gravitational field, the sphere is distorted into an elongated “tear 
drop” shape. The distortion degree increases with drop density and decreases as liquid 
surface or interfacial tension becomes greater. 190 
The shape of a fluid under equilibrium conditions can be described by the Young-
Laplace equation                                                    ∆𝑝 = 𝛾 � 1
𝑆𝑊
+ 1
𝑆𝑒
�                                                         Eq. 2.8 
where ∆p is the pressure difference across the fluid interface, Sw is the smallest diameter of 
the hanging drop and Se is the equatorial and bigger diameter of the pendant drop (Fig. 2.8) 
Once the pendant drop shape is analysed and gravity and liquid densities are known, surface 
tension can be accurately obtained by applying young-Laplace equation. 
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Figure 2.8. Schematic representation of pendant drop experiment. 191 
Pendant drop technique is commonly applied for the study of surfactants behavior, 
as surface tension can be a probe to investigate surfactants micellization and interaction with 
other species. 192 Sodium taurocholate interfacial tension was measured with and without the 
presence of HPMC and PVP, in MilliQ water, phosphate and acetate buffers. The 
experiments were carried out using FTA200 pulsating drop tensimeter (First Ten Angstroms, 
Portsmouth, VA, USA). The appropriate solution of protein or surfactant was placed in a 
glass cuvette. A Hamilton syringe, having a volume of 25 or 50 ml depending on the droplet 
size required, was fitted with a j-shaped needle. The air bubble was formed using the j-
needle and the interfacial tension was measured over 15 minutes. Further details about the 
sample preparation and experiments setting are discussed in Chapter 4.  
 
2.3.10 Scattering Techniques 
Scattering experiments represent a powerful and non-invasive method to determine 
the structure and organization of particles in a homogeneous medium. Suitable scattering 
samples include colloids, polymeric macromolecules and micellar aggregates, with sizes 
ranging from a few angstroms to micrometers. In a dilute system, light and neutron 
scattering techniques can be used to determine the shape and the arrangement of individual 
particles, while in a concentrated system, information about positional correlations and 
spatial arrangement of particles in the sample can be achieved. Furthermore the measure of 
the absolute scattered intensity yields information on the apparent molecular weight of the 
objects. 
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                    Figure 2.9. Schematic representation of the scattering experiment. 
In a typical scattering experiment, an incident beam of wavelength λ is directed on 
the sample, where the radiation is partially scattered and transmitted (Fig.2.9). The scattered 
intensity is measured as a function of the scattering angle θ between incident and scattered 
radii. An important physical parameter is the scattering vector q: defined as the difference 
between propagation vectors of incident and scattered light 
                                                                              q= ki-ks                                                                  Eq.2.9 
For elastic scattering, no change of frequency occurs between incident and scattered 
radiation and the magnitude of incident and scattered wavevector q is equal to |ki |= |ks| = 
2π/λ leading to 193  
                                                                    |q|=q=4π/λ sin (θ/2)                                                               Eq.2.10 
 
In this study two different scattering techniques, dynamic light scattering and 
Nanosight technique, were employed to study the size of polymeric carrier-NaTC aggregates. 
Neutron scattering experiments were carried out to investigate the local structure of the 
aggregates. 
2.3.10.1 Dynamic Light Scattering (DLS) 
In DLS experiments the intensity of the scattered light is studied as a function of 
time. Scattered light intensity is measured during a time period tn at defined intervals ∆t. 194 
Due to the particles “random” motions, scattered light intensity I(q,t) is an averaged value 
defined by Eq. 2.11.                     𝐼(𝑞) = lim𝑡𝑛→∞ 1/𝑡𝑛  ∫ 𝐼(𝑞, 𝑡) ∗ 𝑑𝑡 ≈ lim𝑛→∞ 1/𝑛∑ 𝑖(𝑞, 𝑗Δ𝑡)𝑛𝑗=1𝑡𝑡𝑛0          Eq.2.11 
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Scattered light fluctuations are measured as autocorrelation function C(q,td), that is 
given by Eq. 2.12,                                      𝐶(𝑞, 𝑡𝑑) = lim𝑛→∞∑ 𝐼(𝑞,𝑘Δ𝑡) ∗ 𝐼(𝑞, (𝑘 + 𝑗)∆𝑡)𝑛𝑘=0                                  Eq 2.12 
where td is the aggregates relaxation time, also called τ, that represents the time after which 
the aggregates are not in the scattering volume anymore, thus do not contribute to the 
autocorrelation function.  For τ→∞ I(q,t) and I(q, t+τ) are not correlated and C(q,t) is in this 
case independent from τ. In this condition the autocorrelation function decreases linearly 
from [I(q, o)]2 to [I(q)]2 . Thus the relationship between C(q,t) and its asintotic value [I(q)]2 can be defined by the Siegert equation                                               C(q,t)[𝐼(𝑞)]2 = 𝑔2(𝑞, 𝑡) = 𝐴(1 + 𝑏2|𝑔1𝑞, 𝑡|2)                                      Eq.2.13 
where g2(q, t)  is the time autocorrelation function and g1(t)  is the field autocorrelation 
function, A is the baseline obtained from the experiment and b is the coherence factor that 
depends from the experimental setup and the scattering geometry. 195 According to the 
spectral profile of the scattered light, g1(q, t) can be described by different mathematical 
functions, from which it is possible to estrapolate the distribution of studied structures decay 
rates. The decay rate is directly related to the aggregates diffusion coefficient Dt                                                                       𝐷𝑡 = 𝛾 𝑞2�                                                                 Eq.2.14                                          
where q2 is the scattering vector root square.   By applying the Stoke-Einstein equation (Eq. 
2.7) the aggregates hydrodynamic radius is obtained. 
In this study dynamic light scattering has been used to characterise the size of 
polymers-bile salts aggregates size distribution in different media. Fixed angle scattering 
experiments DLS experiments were performed on a Zetasizer Nano ZS, Malvern Instrument, 
(Malvern, Worcestershire, United Kingdom) fitted with a 633 nm red laser. The 
autocorrelation functions were measured at a fixed 173° angle (back scattering detection).   
2.3.10.2 Nanosight 
Nanosight technique, also known as Nanoparticle Tracking Analysis (NTA), is an 
innovative scattering technique that has been commercialized in 2004. It is based on light 
scattering properties and as for DLS a light beam is scattered by the sample suspension, by 
passing through a prism edged glass flat within the sample chamber. The laser emerging 
from the interface between the glass and the liquid sample, refracts to an intense low profile 
Chapter 2  
 
 58 
resulting in a compressed beam with a reduced profile and a high power density. The 
compressed beam is visualized via a long working distance, x20 magnification microscope 
objective is fitted to an otherwise conventional optical microscope onto which is mounted a 
high-sensitivity CMOS camera, operating at 30 frames per second (fps). The camera 
subsequently captures a video file of particles moving under Brownian motions (Fig.2.10). 
196 
 
                                 Fig.: 2.10 Schematic representation of NTA experiment 196 
 
NTA software records a video of the particles undergoing Brownian motions. Each 
particle is then tracked frame to frame and the distance that each particle move in the x-y 
space is used to calculate the particle diffusion coefficient according the the Stokes-Einstein 
equation                                                                       𝐷𝑡 = 𝑇𝐾𝐵3𝜋𝜂𝑑                                                          Eq.2.15 where KB is the Boltzmann constant, T is the temperature, η is the solvent viscosity and d is the distance moved by the particle. 
Differently from DLS, NTA sizes each particle individually, making the technique 
suitable for more diluited sample compared to DLS. Moreover, NTA can be employed for 
the measurement of particles concentration. The detection threshold is about 10-2000 nm, 
thus smaller than for DLS. Very small particles (lower than 10 nm) can be studies with NTA 
technique in case of very high refractive index. 
In this study a LM10 Nanosight (Nanosight Ltd- Malvern Instruments Ltd, Malvern 
Worcestershire, United Kingdom) has been used to visualize and size polymer, bile salts and 
bile salts-polymer aggregates. The instrument is fitted with a 638 nm laser. Particles tracking 
analysis was performed using NTA software.  
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2.3.10.3 Neutron scattering techniques 
Neutrons are neutral particles that show the ability to interact with nuclei. Neutron 
scattering by sample materials is normally weak, as the nuclear force acts only on short 
distance, but offers the advantage of radiation deep penetration in the sample, enabling the 
study of materials bulk properties. Samples scattering ability varies in a nonsystematic way 
with the atomic number, and interactions can be different for different isotopes, as in the 
case of the hydrogen and the deuterium. 197 
Neutrons can be generated from a nuclear reactor or a particle accelerator. In a 
nuclear reactor, fast neutrons (1-2MeV) are produced in a fission chain reaction, often from 
enriched uranium 235U. Emitted neutrons are scattered in the surrounding moderator where 
they lose energy until they reach an average thermal energy characteristic of the moderator 
temperature. A H2O moderator at 50°C corresponds to the most probable neutron 
wavelength around 1.4 Å. In an electron accelerator source, high-energy electrons interact 
with heavy elements, producing gamma radiations, which in turn interact with nuclei to 
generate neutrons. Finally, in a spallation neutron source, heavy particles such as protons are 
accelerated to very high energies and splinter neutrons from heavy nuclei with a high yield 
(around 30 neutrons per proton). The high energy of neutrons produced has to be reduced by 
a moderator in order to be suitable for scattering experiments. 198 
2.3.10.3.1 Small Angle Neutron Scattering (SANS) 
SANS is a key technique for the elucidation of large scale structures features. It is 
used to study the bulk properties of materials and it can be applied for the study of 
surfactants, colloids, polymers, liquid crystals and other nanomaterials.  199 In a typical 
SANS experiment, an incident neutron beam of wavelength λ and Intensity I0 is directed on 
the sample, where the radiation is partially scattered and transmitted (assuming no 
absorbance from the sample occurs). Generally the wavelength λ ranges 4÷20Å and the 
energy and velocity associated to the neutron beam are respectively about 0.025eV and 
2200m/s. 
 
Figure 2.11. Schematic representation of Small Angle Neutron Scattering equipment. 200 
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By collimation of the incoming beam, the incoming wave vector is fixed. This 
provides structural information in reciprocal space, as measuring the scattered intensity in a 
certain direction the wave vector of the outgoing scattered vector is known. 198 
In SANS experiments different length scales can be investigated in reciprocal space, 
by detecting the number of scattered nuclei as a function of the wave vector Q. The wave 
vector is inversely proportional to the distance d                                                                               𝑄 = 2𝜋 𝑑�                                                          Eq. 2.16 
and is also related to the scattering angle θ and the incident beam wavelength λ as shown in 
equation 2.17                                                                              𝑄 = 4𝜋𝑠𝑖𝑛𝜃 2⁄
𝜆
                                                        Eq.2.17 
Typically a SANS beam line has a two-dimensional area detector, between 2 and 20 
m after the sample. The size and position of the detector relative to the beam determine the 
range of Q at a given detector distance. SANS patterns are reported as the neutron beam 
intensity I(Q) as a function of the scattering wave Q. I(Q) provides information about sample 
size, shape and interactions between scattering centres. According to the samples features, in 
particular shape and monodispersity, different mathematical models can be applied to define 
I(Q) and obtain structural information about the scattering sample. The main parameters are 
the form factor P(Q) which provides intraparticles information (size and shape), and the 
structure factor S(Q) from which interparticle information (scattering particles interactions) 
are obtained (Fig. 2.12). 
Fig.2.12: Representation of P(Q) and (S(Q) for repulsive and attractive spheres and their 
contribution to Q. 200 
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In this study SANS experiments have been performed to investigate the local 
structure of polymer-surfactant aggregates. SANS measurements have been carried out at 
the ISIS SANS2-D spectrometer (ISIS-Rutherford Appleton Facilities-Didcot). Sample have 
been prepared and measured in D-buffer using 2mm cells. Each experiments has been run in 
duplicate. Data Mathematical modelling for analysed samples is reported in Chapter 5. 
2.3.10.3.2 Spin-Echo small Angle Neutron Scattering (SESANS) 
SESANS is a neutron scattering technique based on the use of a polarised neutron 
beam, to determine directly the wave vector transfer in real-space. One of the advantages of 
the use of SESANS is that the use of polarisation yields high resolution without much 
collimation of the beam, resulting in high accumulated beam intensity. 198 
 
 
Fig.2.13: Representation of SESANS equipment 200 
As shown in Figure 2.13, a neutron beam is polarised with the polarisation vector 
perpendicular to the plane. The polarised neutron beam enters in a magnetic region 
composed of two precession devices with tilted interfaces, having opposite magnetic fields. 
The precession devices rotate the neutron polarisation vector from parallel to perpendicular 
to the magnetic field or vice versa, thus starting or stopping, respectively, the Larmor 
precession in this magnetic field. A sample measured using this SANS set-up will break the 
symmetry of the Larmor precession, affecting the echo signal and consequently the neutron 
beam polarization. 201 
In SESANS experiments the neutron beam polarization is measured, yielding the 
correlation between the scattering length density integrated along the path of the neutron 
beam. SESANS technique can be used in a very large length scale, as it can be employed to 
probe structure between 20 nm to 20 µm. In this study, SESANS experiments were 
performed at the ISIS-SESANS spectrometer (ISIS-Rutherford Appleton Facilities-Didcot). 
The instrument is brand new and measured samples were the first set of aqueous samples 
tested with this equipment.  
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2.3.11 Cryogenic Electron Microscopy (Cryo-TEM) 
Cryo-TEM is the electron microscopy performed on thin vitrified aqueous films, 
kept at liquid nitrogen temperature. The technique allows the direct imagining of micellar 
structures in aqueous environments. These dynamic structures requires an aqueous 
environment to form and persist, and do not withstand the drying or the staining and the 
fixation steps of conventional EM, which might impact the structure size and shape. In 
Cryo-TEM method the solution is applied to a microscopy grid in such a way that a very thin 
aqueous film is formed, which then is plunged into a cooling medium, just above its freezing 
point, where the film very rapidly vitrifies, without crystallization. The grid with vitrified 
film is then transferred to the microscope, and examined at liquid nitrogen temperature in 
transmission mode (Fig 2.14). In this way sample images are captured in the vitrified film 
and are observed without dehydration. Normally vitrification happens extremely fast, thus 
no significant reorganization of the analyses structures takes place. 202 
              
Fig. 2.14: TEM micrographs of a holey polymer film, HPF, empty, and after application of 
sample, blotting, and vitrification. 202 
 
The smallest structures that can be resolved using Cryo-TEM are of about 4-5 nm in 
size. Ordinary surfactant micelles are thus seen only as dots, and it is difficult to claim 
anything about the size of an object unless it is clearly larger than 5 nm. However, in a few 
reports the bilayer membrane has been resolved, and its thickness measured. 203 There are 
also limitations on the upper size of an object, set by the thickness of the film. In practice it 
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is limited to about 500 nm; otherwise the scattering of electrons by water gets too large, and 
the cooling rate during vitrification too slow. 202 
Due to the impact of staining and drying steps on samples aggregation TEM was not 
a suitable technique for bile salts micelles and bile salts-polymer aggregates imaging, thus 
Cryo-TEM was used for this purpose. Cryo-TEM analysis has been performed in at the 
Department of Physical Chemistry, Uppsala University, Sweden. The preparation of the 
samples has been performed according to the routine procedure of the laboratory. 203 For 
sample preparation, a small droplet of the sample solution was placed under controlled 
conditions on a pretreated Cu grid of about 20μm thickness, which was covered by a 
perforated cellulose acetate butyrate film. Excess material was removed by a gentle wiping 
off with a filter paper. The specimen was vitrified by a rapid transfer into liquid ethane close 
to its freezing temperature. The sample examination was performed with a Zeiss 902 A 
electron microscope operating at 80 kV at 100K.  
 
2.3.11 In vitro Cellular Drug Absorption and Transport Assessments 
In vitro drug absorption and transport using cell models represent a useful tool to 
preliminarily evaluate cytoxicity and drug permeability across intestinal tissues at the early 
stage development of the new compound. The use of an efficient in vitro cell model can help 
to determine drug solubility at different intestinal conditions (before and after meals), its 
pre-absorptive degradation in the gastro-intestinal environment, the rate of absorption and 
the effective drug amount absorbed. Furthermore, in vitro studies based on cells models can 
give information about the physico-chemical features of the interaction between drug and 
tissues. 204 
Caco-2 cells derived from human colonic adenocarcinoma have been widely used as 
model cells for in vitro drug absorption prediction. Caco-2 cells are morphologically and 
functionally similar to enterocites, since they are able to form junctions and express many of 
the intestinal enzymes. In this project both absorption and transport experiments were 
performed using Caco-2 cell lines. Information about the cell seeding and growing 
procedures are discussed in Chapter 6. 
In absorption studies a monolayer of cells was seeded in the appropriate plate, and 
once confluent were treated with the studied samples. After treatment cells were lysed in 
order to extract and measure the absorbed amount of sample studied. For transport studies a 
Chapter 2  
 
 64 
monolayer of cells was placed in a diffusion apparatus where a lateral and an apical chamber 
are present (Fig.2.15). The two chambers represent the mucosal and serosal intestinal 
surfaces. The drug solution was added to one of the two chambers and the presence of drug 
is measured regularly in the receiving chamber. The small amount of drug required makes 
Caco2-cells transport experiments suitable to perform screening studies, to point out 
possible absorption problems of a potential new drug and the characterise drug release from 
new formulations.  205 The detailed methodologies of drug absorption and transport studies 
are described in Chapter 6.  
 
            
Fig.2.15: Representation of a cells monolayer in vitro experiment 206 
 
2.3.12 High Performance Liquid Chromatography (HPLC) 
HPLC is one of the most widely used technique for complex samples analysis, 
separation and purification. Physical separation of sample components is obtained by their 
partitioning between the mobile phase and the stationary phase, according to their relative 
solubilities or affinities towards the two phases. HPLC is almost universally applicable and 
offers a remarkable assay precision. Moreover, the use of HPLC allows high-quality 
separation achievement in the minimum of time, by passing a mobile liquid phase through a 
finely divided stationary phase under high pressure.  
According to the sample properties, the partitioning of its components between the 
mobile phase and the stationary phase can be based on different criteria. The most 
commonly used approach is the sample separation according to its components polarity: in 
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this case it is possible to work in “direct” phase, with the stationary phase having higher 
polarity than the mobile phase, or in “reverse” phase, with higher polarity in the mobile 
phase.   The mixture separation can be based also on the “ionic exchange” of the sample 
components with an ionic stationary phase (ionic exchange HPLC) or on their “exclusion” 
from the stationary phase interaction according to their steric volume (Steric Exclusion 
HPLC). 207  
HPLC analysis was used for two types of sample: (1) piroxicam steady state 
solubility samples studied in Fed and Fasted state. The simultaneous presence of different 
simulating intestinal fluids components, required their separation from the analyte in order to 
perform a reliable analyte assay. Consequently direct UV-VIS assay was not feasible for 
such samples; (2) piroxicam Caco-2 absorption and transport studies, which could not be 
studied using UV-Vis due to the presence of cell media and possible drug metabolites. 
Samples have been properly processed before being tested by HPLC. Details about sample 
preparation and HPLC analysis can be found in Chapter 6. 
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Chapter 3. Preparation and physical characterisation of spray dried 
solid dispersions 
3.1 Introduction 
The use of amorphous solid dispersion formulations has been shown to be an 
effective approach to increase the dissolution rate of poorly water soluble drugs 3,38,208 and 
potentially improve their oral bioavailability 24,209. As already described in Chapter 1, spray 
drying is one of the most commonly used solvent evaporation method to obtain amorphous 
solid dispersions. 210 In this study spray drying technique was used to prepare solid 
dispersion formulations. HPMC-K4M and PVP Kollidon 30 were used as main polymeric 
carriers. The hydrophobically modified derivatives of HPMC and PVP, HPMC-AS LF and 
PVP-VA, were used to investigate the effect of the polymer hydrophobic modification on 
the formulation behaviour. Three different poorly water-soluble drugs, piroxicam, 
griseofulvin and fenofibrate (all classified as BSC class II drugs which are poorly soluble 
and highly permeable), were applied as model drugs. Detailed description of the 
physicochemical properties of the carriers and model drugs are presented in Chapter 2, 
Section 2.2.1.   
The main focuses of this chapter are the optimisation of the solid dispersion 
preparation through spray drying technique and their physical characterisations concerning 
their solid-state properties and in vitro drug release performance. Solid-state 
characterisations of the spray dried solid dispersions were performed using DSC, TGA, 
SEM, PXRD and ATR-FTIR. Steady state solubility studies were carried out in order to 
investigate the impact of the presence of polymeric carriers on the apparent solubility of 
model drugs in different media. Comparison studies of the dissolution behaviour of spray 
dried solid dispersions and the corresponding physical mixes of crystalline drug and polymer 
were performed to evaluate the effect of the polymer and the spray drying processing on the 
dissolution enhancement of the model drugs. 
 
3.2 Experimental methods 
3.2.1 Preparation for solubility and dissolution studies media 
Two different simulating intestinal media were used in this study: fasted state 
simulating intestinal fluid (FaSSIF), mimicking the intestinal condition before meals, and 
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fed state simulating intestinal fluid (FeSSIF), to reproduce the intestinal environment after 
meals. The FeSSIF and FaSSIF media were prepared by following the method developed by 
Dressman et al. 211 The compositions of the fed and fasted state media are listed in Table 3.1. 
                                 
Table 3.1: FaSSIF and FeSSIF media features and composition 
 Fasted state (FaSSIF) Fed state (FeSSIF) 
Buffer Phosphate buffer Acetate buffer 
pH 6.5 5 
Buffer ionic strength 2.52 4.06 
Sodium Taurocholate 
concentration (mM) 
3 15 
Lecithin concentration 
(mM) 
0.75 3.75 
                                  
For the buffer preparation individual buffer components were accurately weighed 
and dissolved in MilliQ water. The final pH was checked using a calibrated pH meter, and, 
when necessary, adjusted by the addition of small quantities of HCl or NaOH 1M. Sodium 
taurocholate solutions were prepared by dissolving weighed amount of the surfactant in 
previously prepared buffers. Solutions obtained are referred as blank FaSSIF and blank 
FeSSIF in this study. FaSSIF was prepared by adding 11.8 mL of a solution containing 100 
mg /mL lecithin in methylene chloride, obtaining an emulsion. The methylene chloride was 
eliminated under vacuum at about 40°C for fifteen minutes at 250 mbar, followed by 15 
minutes at 100 mbar. This resulted in a clear, micellar solution, having no perceptible odour 
of methylene chloride. After cooling to room temperature, the volume was adjusted to 2 L 
with blank FaSSIF. The same procedure was used for FaSSIF preparation, but in this case 
59.08 mL of a solution containing 100mg/mL lecithin in methylene chloride were added to 
the blank FeSSIF.  
 
 3.2.2 Steady state solubility studies of model drug in dissolution media 
The impact of polymeric carriers on the apparent solubilities of model drugs was 
studied in different media. The media used in this part of study include buffer pH 5, buffer 
pH 6.5, blank FaSSIF, blank FeSSIF, FaSSIF and FeSSIF. Supersaturated solution of the 
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model drugs were prepared by dissolving excess amount of drug in the tested medium. The 
same sample was tested in the presence of HPMC, with concentrations from 2 to 9 mg/ml, 
and of PVP with concentrations from 1 to 19 mg/ml. Samples were left under constant 
magnetic agitation at 37 ºC for 72 hours to allow the dissolution with maximum drug 
concentration to reach equilibrium.  
After 72 hours, samples studied in the two buffers and in the two blank media, were 
filtered using a syringe filter with 0.45µm pore size and the drug concentration was assayed 
using a UV-VIS spectrometer (Perkin Elmer, Whaltam, Massachussets, USA). The 
wavelength of maximum absorbance (λmax) used was 334 nm for Piroxicam, 296 nm for 
Griseofulvin and 290 nm for Fenofibrate. 
For piroxicam samples steady state solubility studies were performed also in FaSSIF 
and FeSSIF, to investigate the impact of lecithin on the drug solubilisation. For the complex 
intestinal media containing lecithin, UV-VIS spectroscopy is not a suitable assay method, as 
the presence of lecithin caused UV-VIS absorbance in a wide range of wavelengths. 
Therefore the piroxicam samples in FaSSIF and FeSSIF were assayed using HPLC Perkin Elmer (Whaltam, Massachussets, USA). After 72 hours of mixing, the samples were 
centrifuged at 5000 rpm for 5 minutes. Approximately 1 ml of supernatant was transferred 
into HPCL chromacol ambered vials. HPLC analysis was performed using a reverse phase 
C18 column, 5 μm (pore size), with 250 x 4.6 mm dimensions (Phenomenex, Macclesfield, 
Cheshire, UK). For the analysis, the mobile phase consisted of acetonitrile (MeCN)-
phosphate buffer (40:60 v/v). Phosphate buffer was prepared by dissolving properly weighed 
buffer components in fresh MilliQ water and the pH was adjusted to pH 2.5 with phosphoric 
acid. An injection volume of 10 μL and a flow rate of 1.0 mL min-1 were used. UV-VIS scan 
of the drug in the mobile phase showed piroxicam maximum absorbance shifted to 316 nm 
in the MeCN/phosphate buffer system. For this reason λ value for UV detection during 
HPLC analysis was set at 316 nm. The retention time of piroxicam was measured as 
approximately 6.5 minutes in this study. Details of piroxicam HPLC calibration curve are 
shown in Appendix. All the samples have been prepared and analysed in triplicate (n=3). 
 
3.2.3 Preparation of physical mixtures 
Polymeric carriers (HPMC and PVP) and APIs physical mixtures (Piroxicam, 
Griseofulvin and Fenofibrate) physical mixtures were prepared by gently mixing raw 
(unprocessed) material powder using mortar and pestel for about 2 minutes. 
 
Chapter 3  
 
 69 
3.2.4 Preparation of drug loaded solid dispersion by spray drying  
HPMC PVP, HPMC-AS and PVP-VA were used as polymeric carriers. Three 
different model drugs, piroxicam, griseofulvin and fenofibrate were loaded into the 
polymeric dispersions via spray drying. The spray drying parameters were set as follows: 
inlet temperature 85 °C, aspirator setting 100%, pump setting 5% (4 ml/min -1). For the 
preparation of piroxicam solid dispersions with three different w/w polymer:drug  ratios (2:1, 
4:1, 9:1) were prepared. Piroxicam was dissolved in ethanol (1.5 mg/ml), while HPMC and 
PVP were dissolved in MilliQ water. The resulting polymer concentrations for the 3 
different drug:polymer ratios employed were: 3 mg/ml for the drug:polymer ratio 1:2, 6 
mg/ml for the drug:polymer ratio 1:4, 13.5 mg/ml for the drug polymer ratio 1:9. Drug and 
polymer solutions were mixed in the proportion 1:1(v/v) before the spray drying process. 
Griseofulvin and fenofibrate solid dispersion were prepared at the polymer:drug ratio 2:1. 
Solution preparation and concentration were the same used for piroxicam solid dispersions 
preparation. 
 
3.2.5 Assay of actual drug content in spray dried formulations  
The actual drug content of spray dried solid dispersions was determined using UV-
Vis spectrophotometer (Perkin Elmer Lambda 35, Whaltam, Massachussets, USA). About 1 
mg of sample was dissolved in 5 ml of ethanol and left under magnetic stirring for 1 hour in 
closed vials. Samples were then diluted up to 1/5 of initial concentration and filtered using a 
Ministar single use filter (0.40 μm; Sartorius AG, Goettingen, Germany). Drug content was 
calculated from the absorbance measured at the λmax of piroxicam, griseofulvin and 
fenofibrate at 334 nm, 296 nm and 290 nm, respectively. Experiments were repeated in 
triplicate (n=3). 
 
3.2.6 Scanning electron microscopy (SEM) 
In order to investigate the morphology of the spray dried microparticles, powder 
samples were attached to double-sided adhesive carbon pads mounted on aluminium stubs. 
Subsequently samples were coated with a thin layer of gold using a Polaron SC7640 Au 
sputter coater (Quorum Technologies, East Grinstead, United Kingdom) fitted with a rotary 
stage. Coating conditions were 2.1kV, 20mA, 30sec, average distance sample-target 50mm, 
coating thickness few nm. Coated samples were examined with a JSM 4900LV SEM (JEOL 
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Ltd, Tokyo, Japan), fitted with a tungsten filament. A 20 kV acceleration voltage and 10mm 
working distance were used. 
 
3.2.7 Powder X-Ray diffraction (PXRD) 
PXRD measurements were performed using a Xtra X-Ray diffractometer (Thermo 
ARL, Thermo Scientific, Waltman, MA). The X-Ray tube composed of Copper was 
operated under a voltage of 45kV and current of 40mA. The PXRD patterns were recorded 
from 3° to 60° 2θ at a step of 0.01°/min. 
 
3.2.8 Differential scanning calorimetry (DSC) 
Thermal behaviour of raw materials, spray dried solid dispersions and physical 
mixtures was analysed using a Q2000 DSC (TA Instrument, Newcastle, USA). Samples (n 
= 3) were accurately weighed (2 to 3 mg) into standard aluminium crimped pans (TA), 
and scanned between -20 ˚C and 250 ºC with a heating rate of 10 ºC/min. 
 
3.2.9 Attenuated total reflectance-Fourier transformed infrared spectroscopy 
(ATR-FTIR) 
Raw materials, physical mixtures and solid dispersions formulations were analysed 
using ATR-FTIR spectroscopy, in order to investigate the occurrence of possible carrier-
drug interactions. ATR-FTIR spectroscopic studies were performed using a Perkin Elmer 
Spectrum BXTR-IR (Whaltam, Massachussets, USA) equipped with attenuated reflectance 
(ATR) accessory (SPECAC, Orpington, UK). Spectra were collected in absorbance mode 
and 64 scans were collected for each sample, at a resolution value of 2 cm-2. All experiments 
were performed in triplicate (n=3). 
 
3.2.10 Thermal gravimetrical analysis (TGA) 
Spray dried samples were analysed using TGA to quantify the residual solvent 
(including organic solvent and moisture) content in the formulations after the spray drying 
process. All TGA measurements were performed using a TGA 5000 (TA Instruments, 
Newcastle, USA) heating from room temperature to 250 ºC at a heating rate of 10oC/minute. 
All experiments were performed in triplicate (n=3). 
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3.2.11 In vitro dissolution studies 
In vitro dissolution studies of the crystalline drugs alone, physical mixtures of 
crystalline drug and polymers, and spray dried solid dispersion formulations were performed 
using a BP paddle method (D8000, Copley Scientific Ltd., Nottingham, UK). Before 
performing the dissolution study, all the samples were sieved using a 63µm sieve, to 
control the particle size.  All tests were performed in 500 ml of medium at 37.0 ± 0.5 ˚C, 
with a rotation speed of 50 ± 1 rpm. Four different media were used for dissolution 
studies, buffer pH5, buffer pH 6.5, blank FaSSIF and blank FeSSIF. At predetermined 
sampling points, 5 ml sample was collected from each vessel using a syringe, filtered 
through a 0.45 μm membrane filter and replaced with an equivalent volume of fresh 
medium. Measurements of drug release were made using a UV-VIS spectrophotometer 
(Perkin-Elmer Lambda 35, USA). The wavelength of maximum absorbance (λmax) used 
was 314 nm for piroxicam, 296 nm for griseofulvin and 290 nm for fenofibrate. The 
dissolution studies were conducted in triplicate and the average drug release was 
calculated.  
 
3.3 Results and discussion 
3.3.1 The effect of polymer on the apparent solubilities of the model drugs  
The aqueous solubility of a drug is one of the determinants of its dissolution rate and 
the intestinal absorption of compounds with aqueous solubility values lower than 0.1 mg/ml, 
is limited by their poor solubility in aqueous environments 212. In order to investigate the 
impact of the polymeric carriers employed on the model drugs apparent water solubility, the 
equilibrium solubility of crystalline model drugs was studied in the different intestinal 
simulating fluids employed. 
3.3.1.1 Piroxicam 
Table 3.2 shows the apparent solubility values of piroxicam (PXM) in different 
media obtained from the steady state solubility studies performed with and without the 
presence of HPMC. 
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Table 3.2: Piroxicam apparent solubility values in different media, with and without the 
presence of HPMC (2, 4 and 9 mg/ml) (n=3) 
Medium Piroxicam apparent solubility values (µg/ml) 
PXM HPMC:PXM 
2:1  
(HPMC 2mg/ml) 
HPMC:PXM 
4:1  
(HPMC 4mg/ml) 
HPMC:PXM 
9:1  
(HPMC 9mg/ml) 
Buffer pH 
6.5 
 
34.1±0.2 
 
186.2±6.2 
 
284.4±62.1 
 
188.2±3.1 
Buffer pH 5  
14.5±0.1 
 
55.3±2.8 
 
54.9±8.1 
 
55.4±4.2 
Blank 
FaSSIF 
 
41.6±3.6 
 
208.8±1.2 
 
203.5±49.2 
 
196.1±8.2 
Blank 
FeSSIF 
 
58.3±8.1 
 
70.8±7.3 
 
77.5±2.3 
 
76.9±2.1 
FaSSIF 206.6±19.1 211.9±31.2 226.6±10.2 258.2±1.9 
FeSSIF 34.9±3.5 45.2±1.8 45.1±16.2 129.3±2.2 
 
As shown by apparent solubility values reported in Table 3.2, piroxicam was more 
soluble at pH 6.5 than at pH 5. This is in agreement with the drug Pka1 and Pka2 values, 
which are 1.86 and respectively 5.46. Bile salts, lecithin and HPMC all show effect on 
increasing the apparent solubility of the model drug. The graph in Figure 3.1 shows how the 
presence of NaTC in the Blank FaSSIF and Blank FeSSIF media causes only a slight in 
increase of the drug solubility in blank FaSSIF, and a more significant increase in blank 
FeSSIF in which piroxicam solubility was 4 times higher than in buffer pH 5. As shown by 
Table 3.1 NaTC concentration in blank FeSSIF is five times higher than in blank FaSSIF. It 
is likely that the presence of bile salt reduces the fluid surface tension, impacting the drug 
powder aggregates wetting and consequently increasing the surface area available for drug 
solubilisation. Furthermore, as reported in literature, bile salts can increase drug solubility 
through direct solubilisation effect by the bile salts micelles. 96 Lecithin also showed to have 
an impact on piroxicam solubilisation, particularly in FaSSIF where drug solubility value 
increased from 41.6±3.6µg/ml (in blank FaSSIF) to 206.6±19.1µg/ml (FaSSIF). Lecithin-
bile salts complexes have been extensively studied and the formation of bile-salts/lecithin 
mixed micelles is widely discussed in literature. 213–215 Bile salts/lecithin aggregates physical 
features are discussed in Chapter 5.  Their effect on enhancing the apparent solubility of 
poorly water-soluble drugs has been extensively described. 216–218 The data obtained in this 
study showed an increase of the FaSSIF and FeSSIF media piroxicam solubilisation ability, 
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compared to blank FaSSIF and blank FeSSIF, as a possible consequence of the lecithin-bile 
salts aggregates solubilisation capacity.   
HPMC effect on drug solubilisation can clearly be observed from data reported in 
Table 3.2 and their plot in Graph 3.1. Compared to the solubility of the drug alone, the 
apparent solubility of piroxicam increased in the presence of HPMC, indicating the 
solubilisation effect of the carrier on the drug. HPMC is known to have self-assembling 
properties and to decrease surface tension as a consequence of its aggregation. 219 Therefore, 
increased piroxicam solubility in the presence of HPMC may be related to HPMC 
microenvironment surfactant properties, as already described by Mitchell. 220 The 
solubilisation effect of HPMC on piroxicam did not increase significantly with increasing 
HPMC concentration, suggesting that a “saturation” of the HPMC solubilisation effect on 
the drug may have reached at the low HPMC concentration used in this study.  
 
 
Fig. 3.1: Phase solubility diagrams of piroxicam at different HPMC concentrations in buffer 
pH5, buffer pH 6.5, blank FaSSIS, blanf FeSSIf, FeSSIF and FaSSIF at 37 ˚C  (n=3) 
 
The same drug solubilisation determinations were performed in the presence of PVP. 
Obtained results, summarised in Table 3.3 and shown in Figure 3.2, confirmed that the 
solubilisation effect of piroxicam increases with increasing PVP concentration. Similar to 
the HPMC:piroxicam systems, this solubilisation effect is most significant when FaSSIF was 
used as the media. Obtained results indicate a significant influence of the presence of both 
polymeric carrier and bile salts on the drug solubilisation. This effect and its possible impact 
on  drug uptake will be discussed in details in the following Chapters of the Thesis. 
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Table 3.3: Piroxicam apparent solubility values in different media, with and without the 
presence of PVP (1, 2, 4, 9 and 19 mg/ml) (n=3) 
Medium Piroxicam apparent solubility values (µg/ml) 
PXM PVP:PXM 
1:1 (PVP 
1 mg/ml) 
PVP:PXM 
2:1 (PVP 
2mg/ml) 
PVP:PXM 
4:1 (PVP 4 
mg/ml) 
PVP:PXM 
9:1 (PVP 9 
mg/ml) 
PVP:PXM 
19:1 (PVP 
19 mg/ml) 
Buffer 
pH 6.5 
 
34.1±0.2 
 
205.9±4.9 
 
0.203±8.3 
 
282.6±83.2 
 
263.1±62.5 
 
319.2±36.7 
Buffer 
pH 5 
 
14.9±1.2 
 
22.5±1.3 
 
19.8±3.2 
 
46.9±3.7 
 
54.8±11.5 
 
68.9±40.1 
Blank 
FaSSIF 
 
41.9±3.5 
 
205.7±20.4 
 
201.1±5.2 
 
344.5±3.2 
 
332.5±4.2 
 
324.7±24.1 
Blank 
FeSSIF 
 
58.4±8.8 
 
52.6±1.2 
 
60.5±1.5 
 
77.3±2.5 
 
76.9±2.1 
 
130.8±12.5 
FaSSIF 206.8±19.2 232.4±29.6 233.5±26.1 312.4±20.8 393.3±32.5 597.1±3.6 
FeSSIF 34.9±3.5 39.8±1.5 38.4±1.8 40.3±1.9 55.6±1.7 56.8±4.3 
 
 
Fig. 3.2: Phase solubility diagrams of piroxicam at different PVP concentrations in buffer pH5, 
buffer pH 6.5, blank FaSSIS, blank FeSSIf, FeSSIF and FaSSIF at 37 ˚C (n=3) 
 
PVP showed stronger impact on piroxicam solubilisation than HPMC. This effect 
can be related to the different physicochemical behaviour of the polymers in aqueous media, 
and possibly different interactions with the components of dissolution media used. Further 
investigation was performed to clarify the different HPMC and PVP solubilisation capability 
and the results are discussed in Chapters 4 and 5. 
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3.3.2.2 Fenofibrate 
Fenofibrate is practically insoluble in water and, having no ionizable function 
groups in the molecular structure, its solubility is not affected by the medium pH. As shown 
in Table 3.4 the solubility values of fenofibrate in the two buffers are extremely low, and the 
data obtained are in good agreement with literature data reporting fenofibrate solubility in 
pure water. 221 This confirms that the pH has no impact on the drug solubilisation, and the 
difference in osmolality between acetate (pH 5) and phosphate (pH 6.5) buffers seemed to 
have a negligible effect on fenofibrate solubilisation. The presence of NaTC caused the drug 
solubility to increase of 10 folds in blank FaSSIF and of 8 folds in FeSSIF. This significant 
solubility enhancement may be attributed to the micellar solubilisation in the media, 
particularly for FeSSIF where, due to the higher NaTC concentration, a higher number of 
micelles is expected. As a consequence of this, the drug solubilisation is more significant in 
blank FeSSIF compared to blank FaSSIF.  
Table 3.4:Fenofibrate apparent solubility values in different media, with and without the 
presence of HPMC (2, 4 and 9 mg/ml) (n=3) 
Medium Fenofibrate apparent solubility values (µg/ml) 
Fenofibrate HPMC:Fenofibrate 
2:1  
(HPMC 2 mg/ml) 
HPMC:Fenofibrate 
4:1  
(HPMC 4 mg/ml) 
HPMC:Fenofibrate 
9:1  
(HPMC 9 mg/ml) 
Buffer 
pH 6.5 
 
0.4±0.3 
 
7.8±4 
 
6.6±1.4 
 
11.5±2.3 
Buffer 
pH 5 
 
0.9±0.5 
 
6.7±1.3 
 
13.5±1.6 
 
12.2±1.2 
Blank 
FaSSIF 
 
4.7.±0.5 
 
14.8±1.6 
 
8.5±1.6 
 
20.3±4.5 
Blank 
FeSSIF  
 
7.2±0.9 
 
13.2±5.4 
 
16.9±2.3 
 
38.4±6.7 
 
In Figure 3.3 fenofibrate solubility values in the different media are shown as a 
function of HPMC concentration.  As for piroxicam, the impact of HPMC on the drug 
solubilisation is extremely significant in all the media used, leading to a solubility increase 
of almost 30 folds in the two buffers and of about 5 times in the blank FaSSIF and blank 
FeSSIF media (compared to the crystalline drug). As in the absence of HPMC, the highest 
solubility value was obtained in the Blank FeSSIF medium, confirming the primary role of 
the NaTC micelles in the drug solubilisation. The solubility value of fenofibrate increased 
from 7.2 µg/ml to up to 38.4 µg/ml increasing the polymer weight ratio. This result suggests 
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a possible formation of new solubilising aggregates in solution, which are likely to be a 
result of NaTC-polymer aggregation. As already mentioned, NaTC-polymers aggregation 
has been studied and characterised and are discussed in Chapters 4 and 5. 
  
 
Fig. 3.3: Phase solubility diagrams of fenofibrate at different HPMC concentrations in buffer 
pH5, buffer pH 6.5, blank FaSSIS and blank FeSSIF at 37 ˚C (n=3) 
 
Fenofibrate apparent solubility has been studied also in the presence of PVP and 
obtained results are summarised in Table 3.5 and Figure 3.4. As showed in Table 3.5 also for 
PVP-fenofibrate systems the presence of polymer caused an increase of the drug solubility. 
Compared to HPMC the impact of polymer on the drug solubilisation seems to be lower, 
differently from what obtained for piroxicam. The different results obtained with piroxicam 
and fenofibrate might firstly be a consequence of the different intrinsic solubility of the two 
drugs, but they also suggest a possible difference in the polymer solubility enhancement 
mechanism for the two drugs. This might be due to different intermolecular interaction of 
piroxicam and fenofibrate with the two carriers, which will be discussed in section 3.3.7 of 
this Chapter. 
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Table 3.5: Fenofibrate apparent solubility values in different media, with and without the 
presence of PVP (2, 4 and 9 mg/ml) (n=3) 
Medium Fenofibrate apparent solubility values (µg/ml) 
Fenofibrate PVP:Fenofibrate 
2:1  
(PVP 2mg/ml) 
PVP:Fenofibrate 
4:1  
(PVP 4 mg/ml) 
   PVP:Fenofibrate  
               9:1  
(PVP 9 mg/ml) 
Buffer 
pH 6.5 
 
0.4±0.3 
 
5.9±2.8 
 
6.6±1.4 
 
5.8±1.7 
Buffer 
pH 5 
 
0. 9±0. 5 
 
6.2±0. 5 
 
13.9±1.6 
 
9.0±0.2 
Blank 
FaSSIF 
 
4.7±0.5 
 
6.0±1.2 
 
7.0±2.1 
 
7.1±1.3 
Blank 
FeSSIF 
 
7.2±0. 9 
 
17.0±5.4 
 
14.4±1.4 
 
14.9±2.4 
        
 
Fig. 3.4: Phase solubility diagrams of fenofibrate at different PVP concentrations in buffer pH 5, 
buffer pH 6.5, blank FaSSIS and blank FeSSIF at 37 ˚C (n=3) 
 
3.3.2.3 Griseofulvin 
Apparent solubility values obtained for Griseofulvin in the different media, with and 
without the presence of HPMC, are summarized in Table 3.6. As for fenofibrate, 
griseofulvin does not have ionizable groups, thus pH was not expected to impact its 
solubility. Indeed solubility values obtained at pH 5 and pH 6.5 were very close and slightly 
higher than literature data obtained in pure water. 222 Differently from piroxicam and 
fenofibrate, comparing the results obtained in buffer at pH 6.5 and in blank FaSSIF, 
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griseofulvin solubility values did not change significantly with the presence of NaTC in 
blank FaSSIF. In blank FeSSIF griseofulvin solubility was two folds higher than in buffer at 
pH 5. This confirmed the primary role of NaTC micelles in the drug solubilisation in blank 
FeSSIF where, as already discussed, high number of micelles is present compared to blank 
FaSSIF. 
Table 3.6: Griseofulvin apparent solubility values in different media, with and without the 
presence of HPMC (2, 4 and 9 mg/ml) (n=3) 
Medium Griseofulvin apparent solubility values (µg/ml) 
Griseofulvin HPMC:Griseofulvin 
2:1 
(HPMC 2mg/ml) 
HPMC:Griseofulvin 
4:1  
(HPMC 4 mg/ml) 
HPMC:Griseofulvin 
9:1  
(HPMC 9 mg/ml) 
Buffer pH 6.5 115.6±18.9 105.0±1.0 105.8±1.2 95.0±8.1 
Buffer pH 5 106.8±9.7 83.9±1.8 130.2±22.5 128.3±12.6 
Blank FaSSIF 0116.4±16.2 129.9 ±16.4 184.9±3.4 202.3±1.5 
Blank FeSSIF 205.2±28.2 316.5±3.0 305.2±60. 311.7±9.7 
 
Figure 3.5 shows the impact of HPMC on griseofulvin solubilisation. No significant 
effect was obtained in the two buffers and in blank FaSSIF at the lowest HPMC 
concentration (2mg/ml). HPMC concentration increase yielded a slight increase of the drug 
solubility, particularly for blank FaSSIF media, where a drug solubility of 202.3±1.5 µg/ml is 
obtained at the highest HPMC concentration (9 mg/ml) employed.  Results obtained in blank 
FeSSIF show a different trend compared to the other media used. Indeed griseofulvin 
solubility increased to 316.5±3.0 µg/ml in the presence of the carrier (HPMC 
concentration=2mg/ml), but did not further increase when more polymer was present. 
Similar to the piroxicam data, this result suggests a possible “saturation” of HPMC 
solubilisation effect. 
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Fig. 3.5: Phase solubility diagrams of griseofulvin at different HPMC concentrations in buffer 
pH 5, buffer pH 6.5, blank FaSSIS and blank FeSSIF at 37 ˚C (n=3) 
 
As for piroxicam and fenofibrate, griseofulvin solubility studies have been 
performed also in the presence of PVP. Table 3.7 shows griseofulvin solubility values 
obtained in the presence of PVP, in the 4 different media used for the study. 
 
Table 3.7: Griseofulvin apparent solubility values in different media, with and without the 
presence of PVP (2, 4 and 9 mg/ml) (n=3) 
Medium Griseofulvin apparent solubility values (µg /ml) 
Griseofulvin PVP:Griseofulvin 
2:1  
(PVP 2mg/ml) 
PVP:Griseofulvin 
4:1  
(PVP 4 mg/ml) 
   PVP:Griseofulvin  
               9:1  
(PVP 9 mg/ml) 
Buffer 
pH 6.5 111.6±012.3 105.0±01.0 105.8±1.2 95.0±8.1 
Buffer 
pH 5 105.0±1.1 102.8±8.9 103.2±3.7 197.0±4.9 
Blank 
FaSSIF 105.8±12.3 105.6±1.5 158.9±15.9 197.7±17.3 
Blank 
FeSSIF 95.0±8.1 97.5±10.6 149.3±5.6 201.2±1.6 
 
As shown in Figure 3.6 PVP effect on griseofulvin solubilisation resulted to be 
different from HPMC one. No drug solubilisation increase was obtained in the presence of 
PVP (2mg/ml) in the two buffers and in Blank FeSSIF. Griseofulvin solubilisation 
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significantly increased increasing PVP concentration in blank FaSSIF, showing a maximum 
drug solubility value of 201.2±1.6 µg/ml in blank FeSSIF. 
 
Fig. 3.6: Phase solubility diagrams of griseofulvin at different HPMC concentrations in buffer 
pH5, buffer pH 6.5, blank FaSSIS, blanf FeSSIF, FeSSIF and FaSSIF at 37 ˚C (n=3) 
 
 
3.3.3 Spray dried solid dispersion preparation  
The yields of the spray drying processes performed to obtain solid dispersion 
formulation are summarised in Table 3.8. Yields values have been calculated as a percentage 
of the raw materials weight used. Spray drying pf unprocessed piroxicam without the 
presence of polymeric carriers was also attempted, but was not successful.§ 
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Table 3.8: Summary of yield and outlet temperature values obtained during spray drying 
process for the different samples 
Spray dried sample Outlet T(°C) Yield(%) Number of 
replicates 
HPMC 50±1 26.1±1.2 3 
HPMC:Piroxicam 2:1 53.7±4 23.4±5.9 3 
HPMC:Piroxicam 4:1 52±3 11.8±4.9 3 
HPMC:Piroxicam 9:1 51.7±2.1 19.34±4.27 3 
PVP 52±2 13.50±7.02 3 
PVP:Piroxicam 2:1 53.7±4 13.47±6.01 3 
PVP:Piroxicam 4:1 53.67±1.52 15.66±5.05 3 
PVP:Piroxicam 9:1 51.67±2.51 20.26±6.52 3 
PVP-VA 50 7.7 1 
PVP-VA:Piroxicam 2:1 48 10 1 
HPMC-AS 53 <1 1 
HPMC-AS:Piroxicam 2:1 46 2 1 
HPMC:Fenofibrate 2:1 48±1 6.8±0.7 2 
HPMC:Griseofulvin 2:1 48.5±1.5 12.7±1.83 2 
PVP:Fenofibrate 2:1 49.5±2.12 13.83±8.71 2 
PVP:Griseofulvin 2:1 51.15±2.12 20.85±1.2 2 
 
As clearly shown by the table, yield values have been low for all the samples. This 
is a consequence of the low solid concentration used. The practically feasible solid 
concentration was limited by the poor solubility of the model drugs in the EtOH:H2O 
mixture, thus, it was not possible to increase the solid concentration without causing the 
occurrence of drug precipitation. In particular for HPMC-AS and PVP-VA samples only 1 
replicate has been studied, thus the results obtained are preliminary and spray-drying 
parameters for this samples need further optimisation in future work. 
Table 3.9 summarises theoretical and actual drug loadings of the formulation 
prepared. Actual drug loading values were determined assaying the drug concentration by 
UV-VIS analysis, as described in Section 3.2.3. 
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Table 3.9: Summary of theorical and actual drug loading of spray dried formulations 
Spray dried sample Theoretical drug 
loading (%w/w) 
Actual drug 
loading (%w/w) 
Number of 
replicates 
HPMC:Piroxicam 2:1 33.3 35.4±2.7 3 
HPMC:Piroxicam 4:1 25 19.34±4.27 3 
HPMC:Piroxicam 9:1 10 11.8±4.9 3 
PVP:Piroxicam 2:1 33.3 20.26±6.52 3 
PVP:Piroxicam 4:1 25 15.66±5.05 3 
PVP:Piroxicam 9:1 10 13.47±6.01 3 
PVP-VA:Piroxicam 2:1 33.3 10 1 
HPMC-AS:Piroxicam 2:1 33.3 2 1 
HPMC:Fenofibrate 2:1 33.3 6.8±0.7 2 
HPMC:Griseofulvin 2:1 33.3 12.7±1.83 2 
PVP:Fenofibrate 2:1 33.3 13.83±8.71 2 
PVP:Griseofulvin 2:1 33.3 20.85±1.2 2 
 
From values shown in Table 3.9 it is possible to conclude that the drug 
encapsulation efficiency in the spray dried polymeric microparticles was not very 
reproducible for few of the formulation prepared. Furthermore the actual drug loading is 
lower than the theoretical one, a part from PVP formulations with the highest drug loading 
and for the formulation HPMC:Piroxicam 2:1. 
3.3.4 TGA Analysis  
TGA experiments were performed for all the spray dried solid dispersions, in order 
to estimate residual solvent and moisture content of the fresh samples. The presence of water 
and solvents in amorphous system can impact their physical state, as due to its low glass 
transition temperature (Tg) value (136-165K), 223  water can lower the Tg of the amorphous 
systems, increasing the molecular mobility within them. Furthermore residual solvent might 
be toxic and prevent the formulation use in the clinic.  This plasticizing effect can lead to 
physical transition of amorphous systems, facilitated by the gained molecular mobility of the 
system, 224 and can consequently promote crystallization. Obtained TGA results are shown 
in Figure 3.7 a, b and c and summarised in Table 3.10. 
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a 
b 
c 
Figure 3.9:TGA thermograms for HPMC:piroxicam (a), PVP:piroxicam (b) and 
HPMC:fenofibrate, PVP:fenofibrate, HPMC:griseofulvin and PVP:griseofulvin spray dried 
samples (c). 
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As described in Section 3.3.3, samples have been spray dried from a mixture of 
ethanol/distilled water 1:1. The boiling point of the mixture is 79.6 °C. Analysis of the TGA 
curves was performed between 30 and 110 °C. In Figure 3.36a it can be seen that a weight 
loss is present for HPMC:piroxicam samples starting at about 30 °C, which corresponds to 
the moisture/solvent content loss. Piroxicam thermal decomposition occurs after melting 
(200-230 °C in a single step). The occurrence of piroxicam decomposition can be seen in 
Figure 3.9 a and 3.9 b with an onset at about 200-205 °C. Moisture/solvent content loss 
themal can also be seen for PVP: griseofulvin 2:1and PVP:fenofibrate 2:1 spray dried 
samples in Figure 3.9 c.  
                    Table 3.10: summary of residual moisture content of spray dried samples (n=3) 
Spray dried sample Moisture-Solvent content % 
HPMC:piroxicam 2:1 0.81±0.14 
HPMC:piroxicam 4:1 1.582±0.41 
HPMC:piroxicam 9:1 1.438±0.11 
PVP:piroxicam 2:1 2.91±0.83 
PVP:piroxicam 4:1 7.4±0.31 
PVP:piroxicam 9:1 6.97±0.45 
HPMC:fenofibrate 2:1 3.03±0.61 
PVP:fenofibrate 2:1 0.19±0.04 
HPMC:griseofulvin 2:1 0.50±0.04 
PVP:griseofulvin 2:1 0.09±0.01 
 
As summarised in Table 3.10 freshly spray dried samples showed significant 
moisture/solvent content. For both PVP and HPMC based spray dried solid dispersion the 
moisture content% increased increasing the polymer weight ratio. Considering the 
hydrophilic nature of the two polymers, a higher polymer load is expected to increase the 
amount of moisture residual from the processing and moisture absorbed by the final product. 
225 In particular PVP samples show high residual moisture, due to the high polymer 
hygroscopicity. 167 Obtained data clearly show that residual moisture is not only dependent 
on the polymer but also on the hygroscopicity of the whole drug-polymer system. Indeed, 
PVP:griseofulvin solid dispersion showed a low moisture content (0.09 %), compared to 
PVP:fenofibrate and PVP:piroxicam samples. Such difference might be due PVP-
griseofulvin interaction. It has been reported that the strength of polymer-drug interactions, 
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as well as drug–water interaction can influence the system moisture uptake. 226 Therefore, it 
is possible that griseofulvin-water interaction is weaker and less likely to occur compared to 
the other model drugs, while PVP interacts more strongly with griseofulvin than with other 
drugs. TGA analysis has not been performed on PVP-VA and HPMC-AS spray dried 
samples. As previously discussed, such samples have been prepared only in one replicate 
and due to the low spray drying yield, solid state characterisation could not be completed.  
 
3.3.5 Spray dried solid dispersions morphology 
SEM was used to study the morphologies of the spray dried microparticles. Figure 3.8 shows 
spray dried HPMC and HPMC:Piroxicam microparticles.  
 
Fig.3.8 : SEM images of spray dried HPMC, HPMC:Piroxicam 2:1, HPMC:Piroxicam 4:1, 
HPMC:Piroxicam 9:1 microparticles. Blu arrows indicate drug crystals. 
 
HPMC:piroxicam solid dispersions are spherical microparticles with sizes in the 
range of  2-10 µm for all the formulations.  No significant different in size is observable 
changing the drug:polymer ratios. For the formulation with higher drug loading, 
HPMC:piroxicam 2:1 and 4:1, few drug crystals can be observed in the image, suggesting 
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that increasing the polymer amount the drug is more likely to be dispersed in its amorphous 
form in the formulation. For all samples few microparticle appear to be collapsed, effect 
which has been suggested by other researchers to be due to the slow evaporation of the 
solvent. 48  
 
Fig.3.9: SEM images of spray dried PVP, PVP:piroxicam 2:1, PVP:piroxicam 4:1, 
PVP:piroxicam 9:1 microparticles 
 
As shown in Figure 3.9 spray drying of PVP:piroxicam mixtures yielded smaller 
microparticles compared to HPMC:piroxicam systems. Indeed sizes between 0.5 and 5 µm 
were obtained for PVP:piroxicam 2:1 formulation. Sizes obtained are similar to 
PVP:piroxicam spray dried solid dispersions described in literature. 227 Differently from 
HPMC based systems microparticles sizes increased increasing the amount of polymer in the 
solid dispersion. Few piroxicam crystals are visible for samples with higher drug loading. 
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Fig 3.10: SEM images of microparticles of spray dried HPMC:fenofibrate 2:1 and 
PVP:fenofibrate 2:1 
 
Figure 3.10 shows SEM images of HPMC:fenofibrate 2:1 and PVP fenofibrate 2:1 
spray dried solid dispersions. As for piroxicam samples, HPMC based microparticles 
resulted to be bigger that PVP microparticles, confirming HPMC tendency to yield bigger 
particles. Indeed HPMC:fenofibrate microparticle sizes appear to be in the range of 1-10 µm, 
having a spherical shape with the presence of few collapsed particles. PVP:fenofibrate 
microparticles are in the range of 1-5 µm and are more regularly spherical shaped. Few 
particles appear to be broken, confirming that spray drying of fenofibrate formulation needs 
to be optimised, as already highlighted by the very low yield values obtained from the spray 
drying process (see Table 3.9). No drug crystals are visible in any of the two formulations 
despite they contain highest drug loading tested. 
    
   Fig 3.11: SEM images of spray dried HPMC:griseofulvin 2:1 and PVP:griseofulvin 2:1 
microparticles 
 
As shown in Figure 3.12 both HPMC:griseofulvin 2:1 microparticles resulted to be 
in the same range of sizes obtained for HPMC:fenofibrate 2:1 and HPMC:piroxicam 
formulations, 2-10 µm.  Also in this case particles appear spherical shape and few of them 
are collapsed. PVP:griseofulvin 2:1 spray dried microparticles are between 1 and 5 µm in 
size and spherical as for PVP:piroxicam 2:1 and PVP:fenofibrate 2:1 formulation. Thus, the 
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drug does not have a significant effect on the microparticles shape and size, which seems to 
be dependent mainly on the polymeric carrier used. No drug crystals are visible in the SEM 
images. 
 
 
           Fig 3.12: SEM images of spray dried PVP-VA and PVP-VA:piroxicam 2:1 microparticles 
Figure 3.12 shows SEM images of spray dried PVP-VA and PVP-VA:piroxicam 2:1 
spray dried microparticles. As previously specified, only one replicate was performed for 
these particular systems. For this reason obtained results need to be considered preliminary 
data. PVP-VA micropartcles are slightly bigger in size than the ones obtained spray drying 
the correspondent homopolymer PVP, indeed few of the particles in the image are above 5 
µm in size. Piroxicam crystals were not visible in the SEM image, suggesting that the drug 
in the solid dispersions is in its amorphous form. 
 
 
        Fig 3.13:SEM images of spray dried HPMC-AS and HPM-AS:piroxicam 2:1 microparticles 
 
As shown in Figure 3.13 spray dried HPMC-AS microparticles show an irregular 
shape, with few spherical particles and many collapsed ones. The particles surface does not 
appear smooth as for HPMC, PVP and PVP-VA spray dried microparticles. HPMC-AS 
microparticles are smaller than the correspondent spray dried HPMC particles, having sizes 
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in the range of 1-5 µm. In the presence of piroxicam bigger microparticles with irregular 
shapes were obtained. No drug crystals are visible in the image, suggesting that piroxicam is 
mainly in its amorphous form in the spray dried formulation. As only one replicate was 
studied, an optimisation of the spray drying process for HPMC-AS sample would be needed, 
in order to improve the process yield and the features of the obtained microparticles. 
 
3.3.6 PXRD analysis of spray dried formulations 
In order to confirm the physical states (either molecularly dispersed in the polymer, 
being phase separated crystalline drug, or phase separated amorphous domains) of drug in 
the spray-dried formulations, PXRD analysis was performed on all the spray dried samples. 
As already discussed in Chapter 2 (section 2.3.3), X–Ray Diffraction method determines 
crystallinity and polymorphic purity by measuring the diffraction of X-Rays by a powder, 
which is directly dependent on the three dimensional periodicity of the atoms and molecules 
in the crystal lattice. 228 Figure 3.14 shows PXRD results obtained for HPMC:Piroxicam 
formulations. 
          
Fig 3.14: PXRD results of freshly prepared spray dried HPMC:piroxicam formulations 
compared to raw piroxicam and spray dried HPMC. 
 
The PXRD result of the piroxicam as received matches the diffraction pattern of 
piroxicam crystalline form I (cubic form) reported in literature. 229 PXRD patterns of the 
spray dried formulation show the loss of sharp crystalline piroxicam diffraction peaks. It can 
be seen that spray dried HPMC:piroxicam samples with all drug loadings show amorphous 
halos rather than crystalline peak features, indicating that no significant amount of 
crystalline piroxicam is present after spray drying. From Figure 3.14 it is possible to observe 
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few weak crystalline diffraction peaks at 8.6, 16.66 and 27,74 2θ with low intensities in the 
spray dried HPMC:piroxicam 2:1 sample indicating trace of crystalline drug  which is absent 
in the other two formulations with lower drug loadings. This result is in agreement with 
SEM images, in which the presence of piroxicam residual crystals in spray dried 
formulations with 2:1 polymer:drug ratio were present. No crystalline peak were observed 
for the spray dried formulation HPMC:piroxicam 4:1, despite the few drug crystals present 
in SEM image (Fig 3.8). Such disagreement is likely to be due to the difference in the limit 
of detection of different instruments. The few crystal quantity is possibly below the limit of 
detection of PXRD, thus no crystalline peak was observed.  PXRD results suggest that the 
presence of higher proportions of polymer can reduce drug crystallization in the spray dried 
solid dispersions and stabilise the amorphous drug. 
P-XRD analysis has been performed also on spray dried PVP:piroxicam 
formulations, as shown in Figure 3.15. 
              
Fig 3.15: PXRD results of freshly prepared spray dried PVP:piroxicam formulations compared 
to raw piroxicam and spray dried PVP. 
 
As for HPMC:piroxicam samples, spray dried  PVP:piroxicam formulations XRD 
patterns show the presence of amorphous halos, indicating no significant amount of 
crystalline drug in the sample after spray drying process. However, in contrast to the HPMC 
formulations, the formulation with lowest PVP content (PVP:piroxicam 2:1) shows fully 
amorphous pattern.  This indicates that PVP may have stronger inhibitive effect on the 
growth of piroxicam crystals in the spray dried solid dispersions. It may be attributed to the 
stronger interaction between PVP and the model drug than HPMC.  
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Fig 3.16: PXRD results of freshly prepared spray dried PVP:fenofibrate 2:1 and 
HPMC:fenofibrate 2:1  formulations compared to raw fenofibrate. 
 
Figure 3.16 shows P-XRD results obtained for spray dried HPMC:fenofibrate 2:1 
and PVP:fenofibrate 2:1. Despite the absence of drug crystals in the SEM images (see Figure 
3.10), diffraction peaks of crystalline fenofibrate (14.52, 15.22, 15.81, 21.94, 22.22, 26.23 
2θ for spray dried HPMC:fenofibrate 2:1, and 14.2, 15.22, 15.81, 22.22, 26.26, 30.66 2θ for 
spray dried PVP:fenofibrate 2:1) can be clearly seen in the diffraction patterns of the spray 
dried formulations indicating the presence of residual crystalline drug in both formulations. 
No significant difference in the degree of crystallinity of fenofibrate in the spray dried 
formulations can be identified from P-XRD results of PVP and HPMC based spray dried 
samples.  
 
Fig 3.17: PXRD results of freshly prepared spray dried PVP:griseofulvin 2:1 and 
HPMC:griseofulvin 2:1  formulations compared to raw griseofulvin. 
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Spray dried formulations containing griseofulvin were also analysed using P-XRD. 
The results are shown in Figure 3.17. Differently from spray dried fenofibrate and piroxicam 
samples with high drug loading, for which few weakly intense crystalline diffraction peaks 
were present, in this case only the amorphous halo is present for both PVP and HPMC based 
griseofulvin formulations. No diffraction peaks can be observed indicating the amorphous 
nature of the model drug (either as phase separated amorphous drug-rich domains or 
molecular dispersions with the polymers) in the spray dried formulations. This result is in 
agreement with SEM images, where no drug crystals were visible in the spray dried 
formulations  (Figure 3.11).   
 
 
Fig 3.18: PXRD results of freshly prepared spray dried PVP:piroxicam 2:1 and PVP-
VA:piroxicam 2:1  formulations compared to raw piroxicam. 
 
Figure 3.18 shows a comparison between P-XRD patterns of  raw piroxicam, spray 
dried PVP:piroxicam 2:1 and spray dried PVP-VA:prioxicam 2:1. It can be observed that a 
higher level of crystalline drug is obtained in the spray dried formulations of PVP-VA 
piroxicam 2:1. This result indicates that the hydrophobic modification of the polymer with 
vinyl-acetate groups contributes to the reduced stabilisation capability of the polymer on the 
amorphous drug. The lower hydrophilicity of PVP-VA in comparison to PVP was expected 
to reduce the risk of drug crystallisation in the solid disperions, as less water content, which 
can have a plasticizing effect and induce drug crystallization, was expected. 230 However, 
this advantage may be outweight by the fact that the structutral modification also reduced 
the potential hydrogen bonding sites with the model drug which can contribute to lower 
miscibility and solubulity with the model drug.   
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Fig 3.19: PXRD results of freshly prepared spray dried HPMC:piroxicam 2:1 and HPMC-
AS:piroxicam 2:1  formulations compared to raw piroxicam. 
 
P-XRD analysis has been performed also on HPMC-AS:piroxicam 2:1 sample and 
the obtained diffraction pattern is shown in Figure 3.19. Diffraction peaks of crystalline drug 
can be clearly observed in both spray dried HPMC:piroxicam 2:1 and HPMC-AS:piroxicam 
2:1 solid dispersion samples, suggesting that, as for PVP-VA, the hydrophobic modification 
of the polymeric carrier did not lead to improved stabilisation and solubilisation of 
amorphous drug by the polymer. It is interesting that the peak position of the diffractions in 
the two spray dried formulations are different indicating different polymorphic forms of 
piroxicam were obtained in the HPMC and HPMC-AS based solid dispersions.  
 
3.3.7 ATR-FTIR spectroscopic analysis  
Physical properties of raw drugs, physical mixtures and spray dried samples were 
also investigated using ATR-FTIR spectroscopy. In particular the technique was employed 
to study the possible polymeric carrier-APIs interaction, which has been reported to have an 
important impact on the stabilisation effect of the amorphous drug at solid state and 
dissolution performance of solid dispersions, due to the reduction of agglomeration of the 
hydrophobic drug particles. 231 
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Fig 3.20: ATR-FTIR spectra of raw Piroxicam, HPMC:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures  and spray dried HPMC:piroxicam 2:1, 4:1 and 9:1 samples. 
 
Figure 3.20 shows ATR-FTIR results obtained for piroxicam, HPMC:piroxicam 
physical mixtures and spray dried solid dispersion formulations. As described in the 
literature, different piroxicam polymorphic forms have been reported to have different FTIR 
spectra. Three main polymorphic forms, known as cubic form β, needle form α and a 
monohydrate, have been studied. Recently, a new polymorphic structure was proposed by 
Reck et al. and was designated as α2, but only minor crystallographic differences were 
proposed between the needle form, renamed as α1, and form α2. 168 According to Mihalić, 
piroxicam cubic and needle forms FTIR spectra differ only slightly in the fingerprint region, 
while the overlapped –NH and –OH stretching bands at 3385 cm-1 in the spectrum of the 
needle form and at 3330 cm-1 in the spectrum of the cubic form. 232 Further work from Janik 
et al indicated that absorption bands at 3393 and 3341cm-1 correspond to the vibration of 
free –NH and H-bonded –NH groups (intermolecular H-bonding between piroxicam 
molecules). 233  
 In Figures 3.20 it can be observed that a well-defined peak is present in the 
piroxicam ATR-FTIR spectrum at 3337 cm-1, confirming that the raw crystalline drug is 
cubic form β, as already proved by PXRD pattern (section 3.3.5). In the spectra of the 
physical mixtures, an intense peak at 1060 cm-1 is assigned to HPMC. It can also be seen 
that the ATR-FTIR spectra of the physical mixtures are summations of piroxicam and 
HPMC spectra. No shift on the NH 3337 cm-1 peak of the crystalline drug can be observed, 
suggesting that no interaction between the drug and the polymeric carrier occurred in the 
physical mixtures.  
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The spectra of the spray dried solid dispersions show clear shifts of the piroxicam 
N-H streching towards higher wavenumbers (3393 cm-1), ß cubic form of piroxicam is 
known to be composed of dimers where two piroxicam molecules are connected via the 
formation of intermolecular H-bond between amide –NH group and oxygen in the sulfoxide 
group.233,234 The lack of hydrogen bonding  revealed by ATR-FTIR for the spray dried 
formulation is likely to be due to the drug amorphisation and consequent reduction of 
intermolecular interaction between piroxicam molecules. In the spray dried 
HPMC:piroxicam 9:1 spectrum no -NH or -OH strecthing peak is observed. This is likely to 
be due to the drug concentration is below the limit of detection of ATR-FTIR.  
 
Fig 3.21: ATR- FTIR spectra of raw piroxicam, pvp:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures  and spray dried PVP:piroxicam 2:1, 4:1 and 9:1 samples. 
 
 ATR-FTIR spectra of raw piroxicam, PVP:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures and spray dried solid dispersions are shown in Figure 3.21. In the presence of PVP 
a broad well defined peak can be observed at 1650 cm-1 which is assigned to the polymer 
carbonyl stretching vibration. 227 As reported in literature, each pirrolidone moiety of PVP 
has two functional groups , =N- and C=O that can potentianlly interact with the drug via 
hydrogen bonding. Due to steric hindrance of the tertiary amine, the carbonyl group of PVP 
is more favorable for hydrogen bonding. 235 The ATR-FTIR spectra of PVP:piroxicam 
physical mixtures are simply the summation of the PVP and crystalline piroxicam spectra, 
revealing that no interaction between the drug and the carrier occurred in the physical 
mixtures. In contrast,  the ATR-FTIR spectra of spray dried solid dispersions show a shift in 
the piroxicam -NH stretching vibration peak from 3337 to 3392 cm-1, suggesting that,  
piroxicam -NH groups are not involved in intermolecular H-bonding network (between 
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piroxicam molecules), as a result of the drug amorphisation. The weakening in intensity of  
the N-H or O-H strecthing piroxicam peak can be related to the conversion of piroxicam 
from crystalline to amorphous form. It can be seen that the piroxicam  –NH  strecthing 
vibration peak intensity is not visible in the sample PVP:piroxicam 9:1. As already 
mentioned, the lack of –NH drug peak in spray dried with low drug loading is likely to be 
due to the drug concentration is below the instrument detection limit. 
 
Fig 3.22: ATR-FTIR spectra of raw piroxicam, PVP:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures  and spray dried PVP:piroxicam 2:1, 4:1 and 9:1 samples. 
 
 
Fig 3.23: ATR-FTIR spectra of raw fenofibrate, HPMC:fenofibrate 2:1 physical mixture and 
spray dried solid dispersion. 
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ATR-FTIR analysis has been perfomed also on the physical mixtures and spray 
dried solid dispersions of HPMC:fenofibrate 2:1 and PVP:fenofibrate 2:1. Obtained spectra 
are shown in Figure 3.23 and 3.24.   Fenofibrate lacks proton donors but the two  –C=O 
groups can act as proton acceptors, 236 leading to the occurrence polymeric carrier-
fenofibrate interaction, which has already been reported in literature. 237 Figure 3.23 shows 
that fenofibrate peaks are broader and less resolved in the spectra of spray dried solid 
dispersion, particularly for the stretching vibration peak of alkylic groups at 2982 cm-1. This 
suggests that the drug might be mainly amorphous in the solid dispersion. A slight shift on 
the fenofibrate carbonyl group from 1647 cm-1 to 1650 cm-1 can be observed, which may be 
due to the interaction of the fenofibrate carbonyl group with HPMC proton donor groups.  
 
Fig 3.24: ATR-FTIR spectra of raw fenofibrate, PVP:fenofibrate 2:1 physical mixture and 
spray dried solid dispersion. 
 
Figure 3.24 shows ATR-FTIR analysis of PVP:fenofibrate 2:1 physical mixtures and 
spray dried samples, compared to the raw drug and the spray dried polymeric carrier. In this 
case fenofibrate carbonyl group peak (1647 cm-1) cannot be used as a reference of hydrogen 
bonding formation, due to the overlapping with the PVP carbonyl peak. As for 
HPMC:fenofibrate samples, fenofibrate peaks appear less defined, particularly for the the 
alkylic group peak at 2982 cm-1, suggesting that the physical state of fenofibrate in the 
formulation may be mainly amorphous, as already obeserved by P-XRD studies. 
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Fig 3.25: ATR-FTIR spectra of raw griseofulvin, HPMC:griseofulvin 2:1 physical mixtures and 
spray dried samples. 
 
 
The ATR-FTIR spectrum of crystalline griseofulvin (Figure 3.25) shows sereval 
peaks in the region 1750-1550 cm-1, which are related to the carbonyl stretching of the 
benzofuranone ring, the carbonyl stretching of the cycloexanone ring and the C=C stretch of 
the cyclic ring. 238 The wavenumbers of these groups bands are 1703 cm-1, 1614 cm-1 and 
1583 cm-1, respectively. No significant shift of the peaks is observed in the spectrum of the 
spray dried HPMC:griseofulvin solid dispersion, indicating that minimal  interaction 
between the drug and the polymeric carrier occurred. Nevertheless significant peak 
broadening can be observed, as a possible consequence of  the drug conversion from 
crystalline to amorphous state. 
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Fig 3.26: ATR- FTIR spectra of raw griseofulvin, PVP:griseofulvin 2:1 physical mixtures and 
spray dried samples. 
 
Similar result can be observed for PVP:griseofulvin 2:1 spray dried solid dispersion 
(Figure 3.26). Only minimal shift (1-2 wavenumbers) of the peaks were observed (1701cm-1, 
1616 cm-1 and 1584 cm-1), suggesting that no significant interaction occurred between 
griseofulvin and PVP. Obtained results are in agreement with literature data, which reported 
a lack of interaction between PVP and griseofulvin. 239 As for HPMC:griseofulvin samples, 
peak shape changes can be seen, suggesting drug amorphisation in the spray dried 
formulation. 
      
Fig 3.27: ATR-FTIR spectra of raw Piroxicam, spray dried PVP-VA:piroxicam 2:1 and spray 
dried PVP-VA samples. 
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ATR-FTIR spectrum of spray dried PVP-VA:piroxicam formulation is shown in 
Figure 3.27. It can be seen that the –NH piroxicam band at 3337 cm-1, is not present in the 
spray dried sample spectrum. Piroxicam peaks in the fingerprint region are overlapped with 
the PVP-VA ones, thus they cannot be used as a reference for the drug characterization. Due 
to the absence of NH drug peak in the spectrum, it was not possible to predict 
drug/polymeric carrier interaction occurrence or possible drug amorphisation. As already 
mentioned in section 3.3.3 for spray dried PVP-VA samples, only one replicate was 
prepared and analysed. Therefore further studies on PVP-VA possible use to prepare 
piroxicam solid dispersions would be necessary. 
 
Fig 3.28: ATR-FTIR spectra of raw Piroxicam, spray dried HPMC-AS:piroxicam 2:1 and spray 
dried HPMC-AS  samples. 
 
Similar observations can be obtained for HPMC-AS spray dried formulation 
spectrum, shown in Figure 3.28. The piroxicam–NH band is not visible in the spray dried 
HPMC-AS:piroxicam 2:1. Also in this case drug peaks in the fingerprint region are 
overlapped with the HPMC-AS peaks, thus they cannot provide indication of drug physical 
state and drug/polymer interaction occurrence. Further studies would be useful to better 
clarify these points. 
 
3.3.8 DSC Analysis  
DSC analyses were performed on raw APIs, polymeric carrirers:APIs physical mixtures and 
spray dried solid dispersions, in order to evaluate qualitatively and quantitatively the  
possible occurrence of physical state modifications of the spray dried solid components. 
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Figure 3.29 shows DSC results obtained for raw piroxicam, HPMC:piroxicam 2:1, 
4:1 and 9:1 physical mixtures  and spray dried HPMC:piroxicam 2:1, 4:1 and 9:1 solid 
dispersions. The thermogram of crystalline piroxicam shows a melting endothermic peak at 
201.0 °C, which is in good agreement with literature data. 154  
 
Figure 3.29: DSC thermograms, raw Piroxicam, HPMC:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures  and spray dried HPMC:piroxicam 2:1, 4:1 and 9:1 samples. 
 
The melting endotherm peak temperatures of piroxicam for the physical mixtures 
(between 200.8 to 201.1 °C) were very close to the raw drug melting point value (201.66 °C; 
Table 3.11). Therefore minimal melting point depression was obtained. Melting point 
depression provides indication about the drug-polymer miscibility. 240 Obtained data 
indicates piroxicam and HPMC have low miscibility.  
 From Figure 3.31 it can be seen that no melting endotherm peak was noted in the 
thermogram of spray dried HPMC:piroxicam 9:1, suggesting the formation of a completely 
amorphous system. Samples with higher drug loading, HPMC:piroxicam 2:1 and 4:1, 
showed the presence of drug melting endothermic peaks, revealing the presence of drug 
crystals in the spray dried sample. In order to quantitatively estimate the crystallinity of the 
model drug in the spray dried formulations, the melting enthalpy obtained for the spray dried 
samples were divided by the melting enthalpy of the pure crystalline drug and the obtained 
results are summarised in Table 3.10. The crystallinity of the model drug were 13.38% and 
4.38% for HPMC:piroxicam 2:1 and 4:1, respectively. Data clearly show that at lower 
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HPMC weight fractions both amorphous and crystalline drug are present. This is in 
agreement with literature data, 48 which showed that the barrier to drug crystallization 
increases increasing HPMC weight fraction. DSC data are in agreement with SEM and P-
XRD data which revealed the presence of crystalline drug in the two HPMC:piroxicam spray 
dried solid dispersion having drug loadings of 33.3% and 20% (w/w). This indicates the 
solubility between piroxicam and HPMC is below 20% (w/w).  
 
Table 3.10: Melting points, melting point onsets and melting entalphy values obtained by DSC 
analysis for the raw drug, HPMC:piroxicam physical mixtures and spray dried solid 
dispersions, and residual drug crystallinity in spray dried samples (n=3). 
Sample Melting Point (°C) 
Melting point 
onset (°C) 
Melting 
enthalpy (J/g) 
Drug 
crystallinity % 
Piroxicam 201.7±0.01 201.0±0.01 115.50±3.88 - 
Physical Mixture 
HPMC:piroxicam 2:1 201.1±0.43 199.2±0.01 28.65±1.77 - 
Physical Mixture 
HPMC:piroxicam 4:1 201.0±0.33 199.5±0.11 17.97±2.41 - 
Physical Mixture 
HPMC:piroxicam 9:1 200.8±0.01 199.6±0.14 5.41±1.93 - 
Spray dried  
HPMC:piroxicam 2:1 196.7±0.01 190.7±0.14 15.46±0.27 13.38 
Spray dried 
HPMC:piroxicam 4:1 191.7±0.09 187.5±0.20 5.05±0.68 4.38 
Spray dried 
HPMC:piroxicam 9:1 - - - - 
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Figure 3.30: DSC thermograms, raw Piroxicam, PVP:piroxicam 2:1, 4:1 and 9:1 physical 
mixtures  and spray dried PVP:piroxicam 2:1, 4:1 and 9:1 samples. 
 
Figure 3.30 shows DSC results obtained  for PVP:Piroxicam physical mixtures and 
spray dried samples. Differently from HPMC:piroxicam systems, significant melting point 
depression was obtained for the PVP:piroxicam physical mixtures (Table 3.11). The drug 
melting peak also shows significant reduction of melting enthalpy in comparison to the raw 
crystalline drug. Both results indicates high miscibility between PVP and piroxicam, 
suggesting that, despite the high heating rate used (10 °C/min) during the DSC analysis, 
PVP:piroxicam interaction occurred during the melting which leads to the melting point 
depression of the crystalline drug in the physical mixtures. Compared to HPMC:piroxicam 
system low amount of crystalline drug were detected in the solid dispersion with 
polymer:drug ratio 2:1 and 4:1, as summarised in Table 3.10. As for HPMC:piroxicam 
sample system, the sample with highest polymer weight fraction did not shown any 
endothermic peaks, revealing that piroxicam is completely amorphous in this sample. 
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Table 3.11: Melting points, melting point onsets and melting entalphy values obtained by DSC 
analysis for the raw drug, HPMC:piroxicam physical mixtures and spray dried solid 
dispersions, and residual drug crystallinity in spray dried samples (n=3). 
Sample Melting Point 
(°C) 
Melting point 
onset (°C) 
Melting 
enthalpy (J/g) 
Drug 
crystallinity % 
Piroxicam 201.7±0.01 201.0±0.01 115.50±3.88 - 
Physical mixture 
PVP:piroxicam 2:1 
189.0±0.11 174.1±0.37 47.24±4.49 - 
Physical mixture 
PVP:piroxicam 4:1 
190.1±0.01 172.9±0.19 47.39±1.60 - 
Physical mixture 
PVP:piroxicam 9:1 
184.8±0.28 152.5±1.15 28.03±6.14 - 
Spray dried 
PVP:piroxicam 2:1 
167.4±0.04 156.3±1.28 8.35±3.02 7.22 
Spray dried 
PVP:piroxicam 4:1 
153.8±0.30 137.9±0.08 1.06±0.09 0.92 
Spray dried 
PVP:piroxicam 9:1 
- - - - 
 
 
Figure 3.31: DSC thermograms of raw piroxicam,  spray dried HPMC:piroxicam, 
PVP:piroxicam, HPMC-AS:piroxicam and spray dried PVP-VA:piroxicam samples. 
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Figure 3.31 reports DSC thermograms obtained for spray dried HPMC-
AS:piroxicam and PVP-VA:piroxicam 2:1, compared to the correspondent spray dried 
homopolymer:piroxicam system. No melting endothermic peaks could be seen in the 
thermograms of the spray dried formulations except for the piroxicam-HPMC formualation. 
This result is in disagreement with P-XRD results, which showed the presence of trace 
amount of crystalline drug in PVP-VA:piroxicam and HPMC-AS:piroxicam solid 
dispersions. This disagreement is likely to be associated with the characterization method 
used. During the DSC heating, the trace amount of crystalline drug could easily dissolved 
into the heated and viscous glassy polymer and lead to the absence of clear melting of 
crystalline drug.  
 
Figure 3.32: DSC thermograms of  raw fenofibrate, spray dried HPMC:fenofibrate 2:1 and 
PVP:fenofibrate samples. 
 
Figure 3.32 shows DSC results of spray dried HPMC:fenofibrate and 
PVP:fenofibrate 2:1 solid dispersions compared to the thermogram of the raw crystalline 
drug. Crystalline fenofibrate shows a melting endothermic peak at 81°C, in agreement with 
literature data. 27 The DSC result of the spray dried HPMC:fenofibrate solid dispersion 
shows no fenofibrate melting peak, indicating that the drug was mainly amorphous in the 
spray dried formulation. Differently HPMC:fenofibrate thermogram showed an intense 
endothermic peak having a melting enthalpy of 12.74 J/g. This is associated with the 
presence of 13.05% (w/w) crystalline drug in the PVP:fenofibrate 2:1 spray dried 
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formulation. PXRD results (section 3.3.6) showed the presence of residual crystallinity in 
both formulations. The absence of the crystalline drug melting is likely to be associated with 
the dissolution of the low quantity of the crystalline into the formulation during DSC heating.  
 
Figure 3.33: DSC thermograms of raw griseofulvin, spray dried HPMC:griseofulvin 2:1 and 
PVP:griseofulvin 2:1 samples. 
 
DSC results obtained for PVP:griseofulvin and HPMC:griseofulvin 2:1 are shown in 
Figure 3.33. Raw griseofulvin melting point was in complete agreement with reported data. 
27 No melting peak was observed for the two spray dried samples, proving that no residual 
drug crystallinity was present in the two samples. The DSC results are in good agreement 
with the PXRD data, which showed the presence of amorphous halos in the PXRD patterns 
(Section 3.3. 6). Figure 3.33 also shows the presence of broad endothermic peaks for both 
spray dried HPMC:griseofulvin and PVP:griseofulvin samples between 50 and 120°C. These 
broad endothermic peaks correspond to the release of residual solvent/moisture from the 
formulation. The absence of exothermic melting peak of crystalline griseofulvin in the DSC 
result of the spray dried formulation indicates higher miscibility and solubility of 
griseofulvin in the polymeric carriers employed in comparison to the other model drugs.  
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3.3.9 Dissolution Studies 
 Dissolution studies of raw model drugs, physical mixtures and freshly spray dried 
samples were carried out in buffer pH 5, buffer pH 6.5, Blank FaSSIF and blank FeSSIF in 
non-sink conditions. As for solubility studies, the use of different media allowed the study 
and comparison of the drug dissolution performance in conditions simulating the ionic 
strength, the pH and the GIT surfactant concentrations of the intestinal media. As reported in 
literature, 67,241 each of this factor can significantly impact the drug dissolution profile, 
together with the carrier used. Due to its influence on the dissolution rate, 242 particle size 
was controlled by sieving of the samples as previously described in section 3.2.8.  
 
Figure 3.34 shows results obtained for HPMC:piroxicam physical mixtures and 
spray dried formulations  in buffer pH 5 and Blank FeSSIF, compared to the raw drug. It can 
be seen that the for all the drug:polymer ratios employed, the physical mixtures showed 
faster drug dissolution compared to the raw drug in the buffer (pH=5). This indicates that 
HPMC has a dissolution enhancing effect, as already shown by steady state solubility results 
(Section 3.3.2).  The rates of dissolution of piroxicam from spray dried samples are faster 
than the correspondent physical mixture in buffer, indicating that dissolution enhancement 
effect of formulating the drug in solid dispersion. Such result can be related to the physical 
state of the drug, that, as shown by the solid-state characterisation of the spray dried sample, 
is mainly in its amorphous form. For all the samples fastest dissolution profile was obtained 
in blank FeSSIF, confirming the important effect of NaTC on the drug solubilisation. NaTC 
effect can be observed also from the behaviour of the raw drug, for which the dissolution is 
much faster in the blank FeSSIF than in the buffers. 
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Figure 3.34: Dissolution profile of raw piroxicam, physical mixtures HPMC:piroxicam and 
freshly spray dried HPMC:piroxicam sample  in buffer at pH 5 and Blank FeSSIF (polymer 
drug ratio: a=2:1, b=4:1, c=9:1) (n=3).  
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Comparing Figure 3.34 a, b and c, it is possible to observe that the fastest 
dissolution profile was obtained for the spray dried solid dispersion having polymer:drug 
ratio 4:1. Indeed, the dissolution rate resulted to be lower for the sample HPMC:piroxicam 
9:1 in the same condition. This suggests that high HPMC weight load can result in “slowing 
effect” of the drug dissolution. HPMC is well known to swell after imbibition of water, 
forming a gel network. 164 Therefore when the HPMC:piroxicam system is in contact with 
water,  a gel diffusive layer is formed. The presence of higher proportion of HPMC is likely 
to render the diffusion layer more viscous, resulting a slower drug diffusion and release.  
 
Figure 3.35 shows dissolution results obtained for the same samples in buffer pH 6.5 
and Blank FaSSIF.  Dissolution rate is faster than at pH 5 and Blank FeSSIF, confirming the 
higher piroxicam solubility at pH 6.5 than at pH 5, as already revealed by steady state 
solubility studies (Section 3.3.2). Differently from the previous dissolution result, the 
dissolution profiles obtained of raw piroxicam in buffer pH 6.5 and in blank FaSSIF were 
similar, revealing a limited NaTC effect on piroxicam solubilisation. The same result can be 
observed also for the physical mixtures and the spray dried solid dispersions. The different 
effect of the blank FaSSIF and blank FeSSIF is due not only to the pH values, but also to the 
NaTC concentrations used and to the micellar species present in solution. A full 
characterisation of the NaTC aggregates present in blank FaSSIF and blank FeSSIF will be 
discussed in Chapter 5.  For all the drug:polymer ratios used the fastest dissolution profiles 
were obtained for the spray dried formulations, confirming that the spray drying processing 
impacted positively the drug solubilisation due to the amorphous state of the drug in the 
solid dispersions. The comparison of Figure 3.35 a, b and c indicates that the fastest 
dissolution profile was obtained from the spray dried formulation having polymer:drug ratio 
2:1, for which 100% of drug release was reached in 30 minutes, yielding a drug 
concentration of 0.022 mg/ml.  
Chapter 3  
 
 110 
 
Figure 3.35:Dissolution profile of raw piroxicam, physical mixtures HPMC:piroxicam and 
freshly spray dried HPMC:piroxicam sample  in buffer at pH 6.5 and Blank FaSSIF(polymer 
drug ratio: a=2:1, b=4:1, c=9:1) (n=3).  
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The dissolution profiles of physical mixture and spray dried PVP:piroxicam 2:1(a), 
4:1(b) and 9:1(c) samples in buffer pH5 and FeSSIF are reported in Figure 3.36. As for 
HPMC:piroxicam systems, the primary effect of NaTC  on the drug solubilisation can be 
observed for the physical mixtures and the spray dried samples. Figure 3.36 a shows that for 
the sample PVP:piroxicam 2:1 the fastest piroxicam dissolution profile was obtained from 
the spray dried formulation. Figures 3.36 b and c clearly show that this result is not 
confirmed by PVP:piroxicam 4:1 and 9:1 dissolution results. Indeed, for these two samples 
the drug dissolution resulted to be faster for the physical mixtures than for the spray dried 
formulations.  
 
PVP is widely used as solubility and dissolution enhancer, due to its ability to 
increase the wettability of poorly soluble components. Obtained results clearly show that 
PVP is able to significantly increase the drug dissolution profile, even when it is in its 
crystalline form. The higher rate obtained with physical mixtures is still not well understood. 
A possible explanation may be the formation of PVP:piroxicam interaction (such as 
hydrogen bonding) in the spray dried solid dispersions. The occurrence of PVP:piroxicam 
interaction has already been demonstrated by ATR-FTIR and DSC results. The 
drug:polymer interaction might retard the drug solubilisation, as the drug is bound to the 
carrier and this might retard the occurrence of the drug interaction with water, slowing it 
solubilisation and and its diffusion through the diffusive layer. Indeed for physical mixtures 
both drug and polymer are not involved in intermolecular interactions and the drug diffusion 
is only dependent on the PVP hydration and on the diffusive layer formation.  
 
The same results can be observed also for PVP:piroxicam dissolution studies 
performed in buffer pH 6.5 and blank FaSSIF (Figure 3.37). Also in this case physical 
mixtures yielded faster dissolution profile compared to the correspondent spray dried 
samples, confirming the possible effect of polymeric carrier:drug interaction on the drug 
dissolution performance. 
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Figure 3.36: Dissolution profile of raw piroxicam, physical mixtures PVP:piroxicam and freshly 
spray dried PVP:piroxicam sample  in buffer at pH 5 and Blank FeSSIF (polymer drug ratio: 
a=2:1, b=4:1, c=9:1) (n=3).  
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Figure 3.37: Dissolution profile of raw piroxicam, physical mixtures PVP:piroxicam and freshly 
spray dried PVP:piroxicam sample  in buffer at pH 6.5 and Blank FaSSIF (polymer drug ratio: 
a=2:1, b=4:1, c=9:1) (n=3). 
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Figure 3.38: Dissolution profile of raw piroxicam, physical mixtures HPMC:fenofibrate 2:1 and 
freshly spray dried HPMC:fenofibrate 2:1 sample  in buffer at pH 5 and Blank FeSSIF (a) and 
in buffer pH 6.5 and FaSSIF (b) (n=3).  
 
Dissolution data of raw fenofibrate, HPMC:fenofibrate 2:1 physical mixture and 
spray dried solid sample are reported in Figure 3.38. Fenofibrate dissolution was extremely 
slow and less than 10% of the drug was released after 2 hours in the two buffers employed, 
in agreement with reported data. 243 No significant difference can be seen between buffer pH 
5 and blank FaSSIF (b), while a higher fenofibrate solubilisation was reached in blank 
FeSSIF (a), with 30% of drug released after 2 hours. Dissolution rate did not increase 
dramatically for physical mixtures and spray dried samples, but a solubilisation 
enhancement effect is observable for both systems.  Fenofibrate dissolution extent resulted 
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to be higher in blank FeSSIF, confirming the effect of NaTC micelles on the drug 
solubilisation.   
 
Figure 3.39: Dissolution profile of raw fenofibrate, physical mixtures PVP:fenofibrate 2:1 and 
freshly spray dried PVP:fenofibrate 2:1 sample  in buffer at pH 5 and Blank FeSSIF (a) and in 
buffer pH 6.5 and FaSSIF (b) (n=3).  
 
Figure 3.39 shows dissolution results obtained for HPMC:fenofibrate 2:1 physical 
mixtures and spray dried solid samples, compared to raw fenofibrate data. Fenofibrate 
dissolution resulted very slow also for PVP:fenofibrate systems and the dissolution extent 
was slightly lower than for HPMC:fenofibrate samples. As for HPMC:fenofibrate systems 
physical mixtures and spray dried solid dispersions yielded higher fenofibrate dissolution 
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extent, but the release remains slow in both cases. As already observed in steady state 
solubility results, fenofibrate solubilisation was not affected by media pH and ionic strength.  
 
Figure 3.40: Dissolution profile of raw griseofulvin, physical mixtures HPMC:griseofulvin 2:1 
and freshly spray dried HPMC:griseofulvin 2:1 sample  in buffer at pH 5 and Blank FeSSIF (a) 
and in buffer pH 6.5 and FaSSIF (b) (n=3).  
 
Dissolution profiles of raw griseofulvin, HPMC:griseofulvin 2:1 physical mixtures 
and spray dried samples are shown in Figure 3.40. The dissolution behaviour of griseofulvin 
is pH independent, as the results obtained for the raw drug at pH 5 and 6.5 are very similar. 
NaTC slightly affected the dissolution profile of the drug, as well as the presence of polymer. 
The graph clearly shows that the dissolution profiles obtained are very similar for physical 
mixtures and spray dried formulations, and no significant difference can be observed 
between them. Griseofulvin intrinsic water solubility is higher than for piroxicam and 
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fenofibrate, therefore higher griseofulvin weight ratio should probably be tested to observe a 
significant difference between the samples studies.  
 
 Similar results can be observed for PVP:griseofulvin sample (Figure 3.41). Indeed 
also for this system no significant difference between physical mixture and spray dried 
sample was observed. Dissolution profile of PVP:griseofulvin system were slightly slower 
than HPMC:griseofulvin ones. 
 
 
Figure 3.41: Dissolution profile of raw griseofulvin, physical mixtures PVP:griseofulvin 2:1 and 
freshly spray dried PVP:griseofulvin 2:1 sample  in buffer at pH 5 and Blank FeSSIF (a) and in 
buffer pH 6.5 and FaSSIF (b) (n=3).  
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The dissolution results obtained for the different sample tested clearly indicate that 
more factors are involved in the drug solubilisation mechanism. The concomitant presence 
of polymeric carrier and surfactant in the dissolution media yielded the fastest dissolution 
profiles. The role of the carrier, of the surfactant and of their possible interaction in the drug 
dissolution process is not well understood and will be investigated in Chapters 4 and 5. 
 
3.4 Conclusions 
In this Chapter the preparation and characterisation of spray dried solid dispersion 
was discussed. Three different model drugs, piroxicam, fenofibrate and griseofulvin, and 
two model polymers, HPMC and PVP, were used to prepare the spray dried solid dispersion. 
Round shaped microparticles were obtained as revealed by SEM analysis. The solid-state 
characterisation of the systems was performed using PXRD, ATR-FTIR, DSC and TGA 
experiments. Obtained results confirmed the transition of the model drug from their 
crystalline to their amorphous state (and molecular dispersions in the cases of solid 
dispersions with low drug loadings) after spray drying process, although residual 
crystallinity was revealed by DSC and PXRD analysis in the samples with high drug 
loadings. The interaction (hydrogen bonding) between the polymer and the drug were 
confirmed by ATR-FTIR analysis. 
Solubility studies of the model drugs were performed in different media. In order to 
mimick the intestinal pH and ionic strength two different buffers were employed. The 
additions of NaTC and lecithin to the media were performed to further simulate the 
biorelevant intestinal fluids before and after meal. The medium composition resulted to be 
critical for the drug solubilisation, together with the type of polymer and polymer 
concentration used in the formulations. Higher solubility values were obtained in the 
presence of polymeric carrier and of NaTC. 
To investigate the impact of the spray drying process on the drug dissolution 
performance, dissolution studies were carried out for the raw drugs, polymeric carrier:drug 
physical mixtures and spray dried samples in four different media. The use of different 
media allowed the study of the effects of pH and ionic strength on the drug dissolution 
behaviour of the spray dried solid dispersions.  Both factors have significant effects on the in 
vitro dissolution behaviour of piroxicam loaded formulations due to pH-sensitivity of the 
drug. The presence of NaTC showed significant impact on the drugs dissolution rate and 
extent (which can be interpreted as solubilisation), particularly for piroxicam and fenofibrate. 
The solid-state characterisation revealed the physical state of the drug and gave essential 
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indication about the possible choice of a carrier. The mechanism of drug solubilisation was 
further investigated in the following chapters via studying the behaviour of polymer and bile 
salts in simulated intestinal fluids.   
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Chapter 4. Probing the molecular interactions between polymeric 
carriers and Bile Salts  
4.1 Introduction 
The use of hydrophilic polymeric carriers for the delivery of poorly water-soluble 
drugs has been extensively studied.244 Polymer based solid dispersions have shown to be a 
successful approach to improve the dissolution rate of poorly soluble drugs. 11,24 Furthermore, 
in the last decades, increasing attention has been paid to the composition of the dissolution 
media employed in dissolution in-vitro screening tests. 70 Different studies have shown that 
the composition of the dissolution media used can significantly impact on in vitro drug 
dissolution performance. The use of simulating fluids mimicking the gastro-intestinal 
condition resulted to be useful to achieve good in-vitro/in vivo correlations, as correlation 
between in vitro dissolution test and in vivo absorption may be more similar when 
physiological conditions are mimicked. 71,245 
Therefore both the choice of carrier polymer and the dissolution media can have 
significant effects on the dissolution study of a solid dispersion containing poorly soluble 
drugs. However the possible intermolecular interaction occurring between the polymeric 
carrier and the components of the biorelevant medium, such as bile salts, cholestral and 
other digestic enzymes, are still poorly understood due to the complex nature of the 
simulated GI fluids. Even less is known about the impacts of these possible interactions 
between polymeric carriers and media components on poorly water-soluble drug dissolution 
behavior. This project only focused on investigating the intermolecular interactions between 
polymers and bile salts. Qi and her co-workers’ study on HPMC/surfactant interactions 
showed some indicative results on the possible role of such interactions in the drug 
solubilisation solid dispersions during dissolution process. 246 Therefore a fuller 
understanding of polymeric carriers-bile salts interaction and of its possible role on drug 
solubilisation during dissolution from solid dispersions will benefit the further exploit of 
solid dispersions. 
The focus of this Chapter was to characterise the potential molecular interactions 
between polymeric carriers employed in Chapter 3 (PVP and HPMC) and the model bile salt 
(NaTC) used to prepare the biorelevant media for steady state solubility and dissolution 
studies. 1H and DOSY NMR techniques were used to study the NaTC aggregation behaviour, 
with and without the presence of polymer, in conditions reproducing the intestinal pH and 
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osmolarity. The same characterisation was performed by interfacial tension measurements, 
carried out using pendant drop technique. 
4.2 Experimental methods 
4.2.1 NMR Spectroscopy 
Two different NMR techniques, 1H NMR and diffusion-ordered spectroscopy 
(DOSY) were employed in this part of the study. Both experiments were performed using a 
Bruker Ultrashield Plus 400 MHz Spectrometer (Bruker, BioSpin Corporation, The 
Woodlands, TX). 
4.2.1.1 1H proton NMR 
1H proton NMR measurements were carried out using 5mm NMR tubes. All 
experiments were performed at 37 °C, in order to simulate the physiological temperature. 
124 scans were acquired, relaxation delay was set at 1s and the pulse length was 90 ˚. All the 
samples were prepared in D2O.  In order to investigate the NaTC aggregation, 1H proton 
NMR was performed on NaTC/D2O samples with NaTC concentrations from 1 to 90 mM. 
This concentration range was employed to allow the study of the system from below to well 
above the bile salt CMC (3-12mM). The same experiments were performed in phosphate 
and acetate buffers with pH 5 and 6.5, respectively. These are the conditions employed in 
steady state solubility and dissolution studies described in Chapter 3. In order to make the 
NMR experiments feasible, buffers were prepared in D2O. The actual pH values of the 
deuterated buffers were 4.89±0.06 for the buffer at pH 5 and 6.48±0.34 for the buffer at pH 
6.5 (n=3). The chemical shift of NaTC was measured in D2O, in the two deuterated buffers 
and also in the presence of PVP and HPMC (0.5 mg/ml), in order to evaluate the impact of 
the polymer on the surfactant chemical shift. Samples were prepared by weight and were 
allowed to equilibrate for 1 hour before taking the measurement. All the samples were 
analysed in triplicate (n=3). The proton chemical shift of NaTC was determined as a 
function of concentration. Internal referencing was performed as described in section 4.3.1. 
Data were analysed using TopSpin 3.2 Software. 
4.2.1.2 DOSY NMR 
DOSY NMR experiments were performed using 5mm NMR tubes. Experiments 
were carried out at 37 °C. 16 scans were acquired for each sample. Relaxation delay and the 
pulse length were set at 1s and 90 ˚, respectively. Diffusion was measured using stimulated 
echo and Eddy current compensation, applying bipolar gradient pulses for diffusion and 2 
spoil gradient pulse. The gradient pulse duration and the diffusion delay length were set at 
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2.5 s and 0.2 s, respectively. The list of samples analysed and their preparation methods can 
be found inSection 4.2.1.1. Data were analysed using TopSpin 3.2 Software. No restricted 
diffusion was observable. Experiments were performed in triplicate (n=3). 
 
4.2.2 Interfacial tension measurements 
Interfacial tension measurements were carried out using FTA200 pulsating drop 
tensiometer (First Ten Angstroms, Portsmouth, VA, USA). NaTC interfacial tension was 
measured with and without the presence of HPMC and PVP (0.5 mg/ml). All experiments 
were performed in MilliQ water, phosphate and acetate buffers with pH 5 and 6.5, 
respectively. The appropriate solution was placed in a glass cuvette. A Hamilton syringe, 
having a volume of 50 µl, was fitted with a j-shaped needle. An air bubble was formed using 
the j-needle and the interfacial tension was measured over 15 minutes. Samples were 
prepared by dissolving the polymer at the required concentration in the medium. Obtained 
polymeric solutions were left at 37 °C for 1 hour, to allow system equilibration. Increasing 
amounts of NaTC were added to the sample and interfacial tension measurement for 15 
minutes. NaTC concentration between 1 and 20mM were analysed. All experiments were 
performed in duplicate (n=2). 
 
4.3 Results and discussion 
4.3.1.1H proton NMR of raw materials 
Figure 4.1 shows the 1H NMR spectrum of NaTC. 1H peaks were assigned according 
to literature data. 247,248 The detailed peaks assignment is summarised in Table 4.1. 
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Figure 4.1: Chemical structure (a) and 1H NMR spectrum of NaTC (b) 
 
Table 4.1: NaTC 1H NMR peak assignment according to literature data 247,248 
Proton Resonance (ppm) Proton Resonance (ppm) 
1 CH2- 1.06(β), 1.82(α) 15 –CH2- 1.24(α), 1.70(β) 
2 –CH2 1.35(α), 1.61(β) 16 –CH2- 1.35, 1.94 (remains 
unassigned) 
3 HO-CH 3.48 17 –CH 1.70 
4 -CH2 1.52(β), 1.97(α) 18  -CH3 0.64 
5 –CH 1.49 19 -CH3 0.83 
6 -CH2 1.52(α), 2.01(β) 20 –CH 1.45 
7 HO-CH 3.82 21 –CH3 0.93 
8 –CH 1.67 22 –CH2 1.32, 1.74 
9 –CH 2.11 23 –CH2- 2.24 
11 –CH2- 1.59(β), 1.65(α) 25 –CH2- 3.16 
12 –CH-OH 3.99 26 –CH2- 3.00 
14 –CH 1.82 
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H12 signal exhibited a larger change when NaTC concentration was varied 
compared to the other protons, showing chemical shift variation and peak brodening. For 
this reason its chemical shift was used as a reference to study the impact of NaTC 
concentration of micelles formation, with and without the presence of polymers (HPMC and 
PVP), in MilliQ water and buffered solutions. In order to have reliable measurements, 
internal referencing of the H12 signal was performed. The chemical shift of H12 was 
compared to the one of proton H18.  
It is well known that liquid state NMR is normally a limited approach to characterise 
polymeric system. Indeed a fast decay of the NMR signal, due to relaxation, can occur. The 
line widths in the NMR spectra are proportional to the relaxation rates. Therefore the signal-
to-noise ratios of the NMR spectra of large molecules, such as polymers, are often poor. 249 
In order to exclude possible interference of the PVP and HPMC signals with the 
NaTC spectrum, 1H NMR was performed on different concentrations of the two polymers. 
As shown by Figure 4.2 a and b, the signal of the two polymers is poor and very weakly 
intense in comparison with the signal of D2O. Therefore no significant interference with the 
NaTC signal was observed.  
 
 
Figure 4.2: 1H NMR spectra of PVP and HPMC in D2O 
Chapter 4 
 
 125 
4.3.2. 1DOSY NMR of raw materials 
Figure 4.3 shows DOSY NMR spectrum of NaTC 30mM. Self-diffusion coefficient 
(D) values are plotted against log D as a function of chemical shift δ values (ppm). It can be 
seen that two self-diffusion coefficients are present on the y-axis, one related to NaTC and 
the other to D2O. D2O self-diffusion coefficient was 1.58 D/10-9 m2/s which is in agreement 
with literature data. 250 
Figure 4.3: DOSY NMR spectra of NaTC 30mM in D2O 
 
Self-diffusion coefficient measurements were performed also for HPMC and PVP 
(data not shown). However due to slow diffusion of the polymers in solution, it was not 
possible to obtain the self-diffusion coefficient values of the polymers alone.  
 
4.3.3 1H NMR and DOSY studies on the aggregation behaviour of NaTC  
As already discussed in Chapter 1, the aggregation behaviour of bile salts is still not 
completely clarified in literature. 82,251 NaTC has widely been studied as one type of model 
bile salts, but its aggregation pattern is still not well understood and different CMC values 
have been proposed in literature. Table 4.2 summarises CMC values of NaTC reported in 
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literature. The experimental conditions and characterisation techniques employed are also 
indicated. 
 
Table 4.2: Summary of NaTC CMC values reported in literature 
Reference Technique Experimental conditions CMC (mM) 
252 Light Scattering 37 °C, pH 7.4, [Na
+] 
0.15 8.5 
253 Fluorescence 20±1°C, water 8-12 
91 Electric paramagnetic resonance (ESR) 
25°C, pH>10,  [Na+] 
0.15 M 5-7 
254 Electrode measurements 25°C, [NaCl] 0.01 M 12 
255 Chromatography PBS pH 7.4, [Na
+] 
154mM Not defined 
256 Fluorescence 25°C, water 8-12 
257 Light scattering 25°C, water 12 
258 Spectral shift 25°C, water 3-5 
259 NMR 25±1°C, D20 6.5-8.3 
260 Fluorescence, Light scattering 
15±1°C, [NaCl] 15-
300mM 1-15 
 
As shown by the data in Table 4.2, the CMC value of NaTC appears to be dependent 
on the characterisation technique and the testing conditions employed. Few research groups 
have described the aggregation behaviour of NaTC being a not well-defined and a 
“progressive process” even at very low concentrations rather than a sharp transition of 
aggregation behaviour at a critical concentration point. 255,260 
In this work 1H proton NMR was employed to assess NaTC aggregation in D2O and 
in phosphate and acetate buffers used in dissolution and solubility studies. NaTC H12 
chemical shift was plotted as a function of NaTC concentration. Figure 4.4 shows the results 
obtained using three different media. 
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Figure 4.4: NaTC H12 chemical shift as a function of NaTC concentration in D2O, buffer pH 5 
and buffer pH 6.5 
 
From Figure 4.4 it can clearly be seen that NaTC H12 ∂ did not change significantly 
within the NaTC concentration range of 1-12mM. When NaTC concentration was further 
increased to 15mM, a significant ∂ change was observed, as shown in Figure 4.4. Therefore 
12mM can be assigned as the CMC of NaTC. This value is in very good agreement with 
NaTC CMC values obtained in water by previous works as shown in Table 4.2. Experiments 
performed in deuterated buffer (d-buffer) yielded a completely different trend. The ∂ values 
were observed at much lower NaTC concentrations, indicating a dramatic impact of the 
presence of salts on the NaTC aggregation. In both buffered solutions NaTC aggregation 
occurred at much lower NaTC concentrations (about 3mM in the two buffers). 
Taurine-conjugated bile acids are strong sulfonic acids with pKa values <2. 251 
NaTC pKa value is about 1.8 at 37 ºC. 261 Being an anionic surfactant, NaTC self-assembling 
behaviour can be affected by the medium pH, but considering its pKa value, no significant 
difference is expected between  pH 5 and pH 6.5. Indeed both media are weakly acidic and 
have pH values well above the pKa of the surfactant. If the pH is sufficiently above the pKa 
of the bile salt, all the bile salt molecules are in their ionized form. 262 A pH close to the pKa 
implies that dissociated and undissociated, i.e. charged and uncharged, molecules are both 
involved in micelle formation, effect that has been reported to lower CMC. 94 Thus, as 
already described in the Introduction Chapter (section 1.4.2), a change in pH has a 
significant effect only when the ionization state of the bile salt molecules is changed. 
Considering the pH values of the media employed in this study, the ionization state of NaTC 
Chapter 4 
 
 128 
was similar in the buffered media and consequently the pH did not have an impact on NaTC 
micellization.  
Another important factor that can influence bile salt aggregation is the ionic strength 
of the medium. Ionic strength increase leads to reduction of the electrostatic repulsion 
between charged groups. Such effect is more significant for micellar than monomeric bile 
salt molecules. This is because that charges carried by the molecules are closer in micelles 
than in bulk solution. Therefore increasing the ionic strength favours aggregation and 
decreases the CMC. 85 The two buffers employed differed significantly for their ionic 
strength and osmolarity values, as described in Chapter 3 (Section 3.2.1, Table 3.1). Despite 
these differences (much higher osmolarity at pH 5, 670 mOsmol/l, than at pH 6.5, 270 
mOsmol/l) the effects of the two buffers on the NaTC aggregation were very similar. Thus, 
this may suggest that the effects of the buffer ions on the surfactant anions were already 
saturated in the phosphate buffer (pH 6.5) with an osmolarity of 270 mOsmol/l, and the 
presence of higher salts concentration in the acetate buffer (pH 5) could not further impact 
on the aggregation. 
The same samples have been analysed using DOSY NMR technique. The NaTC 
self-diffusion coefficients (D) obtained in D2O, acetate and phosphate d-buffers were plotted 
as a function of NaTC concentration and the results are shown in Figure 4.5 and Table 4.3. 
     
Figure 4.5: NaTC self-diffusion coefficient as a function of NaTC concentration, in D2O, acetate 
(pH 5) and phosphate buffers (pH 6.5). (n=3)  
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Table 4.3: NaTC self-diffusion coefficients in D2O, acetate (pH 5) and phosphate buffers (pH 
6.5). (n=3) 
 
NaTC concentration 
(mM) 
D/10-9(m2/s) D2O D/10-9(m2/s) pH 5 D/10-9(m2/s) pH 6.5 
1 0.295±0.011 0.293±0.008 0.299±0.010 
2 0.294±0.011 0.286±0.011 0.285±0.021 
3 0.295±0.005 0.268±0.005 0.266±0.019 
6 0.286±0.002 0.235±0.003 0.219±0.015 
9 0.270±0.023 0.213±0.006 0.198±0.020 
12 0.268±0.022 0.190±0.006 0.178±0.022 
15 0.181±0.005 0.161±0.018 0.165±0.010 
20 0.154±0.007 0.132±0.005 0.147±0.022 
60 0.097±0.017 0.093±0.006 0.102±0.021 
90 0.082±0.018 0.075±0.009 0.085±0.006 
 
It can be seen that the D value of NaTC does not vary significantly in D2O at NaTC 
concentration ranging between 1-12mM. This indicates that no aggregation between the 
NaTC monomers occurred in this concentration range, as the diffusion of NaTC molecules 
did not slow down (the slow-down of diffusion should be observed in the case of formation 
of aggregates). For the samples with NaTC concentration of 15 mM, the self-diffusion 
coefficient lowered from 0.268±0.022 to 0.181±0.005 (10-9(m2/s)), indicating the occurrence 
of NaTC aggregation (most likely to be micellization). The reduced self-diffusion coefficient 
value indicates the formation of bigger aggregates, which diffuse slower in solution. The 
CMC of NaTC measured by the DOSY experiments is 3 mM in both d-buffers, which agrees 
well with  the 1H NMR results.  
In summary, the NMR results have provided useful information on the aggregation 
states of NaTC in blank FaSSIF and blank FeSSIF. In the case on blank FeSSIF, a large 
number of micelles are already formed, as the NaTC concentration is 15mM and 
consequently well above the CMC value indicated by NMR results at pH 5. The obtained 
data confirmed the presence of NaTC micelles mainly in blank FeSSIF medium. The NaTC 
concentration in blank FaSSIF is 3mM, which corresponds to the initiation concentration of 
the surfactant micellisation process. Therefore only few micelles can be present in this 
condition.  
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4.3.3.1 1H and DOSY NMR studies on NaTC-polymers interaction 
1H and DOSY NMR experiments were used to study the molecular interaction 
between NaTC and the two model polymers employed as polymeric carriers for the 
preparation of solid dispersions formulations in Chapter 3, HPMC and PVP. Polymer 
concentration of 0.5 mg/ml was used in order to work in a diluite regime, which is close to 
the polymer concetration in intestinal condition after the dissolution of a polymer based solid 
dispersion formulation.  
 
Figure 4.6: NaTC H12 chemical shift as a function of NaTC concentration in D2O, HPMC 0.5 
mg/ml and PVP 0.5 mg/ml solutions (n=3). 
 
NaTC H12 ∂ were measured in D2O at different NaTC concentrations in the 
presence of PVP and HPMC and plotted as a function of NaTC concentrations. Data shown 
in Figure 4.6 clearly indicate that the apparent CMC of NaTC was lowered in the presence 
of the polymers. This value is referred as critical aggregation concentration (CAC) in 
polymer-surfactant system. 132 This result indicates the presence of NaTC-polymer 
interaction. From the plot it can be seen that the CAC values of NaTC-HPMC and NaTC-
PVP CAC values are very similar and both in the range of 3-6 mM. A plateau region 
between 12 and 15mM can be observed in Figure 4.6, indicating the continuous binding of 
NaTC to the polymers in this concentration range. A new shift of 12H ∂ occurred above 
15mM. This second change in slope indicates that free NaTC micelles started to form and 
that no NaTC further binding occurred onto the polymers. This concentration therefore can 
be treated as the CMC* of NaTC.  
As described by La Mesa, the solution phase in polymer-surfactant systems can be 
divided into three parts. Figure 4.7 shows a schematic representation of these three phases 
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for NaTC-polymer systems based on their 1H NMR results. In phase I no significant 
interaction between NaTC and the polymer occurs, and only free NaTC molecules and 
polymeric chains/entanglements are present in solution. Once CAC is reached, the solution 
phase starts to change and NaTC-polymer interaction is dominant. Therefore in phase II 
mixed NaTC-polymer aggregates are formed. In phase 3 there is competition between 
NaTC-polymer interaction and micellization, and when saturation of the polymer binding 
sites by micellar aggregates is reached (CMC*), free surfactant micelles are formed.  
 
Figure 4.7: Schematic representation of the phase behaviour of NaTC-polymer solutions 
 
 
 
Figure 4.8: NaTC self-diffusion coefficients as a function of NaTC concentration in D2O, HPMC 
0.5 mg/ml and PVP 0.5 mg/ml solutions (n=3). 
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Table 4.4: NaTC self-diffusion coefficients in D20, with and without the presence of polymer. 
(n=3) 
 
NaTC concentration 
(mM) 
D/10-9(m2/s) D2O 
D/10-9(m2/s) HPMC 
0.5mg/ml/D20 
D/10-9(m2/s) PVP 
0.5mg/ml/D20 
1 0.295±0.011 0.300±0.008 0.294±0.001 
2 0.294±0.011 0.313±0.009 0.293±0.006 
3 0.295±0.005 0.292±0.008 0.294±0.007 
6 0.286±0.002 0.279±0.017 0.264±0.017 
9 0.270±0.023 0.231±0.014 0.233±0.024 
12 0.268±0.022 0.205±0.014 0.204±0.018 
15 0.181±0.005 0.176±0.011 0.189±0.016 
20 0.154±0.007 0.136±0.010 0.153±0.007 
60 0.097±0.017 0.106±0.006 0.109±0.010 
90 0.082±0.018 0.087±0.004 0.009±0.010 
 
NaTC interaction with HPMC and PVP in D2O were also investigated by measuring 
the self-diffusion coefficients of the species using NMR. Obtained NaTC self-diffusion 
values are plotted in Figure 4.8 as a function of NaTC concentration. The data are 
summarised in Table 4.4. In the presence of polymers NaTC self-diffusion coefficient (D) 
values showed a significant decrease at a NaTC concentration of 6mM. This decrease of 
NaTC self-diffusion coefficient indicates the slowing down of surfactant molecules diffusion. 
Such effect cannot be attributed to the surfactant micellization, which, as proved by both 1H 
and DOSY NMR data, occurs at 12mM. Therefore the decrease of NaTC self-diffusion 
coefficient at 6mM may be related to the bile salt aggregation with the polymers, which was 
shown to occur between 3 and 6mM for both HPMC and PVP by 1H NMR data. Differently 
from 1H NMR results, it is not possible to observe a second shift in the NaTC-polymer graph 
plots (Figure 4.8) of DOSY data. Hence it is not possible to assign a precise NaTC CMC* 
value. Nevertheless, considering the high NaTC concentration (90mM) reached during the 
experiments, the possibility of the formation of free NaTC micelles in solution cannot be 
excluded, despite the absence of a clear second shift in NaTC/HPMC and NaTC/PVP D 
plots. The absence of a clear shift indicating NaTC CMC* can be due to similar diffusional 
behaviour of NaTC micelles and NaTC-polymer aggregates, which makes not possible the 
identification the onset of NaTC micellization. 
1H NMR experiments on NaTC-PVP and NaTC-HPMC systems have been 
performed also in acetate and phosphate d-buffers in order to investigate the impact of pH 
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and ionic strength of the buffers on the NaTC-polymer aggregation. Obtained results are 
shown in Figure 4.9. As previously discussed in Section 4.3.1.2, the presence of salts had a 
critical impact on NaTC aggregation in both acetate and phosphate buffers. In Figure 4.9 it 
can be seen that the presence of salts had a dramatic impact on NaTC-polymer aggregation. 
The plot shows progressive aggregation behaviour. At pH 5 (Figure 4.9a) the plots of NaTC 
and of NaTC-PVP and NaTC-HPMC systems are very similar, showing a H12 NaTC shift at 
3mM. At pH 6.5 (Figure 4.8b), such shift can be observed at slightly lower NaTC 
concentration, 2mM. For the NaTC-polymer-d-buffer systems this value is likely to 
represent CAC, as it is close to the CAC value obtained for the same system in D2O (3-
6mM).  
 
Figure 4.9: NaTC H12 chemical shift as a function of NaTC concentration in buffer pH 5, 
HPMC 0.5 mg/ml and PVP 0.5 mg/ml solutions (buffer pH 5; a) and in buffer pH 6.5, in HPMC 
0.5 mg/ml and PVP 0.5 mg/ml solutions (buffer pH 6.5;b). (n=3) 
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Figure 4.10: NaTC self-diffusion coefficients as a function of NaTC concentration in buffer pH 5, 
HPMC 0.5 mg/ml and PVP 0.5 mg/ml solutions (buffer pH 5; a) and in buffer pH 6.5, in HPMC 
0.5 mg/ml and PVP 0.5 mg/ml solutions (buffer pH 6.5;b). (n=3) 
 
NaTC-polymer-d-buffer systems have been characterised also by DOSY NMR experiments. 
It can be seen in Figure 4.10 that the D value of NaTC in the presence of HPMC at pH 5 is 
lower than the value obtained in the absence of the polymers. This may be due to the 
increased viscosity of the system as a consequence of the presence of HPMC. According to 
the Stokes-Einstein equation (Refer to Chapetr 2, section 2.3.10.1, Eq. 2.14), D value is 
dependent of the viscosity of the sample, and an increase of viscosity causes a decrease of 
molecular diffusion. D further decreased at NaTC concentration of 3mM, indicating 2mM as 
CAC. D values did not vary in the region 3-6 mM, while a second D decrease could be 
observed at NaTC concentration 20mM, indicating the onset of free micelles formation 
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between 15 and 20mM, range that can therefore  be considered as CMC* value. For the 
system NaTC-PVP-d-buffer at pH 5, it is possible to observe that the D value at the lowest 
NaTC concentration is almost identical to the one obtained in the absence of polymer. 
Therefore, differently form HPMC, the presence of PVP did not lead to significant changes 
in the viscosity of the system. As for NaTC-HPMC-d-buffer system the NaTC CAC value is 
2 mM. CMC* could not be assigned clearly, as from the CAC the addition of more 
surfactant led to a progressive D reduction and no clear shifts in the plot can be observed. 
Considering D values shown in Table 4.5, it is likely that NaTC free micelles started 
forming at NaTC concentration of 15mM, as the most dramatic D reduction is obtained at 
NaTC 20mM. 
Table 4.5: NaTC self-diffusion coefficients in acetate d-buffer (pH 5) with and without the 
presence of polymer. (n=3)  
NaTC concentration 
(mM) 
D/10-9(m2/s) pH 5 
D/10-9(m2/s) HPMC 
0.5mg/ml/ pH5 
D/10-9(m2/s) PVP 
0.5mg/ml/pH 5 
1 0.293±0.008 0.238±0.002 0.287±0.002 
2 0.286±0.011 0.245±0.003 0.280±0.003 
3 0.268±0.005 0.215±0.001 0.226±0.008 
6 0.235±0.003 0.202±0.001 0.232± 0.002 
9 0.213±0.006 0.188±0.010 0.216±0.009 
12 0.190±0.006 0.185±0.014 0.195±0.005 
15 0.161±0.018 0.185±0.001 0.172±0.001 
20 0.132±0.005 0.143±0.001 0.133±0.006 
60 0.093±0.006 0.095±0.001 0.092±0.005 
90 0.075±0.009 0.076±0.012 0.080±0.001 
 
For the system NaTC-HPMC-d-buffer system at pH 6.5 the association between 
NaTC and HPMC seemed to start at the lowest NaTC concentration tested (1mM). Indeed a 
first decrease of the D value was observed at the NaTC concentration 2mM. As for the same 
system at pH 5, a plateau region for the D values between 6 and 12 Mm (Table 4.5) can be 
observed. The D value of NaTC further decreased at 15 mM, suggesting that the formation 
of free micelles started at NaTC 12-15mM. Hence both CAC and CMC* of the NaTC-
HPMC system resulted to be lower in the phosphate d-buffer at pH 6.5 than in the acetate d-
buffer at pH 5. Such result is in contrast with the higher osmolarity of the acetate buffer, 
which, considering the much higher concentration of ions, was expected to have more 
dramatic impact on the NaTC/polymer aggregation. The higher impact of the phosphate 
buffer may be due to a different effect of the phosphate and acetate ions on the NaTC-
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HPMC aggregation, and further investigation is required. NaTC-PVP-d-buffer at pH 6.5 
system showed a very similar behaviour compared the same system at pH 5. 
Table 4.6: NaTC self-diffusion coefficients in phosphate d-buffer (pH 6.5), with and without the 
presence of polymer. (n=3) 
NaTC concentration 
(mM) 
D/10-9(m2/s) pH 6.5 D/10-9(m2/s) HPMC 
0.5mg/ml/ pH6.5 
D/10-9(m2/s) PVP 
0.5mg/ml/pH 6.5 
1 0.299±0.010 0.259±0.027 0.253±0.030 
2 0.285±0.021 0.223±0.003 0.253±0.033 
3 0.266±0.019 0.203±0.002 0.248±0.003 
6 0.219±0.015 0.162±0.001 0.209±0.001 
9 0.198±0.020 0.156±0.002 0.165±0.002 
12 0.178±0.022 0.159±0.003 0.154±0.001 
15 0.165±0.010 0.127±0.001 0.146±0.004 
20 0.147±0.022 0.131±0.002 0.129±0.007 
60 0.102±0.021 0.102±0.001 0.099±0.001 
90 0.085±0.006 0.078±0.018 0.083±0.005 
 
A summary of CMC, CAC and CMC* values is shown in Table 4.7. 1H and DOSY 
NMR data indicated the decrease of CAC and CMC* for both HPMC/NaTC and in d-buffer 
media, compared to values obtained in D2O. It has been reported that the addition of 
electrolytes increases the binding ratio of surfactant to polymers. 263 Different studies have 
also shown that the association between polymers and surfactants starts at much lower 
surfactant concentration in the presence of salts, leading to a decrease of the CAC. 264,265 Xia 
et al also proved that the number of micelles bound to polymer increase when higher ionic 
strength is used. 266 The ions effect on NaTC-polymer association is related to the ions 
charge screening effect on the surfactant anions, but can also be attributed to the ions effect 
on the polymers behaviour. Both HPMC and PVP are non-ionic polymers, therefore the 
presence of salts is not expected to impact he polymers behaviour. Nevertheless, previous 
studies have demonstrated that ions can affect polymer behaviour in solution, exerting 
salting-in and salting out effects. The ions effect is mainly due to their water structuring 
capability. The formation of a more ordered water structure causes a reduction of the number 
of free water molecules available to interact with the polymer chains. 267 Therefore the 
reduction of CAC is likely to be a consequence of ions effect on both NaTC and polymeric 
carriers. This effect from the presence of ions seemed to favour polymer-NaTC association.  
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Table 4.7: CMC, CAC and CMC*(mM) value in the different media studied obtained by NMR 
studies 
Medium CMC CAC CMC* 
D2O 12 - - 
Acetate D-buffer 3 - - 
Phosphate D-buffer 3 - - 
HPMC/D20 - 3-6 15 
PVP/D20 - 3-6 15 
HPMC/Acetate D-
buffer pH5 - 2 15 
HPMC/Phosphate D-
buffer pH6.5 - 1 12 
PVP/Acetate D-buffer 
pH5 - 2 Not assignable 
PVP/Phosphate D-
buffer pH6.5 - 3 15 
 
4.3.3.2 Predicted solution phase composition of blank FaSSIF and blank FeSSIF 
media containing model polymers  
NMR results suggested the possible NaTC-HPMC and NaTC-PVP aggregations in 
d-FaSSIF and d-FeSSIF. Therefore obtained results can provide information about the 
nanostructure of the solutions of blank FaSSIF and FeSSIF during the dissolution of a solid 
dispersion formulation. 1H and DOSY data showed that NaTC interacts with both PVP and 
HPMC even at very low concentrations. In particular for NaTC-HPMC system CAC was 
1mM at pH 6.5 and 2mM and pH 5. As the NaTC concentration in blank FaSSIF is 3mM, 
NaTC-HPMC aggregation hence can occur during the dissolution of spray dried HPMC 
solid dispersions in blank FaSSIF. CMC* value for the same system was 15 mM in both 
acetate and phosphate d-buffers. Therefore no NaTC free micelles can form in blank FaSSIF. 
Instead in blank FeSSIF, due to the higher NaTC concentration (15mM), both CAC and 
CMC* are reached. This can lead to the formations of both NaTC-HPMC complexes and 
free NaTC micelles. The possible solution composition of blank FaSSIF and blank FeSSIF 
in the presence of HPMC are schematically illustrated in Figure 4.11. 
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Figure 4.11: Schematic representation of HPMC/NaTC aggregation in blank FaSSIF and blank 
FeSSIF media. 
 
PVP also interacts with NaTC in the blank FaSSIF medium, as NaTC concentration 
in blank FaSSIF medium close to the CAC value of NaTC-PVP system. However only few 
aggregates can be formed in solution as 3mM represents the onset point for NaTC-PVP 
aggregation. As for NaTC-HPMC system in blank FeSSIF, the NaTC concentration matches 
the CMC* value of NaTC-PVP system, which makes the saturation of PVP binding sites 
possible and leads to the presence of free NaTC micelles formation, as illustrated in Figure 
4.12. The detailed physicochemical properties of the NaTC-HPMC and NaTC-PVP 
aggregates were investigated by light and neutron scattering techniques, and the obtained 
results are discussed in Chapter 5. 
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Figure 4.12: Schematic representation of NaTC/PVP aggregation in blank FaSSIF and blank 
FeSSIF media. 
 
  
4.3.4. NMR investigation into the effect of polymer-bile salts aggregation on 
piroxicam solubilisation  
 1H NMR was employed to study the possible impact of HPMC and PVP association 
with NaTC on piroxicam solubility in aqueous based solutions. As shown by steady state 
solubility studies described in Chapter 3 (Section 3.3.2), piroxicam was more soluble in 
FaSSIF than FeSSIF medium. The drug solubility obtained in the presence of PVP (≈0.3 
mg/ml) was higher than the one obtained in the presence of HPMC (≈0.2 mg/ml). Figure 
4.13 shows that piroxicam spectrum in D2O is characterised by the presence of poorly 
resolved peaks and a low signal-to-noise ratio. This is a consequence of the poor water 
solubility of the drug, which limited piroxicam solubilisation in D2O and consequently the 
NMR resonance of the sample. The signal-to-noise ratio of the piroxicam spectrum 
improved in blank FaSSIF, suggesting a higher solubilisation of the drug in the medium 
compared to D2O. Further spectrum quality improvement was obtained in the presence of 
HPMC, but the most resolved spectrum was obtained in the presence of PVP. Although the 
1H NMR spectrum quality was still not ideal, the comparison provided clear indication of 
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piroxicam solubility increase in the presence of both the NaTC and polymer, which is in 
agreement with steady state solubility studies. 
 
Figure 4.13: 1H piroxicam NMR spectra in D2O, blank FaSSIF, blank FaSSIF in the presence 
on HPMC and blank FaSSIF in the presence of HPMC.  
 
Figure 4.14 shows piroxicam 1H NMR results obtained in blank FeSSIF, with and 
without the presence of polymers. In this case the presence of NaTC and the polymers 
yielded a complete different effect on the drug spectrum. Indeed the number of peaks 
decreased in the presence of surfactant. Such effect is likely to be due to the drug 
solubilisation in NaTC micelles and/or NaTC/polymer aggregates, leading to the hindrance 
of the original drug peaks in the spectrum. 268  
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Figure 4.14: piroxicam 1H NMR spectra in D2O, blank FaSSIF, blank FaSSIF in the presence 
on HPMC and blank FaSSIF in the presence of HPMC.  
 
The different effects of blank FaSSIF and blank FeSSIF on the piroxicam 1H NMR 
spectrum suggest that drug solubilisation effect is governed by different mechanisms in the 
two media. In blank FaSSIF the higher solubilisation of piroxicam is mainly due to the pH of 
the media causing disassociation of the drug. As described in Chapter 3 piroxicam is pH 
sensitive and is more soluble in blank FaSSIF. Therefore the primary role in the drug NMR 
signal improvement might be played by the pH rather than by NaTC-polymer aggregates. 
Considering that NaTC concentration is slightly above the CAC values of NaTC-HPMC and 
NaTC/PVP systems, it is likely that only low number of aggregates present in solution.  Due 
to the higher NaTC concentration in blank FeSSIF, many more NaTC-polymer complexes 
can be formed. Moreover free NaTC micelles might also be present, as NaTC concentration 
reaches both NaTC-HPMC and NaTC-PVP CMC* values. Therefore free NaTC micelles 
could potentially be involved in the drug solubilisation. It can be concluded that both blank 
FaSSIF and FeSSIF significantly improve the piroxicam 1H NMR signal. Drug signal was 
further improved by the presence of PVP and HPMC, suggesting that the polymer and 
NaTC-polymer complexes may play an role in the drug solubilisation.   
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4.4 Surface tension measurements 
4.4.1 Characterisation of NaTC aggregation 
NaTC aggregation behaviour in water, acetate and phosphate buffers was 
investigated by the use of pendant drop technique. The average interfacial tension values 
measured continuously within 15 minutes equilibration using the pendant drop method are 
shown in Figure 4.15. It can be seen that the interfacial tension of NaTC in water was 
relatively high (45mN/m) even at the maximum surfactant concentration studied. This 
indicated a loose arrangement of NaTC at the air-water interface, rather than the formation 
of a compact layer, as described by previous work. 269 The concentration at which the 
interfacial tension starts to be constant corresponds to the saturation of the interface and is a 
good indication of CMC. This result on CMC is in good agreement with the values reported 
in literature. As shown by Figure 4.15 this value was about 12mM, as surface tension value 
did not change between 12 and 20mM, indicating the saturation of the air water interface 
with NaTC micelles. These interfacial tension results indicate a progressive aggregation of 
the surfactant, which is in agreement with data obtained by NMR experiments.  
 
Figure 4.15:NaTC interfacial tension as a function of NaTC concentration in MilliQ water, 
acetate (pH 5) and phosphate buffers (pH 6.5). (n=2) 
 
As already proved by NMR data (Section 4.3.1.3), the presence of salts can 
significantly impact the NaTC aggregation. CMC was lowered as a consequence of the 
decreased electrostatic repulsion between charged groups on the surfactant molecules, which 
favoured the micellisation. The presence of salts decreased NaTC interfacial tension, as seen 
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in Figure 4.15. In particular the saturation point was reached at NaTC concentration of 3mM 
in acetate buffer and at 9mM in phosphate buffer. In contrast to the NMR results, a 
significant difference can be seen between the two buffers. This may suggest that NaTC 
charges that can cause repulsion between NaTC molecules were not neutralized in phosphate 
buffer (270mOsmol/l), and that the higher salts concentration present in acetate buffer led to 
further CMC reduction. 
 
4.4.2 Characterisation of NaTC-polymer aggregation 
Pendant drop experiments were performed to investigate NaTC-polymer aggregation. 
Figure 4.16 shows the effects of PVP and HPMC on the surface tension of the aqueous 
solutions before NaTC addition. It can be seen that, as already described in literature, HPMC 
is surface active even in dilute regime. 270 This caused a reduction of the interfacial tension 
from 72.8mN/m to 63.11mN/m.  In contrast to HPMC, the presence of PVP lead to much 
lower interfacial tension reduction, yielding a value of 68.9 mN/m and confirming the lower 
surface activity of PVP in dilute regime compared to HPMC. 271 
The addition of NaTC caused further surface tension reduction in both systems. In 
the case of NaTC-HPMC system, interfacial tension decreased to 50.78mN/m at NaTC 
concentration of 3mM. Further addition of NaTC did not cause further interfacial tension 
reduction. This suggested the possible formation of NaTC-HPMC aggregates and the 
saturation of the air/water interface with such aggregates. Therefore 3mM can be considered 
as the CAC of NaTC-HPMC solution. Interfacial tension further decreased to 47.09mN/m at 
NaTC concentration of 15mM, indicating the reach of CMC* and the formation of free 
NaTC micelles. Both CAC and CMC* value are in excellent agreement with results obtained 
in D2O by NMR 1H and DOSY measurements.  
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Figure 4.16:NaTC interfacial tension as a function of NaTC concentration in MilliQ water, 
HPMC 0.5 mg/ml and PVP 0.5 mg/ml solution (MilliQ water). (n=2) 
 
 
In the case of NaTC-PVP system, two plateaux can be seen in Figure 4.16. The first 
one is between 3 and 6mM indicating the CAC being 3mM. The second plateau is between 9 
and 20mM, suggesting the occurrence of free NaTC micelles formation. In this case NaTC 
aggregation started at NaTC concentration 9mM, therefore at lower concentration compared 
to NaTC/HPMC system. Such results suggest of HPMC binding sites are saturated at higher 
HPMC concentration than PVP ones, indicating higher binding of NaTC to HPMC than to 
PVP. 
 
Figure 4.17:NaTC interfacial tension as a function of NaTC concentration in acetate buffer (pH 
5), HPMC 0.5 mg/ml and PVP 0.5 mg/ml buffered solutions (pH 5). (n=2) 
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Figure 4.17 shows interfacial tension results obtained in acetate buffer with and 
without the presence of polymers. Results show the impact of salts on the NaTC-polymer 
aggregation. Indeed lower interfacial tension values were obtained in comparison to NaTC-
polymer systems in water. For NaTC-HPMC systems the interfacial tension profile revealed 
a progressive aggregation with a small plateau between 1 and 2mM, suggesting that NaTC-
HPMC aggregation occurred at the lowest NaTC aggregation (1mM). Interfacial tension 
value decreased in the NaTC concentration range from 3-12mM. The second plateau is 
between 12 and 20 mM. The start of the second plateau corresponds to NaTC CMC*. 
Therefore both CAC and CMC* decreased in the presence of salts in NaTC-HPMC system. 
In the case of NaTC-PVP systems interfacial tension progressively decreased with NaTC 
concentrations between 1 and 3mM, indicating 3mM as CAC. The interfacial tension 
reached a plateau between 3 and 20mM, thus it is not possible to establish whether free 
NaTC micelles were formed or not and CMC* was not assignable. 
 
Figure 4.17:NaTC interfacial tension as a function of NaTC concentration in MilliQ water, 
HPMC 0.5 mg/ml and PVP 0.5 mg/ml solution (MilliQ water). (n=2) 
 
Figure 4.17 shows the interfacial tension results obtained in phosphate buffers. It 
can be seen that the interfacial tension values for NaTC and NaTC-PVP and NaTC-HPMC 
in the phosphate buffers are very similar to the ones obtained at pH 5, confirming a similar 
impact of the two buffers on NaTC-polymer aggregation. For NaTC-HPMC systems, the 
CAC value is about 3mM as in acetate buffer and the CMC* value is 15mM. For NaTC-PVP 
systems, the CAC value is 3mM, confirming the result obtained at pH 5. In contrast to the 
results obtained in acetate buffer, a second interfacial tension decrease was observed at 9mM, 
indicating such value as possible CMC*. As summarised in Table 4.8, the interfacial tension 
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results confirmed the occurrence of NaTC-polymers aggregation, yielding CAC and CMC* 
values similar to the one obtained by NMR techniques.  
Table 4.8: CMC, CAC and CMC* (mM) value in the different media studied obtained by 
interfacial tension studies 
Medium CMC CAC CMC* 
H20 12 - - 
Acetate buffer 3 - - 
Phosphate buffer 3 - - 
HPMC/H20 - 3-6 15 
PVP/H20 - 3-6 15 
HPMC/Acetate 
buffer pH5 
- 2 15 
HPMC/Phosphate 
buffer pH6.5 
- 1 12 
PVP/Acetate buffer 
pH5 
- 2 Not assignable 
PVP/Phosphate 
buffer pH6.5 
- 3 15 
 
4.5 Conclusions 
In this Chapter NaTC-HPMC and NaTC-PVP aggregation was characterised by the 
use of NMR analysis and pendant drop technique. The occurrence of NaTC-HPMC and 
NaTC-PVP aggregation was indicated in aqueous medium. Both NMR and interfacial 
tension results confirmed the important impact of salts on the surfactant-polymer 
aggregation. Based on obtained results it is possible to conclude that the occurrence of 
NaTC-HPMC and NaTC-PVP interaction can be expected in blank FeSSIF, as for both 
system NaTC CAC is well below the bile salt concentration employed in blank FeSSIF. The 
presence of few free NaTC micelles is also possible. As CMC* is 15mM for both systems, 
both NaTC-polymer aggregates and NaTC micelles can be present in the blank FeSSIF 
media. In the case of FaSSIF only few NaTC-HPMC aggregates can be expected, as CAC 
value of the system corresponds to NaTC concentration in the medium (3mM). No free 
NaTC micelles can be expected, as NaTC concentration is well below CMC* of the system. 
In the case of NaTC-PVP systems, NMR and pendant drop experiments yielded different 
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CAC values, which are very close. Therefore the phase solution composition of NaTC-PVP 
system in blank FaSSIF is likely to be composed mainly by free NaTC molecules and free 
polymeric chains. 
Size and shape of NaTC/polymer aggregates and NaTC micelles were further 
studied by different light and neutron scattering techniques and cryo-TEM microscopy. The 
possible encapsulation of the drug in the different species of aggregations was also studied 
and is discussed in Chapter 5.   
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Chapter 5. Characterisation of polymer-bile salts complexation in 
simulated intestinal fluids  
5.1 Introduction 
The dissolution mechanism of solid dispersion has widely been studied 69 and the 
possible factors affecting the drug release from solid dispersion formulations have been 
investigated and characterized. 221,272,273 Nevertheless, as discussed in previous Chapters, the 
possible impact of the interactions occurring between intestinal fluids components and 
polymeric carriers used in solid dispersions is still poorly understood and only few studies 
have focused on this topic. 246 
Due to the complexity of intestinal fluid composition, 18 the mechanistic study of 
solid dispersion dissolution in gastrointestinal condition is extremely challenging. In 
particular the study of the interaction between each key component of intestinal fluid and the 
polymeric carrier and the characterization of species yielded by such interaction are very 
difficult to perform. For this reason this study solely focused on the characterization of the 
interactions of NaTC, a model bile salt, with HPMC and PVP, two of the model polymeric 
carriers employed for the preparation of solid dispersions in this research project (Chapter 3). 
As shown in Chapter 4 hydrophilic polymers can interact with NaTC, which is a 
primary component of intestinal fluids. Similar interactions have been reported in literature 
by studies in which other bile salts where employed. 274,275 These interactions can lead to the 
formation of polymer-surfactant aggregates. 
The focus of this Chapter is to characterise the resulting polymer-bile salts 
aggregates, with particular focus on the aspects of their size, shape and ability to encapsulate 
drug molecules. Dynamic light and neutron scattering techniques were employed to 
investigate these properties of the aggregates in different simulated intestinal media, with 
and without the presence of drug. Cryo-TEM technique was used to image the aggregates in 
FaSSIF and FeSSIF media. 
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5.2 Experimental methods 
5.2.1 Dynamic Light Scattering (DLS) 
DLS experiments were performed on a Zetasizer Nano ZS, Malvern Instrument, 
(Malvern, Worcestershire, United Kingdom) fitted with a 633 nm red laser. Sample were 
prepared by dissolving accurately weighed materials in the medium and left in magnetic 
agitation for 1 hour at 37 °C. Samples were centrifuged at 2000g for 10 minutes, in order to 
remove dust particles from the scattering volume.  Approximately 1 ml of sample was 
transferred in a disposable cuvette (pathlenght 1cm) and left to reach equilibration for 15 
minutes.  The autocorrelation functions were measured at a fixed angle of 173° (Back 
Scattering detection).  Measurements were performed at 37 °C. Each measurement was 
composed of 5 runs of 1 minute and was repeated three times (n=3). All final hydrodynamic 
size distributions (intensity-weighted) of the studied aggregates were derived by fitting 
autocorrelation functions using the CONTIN algorithm. 
5.2.2 Nanosight measurements 
Nanosight experiments were carried out using a LM10 Nanosight (Nanosight Ltd- 
Malvern Instruments Ltd, Malvern Worcestershire, United Kingdom), fitted with a 638 nm 
laser.  Nanosight technique was used to visualize and size polymer, bile salts and bile salts-
polymer aggregates in solution. Experiments were performed at room temperature. The 
temperature of each run was measured and taken into consideration when the size 
calculation was performed by the software. Particle tracking analysis was performed using 
Nano-tracking Analysis (NTA) software. All samples were analysed in triplicate (n=3). 
5.2.3 Neutron scattering measurements 
5.2.3.1 Spin-Echo Small Angle Neutron Scattering (SESANS) 
SESANS measurements were carried out using the ISIS Off-spec reflectometer 
(ISIS-Rutherford Appleton Facilities-Didcot, UK). Sample were prepared by dissolving 
accurately weighed materials in the medium and left in magnetic agitation for 1 hour at 
37 °C. Tested media were prepared in D-buffer and all samples were measured using 1mm 
cells. 
 Off-spec at ISIS was one of the newest equipment installed in the ISIS which is 
able to study a broad range of surfaces and interfaces. This study was the first ever study 
performed using SESANS on such kind of sample (aqueous samples). As described in 
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literature the spin-echo length 𝜁 in a SESANS experiment is described by  
                                                            𝜁 = 𝑐𝜆2𝐵𝐿𝑐𝑜𝑡𝜃02𝜋                                                       𝐸𝑞. 5.4 
where λ is the neutron wavelength, L is the length of the first precession region and B its 
magnetic induction, θ is the inclination angle. c is given by 
𝑐 = 𝛾𝑚
ℎ
 
with γ the gyromagnetic ratio and m the mass of neutrons respectively and h the Plank’s 
constant. 
5.2.3.2 Small Angle Neutron Scattering (SANS) 
SANS measurements were carried out at the ISIS SANS2-D spectrometer (ISIS-
Rutherford Appleton Facilities-Didcot, UK). Sample were prepared by dissolving accurately 
weighed materials in the medium and left in magnetic agitation for 1 hour at 37 °C. Sample 
were centrifuged at 2000g for ten minutes to remove dust particles and un-dissolved drug 
molecules from the samples. Tested media were prepared in D-buffer and all samples were 
measured using 2mm cells. The Q-range covered in these experiment was 0.005-0.5 A-1. 
Experiments were performed at 37 °C. Each measurement was performed in duplicate (n=2). 
Collected data were analysed using SansView software. The data were fitted using 
the Cylinder Elliptical Model, which gave the best fit to the experimental data. The 2-D 
scattering intensity for elliptical cylinders is given by  
𝐼(𝑞) = 𝑆𝑐𝑎𝑙𝑒
𝑉𝑐𝑦𝑙
∫ 𝑑𝜓 ∫𝑑𝜙 ∫𝑝(𝜃,𝜙,𝜓)𝐹2(𝑞,𝑎,𝜓) sin𝜃𝑑𝜃 + 𝑏𝑘𝑔        Eq. 5.1 
where the angles θ and ϕ define the cylinder orientation, while ψ defines the orientation of 
the major axis of the ellipse with respect to the vector Q. bkg is the background, VCyl is the 
cylinder volume, and functions are given by 
                                                      𝐹(𝑞,𝛼,𝜓) = 2 𝐽1(𝑎)
𝑎
∗
sin(𝑏)
𝑏
                                         𝐸𝑞. 5.2 
                                            𝑎 = 𝑞 ∗ sin(𝛼)[𝑟𝑚𝑎𝑗𝑜𝑟2 𝑠𝑖𝑛2(𝜓) + 𝑟𝑚𝑖𝑛𝑜𝑟 2 cos (𝜓)]1/2           𝐸𝑞. 5.3 
                                                                 𝑏 = 𝑞 𝐿2  cos(𝛼)                                                      𝐸𝑞. 5.3 
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where L is the cylinder length.  
5.2.4 Cryogenic-Transmission Electron Microscopy (Cryo-TEM) 
Cryo-TEM measurements were performed to visualize NaTC/HPMC aggregates in 
blank FeSSIF and blank FeSSIF media. Samples were prepared by dissolving appropriately 
weighed solid dispersion in the studied medium and left in magnetic agitation for 1 hour at 
37 °C. Samples were centrifuged at 2000g for 10 minutes and the supernatant solutions were 
analysed after 24 hours. 
All cryo-TEM analysis was performed via a characterisation service provided by the 
Department of Physical Chemistry, Uppsala University, Sweden. Samples were prepared 
according to the reported routine procedure described briefly as follow.203 A small droplet of 
the sample solution was placed under controlled conditions on a pre-treated Cu grid of about 
20 μm thickness, which was covered by a perforated cellulose acetate butyrate film. Excess 
material was removed by a gentle wiping off with a filter paper. The specimen was vitrified 
by being rapidly transferred into liquid ethane. The sample examination was performed with 
a Zeiss 902 A electron microscope operating at 80 kV at 100K.  
 
5.3 Results and discussion 
5.3.1 Light scattering characterisation of simulated intestinal fluids  
In order to investigate the aggregation behaviour of NaTC, DLS analysis was 
performed on blank FaSSIF and FeSSIF media. As reported in Chapter 4, the NaTC 
concentration in blank FaSSIF (3mM) is close to the CMC value of NaTC in phosphate 
buffer. Therefore only few micelles could be present in solution.  Scattering intensity of the 
DLS result was too weak (data not shown) for blank FaSSIF, confirming the absence of 
micelles or the presence of a limited number of them. DLS analysis was also performed for 
blank FeSSIF. Similar to the results obtained for blank FaSSIF, autocorrelation function was 
not reproducible and reliable (data not shown).  For this reason, a different type of light 
scattering technique, Nanosight, with more direct visualisation capability, was used instead 
of DLS. The advantage of Nanosight technique is being suitable for both monodispersed and 
polydispersed samples and can be used for more dilute samples characterisation compared to 
DLS. 276 Nanosight technique was employed to characterize these two samples.  
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Nanosight analysis showed the presence of only few aggregates in solution for blank 
FaSSIF and, consequently, accurate statistic of particle size could not be performed (data not 
shown). This result was in agreement with DLS data that showed an extremely weak 
scattering, suggesting the presence of very low number of micelles in solution.  
  
Figure 5.1: Nanosight size distribution of NaTC (15mM) micelles in MilliQ water and blank 
FeSSIF (a), and Nanosight NaTC micelles in blank FeSSIF image (b). (n=3) 
 
Nanosight analysis was performed on blank FeSSIF and, in order to investigate the 
effect on salts on the NaTC aggregates features, a NaTC 15 mM in milliQ water was also 
analysed (Figure 5.1). It can be seen that large populations of micelles with mean diameters 
of 100 nm are present in both samples. The presence of salts shows an impact on NaTC 
aggregation, as it led to the formation of more polydispersed micelles. As already discussed 
in Chapter 4 an increase of the ionic strength can favour NaTC aggregation by decreasing 
the CMC of the surfactant. 85 Furthermore as described in the Chapter 1, bile salts can form 
secondary micelles via the hydroxyl groups hydrogen bonding interaction. Therefore the 
large size obtained for NaTC micelles is likely to be at least partially due to the occurrence 
of secondary micelles formation. 
                                     
Figure 5.2: DLS intensity autocorrelation function and size distribution by intensity of FaSSIF 
and FeSSIF media (n=3). 
a 
b 
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DLS analysis was performed also on FaSSIF and FeSSIF (with lecithin), in order to 
investigate the impact of lecithin on the aggregation behaviour of the bile salts. Obtained 
results are shown in Figure 5.2. As shown by Figure 5.2 the two media have different 
autocorrelation functions, indicating the presence of different aggregates in the two samples 
solutions. FaSSIF yielded a mono-modal autocorrelation function, suggesting the presence 
of one population of aggregates with size of 258±13 d.nm. For FeSSIF a bimodal decay can 
be seen in Figure 5.2, indicating the presence of two populations of aggregates, labelled as 
fast (smaller) and slow (bigger) modes, having sizes of 133±14 and 552±39 d.nm 
respectively. The formation of two populations of aggregates may be attributed to the higher 
NaTC concentration in FeSSIF than FaSSIF medium, which might lead to the formation of 
mixed lecithin-NaTC aggregates having different sizes. As described in literature, bile salts-
lecithin solution composition and aggregates features are strictly dependent on the lecithin-
bile salts ratios. 277 The phase diagram of phospholipid-surfactant-water mixtures was 
reported by Andrieux et al., as shown in Figure 5.3. 278 At low surfactant concentration 
mainly lecithin vesicles are present in solution, while the increase of surfactant concentration 
leads to the formation of mixed micelles with smaller sizes.  
 
Figure 5.3: Ternary phase diagram of phospholipid/surfactant/water mixture and vesicle to 
micelles transition. 278 
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Boni et al described FaSSIF and FeSSIF phase composition. 279 Reported data 
showed the presence of a mono-modal distribution of aggregates in FaSSIF and a bimodal 
distribution in FeSSIF. This is in good agreement with data obtained in this study. However, 
the sizes of the aggregates reported in literature are significantly smaller than the ones 
obtained in this study. Such difference might be related to different raw materials used 
and/or equipment employed for the media preparation. 
 
5.3.2 Light scattering characterisation of HPMC-NaTC complexes  
DLS was also employed to study the aggregation between HPMC and NaTC. As 
already mentioned in Chapter 4, HPMC is a surface-active polymer, therefore, in order to 
investigate the polymer aggregation on its own, spray dried HPMC dissolved in the buffers 
was firstly analysed. As shown by Figure 5.4, DLS results of spray dried HPMC in pH 6.5 
phosphate buffer show the presence of two populations of polymeric aggregates. The 
bimodal distribution is in good agreement with literature data, which reported the formation 
of two populations of HPMC aggregates even in highly diluted regimes. 150 
  
Figure 5.4: DLS intensity autocorrelation functions and size distribution by intensity of spray 
dried HPMC in buffer pH 6.5, spray dried HPMC in blank FaSSIF and spray dried 
HPMC:piroxicam 2:1 solid dispersion in blank FaSSIF (n=3). 
 
The smaller population of HPMC aggregates is characterized by a size of 40±9 d.nm, 
while the bigger population is 231±45 in size. As shown by sizes distribution graph in 
Figure 5.4, DLS measurements performed in blank FaSSIF yielded the aggregates sizes very 
close to the ones obtained for HPMC in buffer. Two populations of aggregates with sizes of 
48±5 and 238±20 d.nm were obtained for HPMC in blank FaSSIF sample (as summarised in 
Table 5.1). This data indicates that the presence of NaTC did not impact significantly on the 
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aggregation behaviour of HPMC. As reported in Chapter 4 NaTC concentration (3mM) of 
blank FaSSIF close to the CAC value of the system, which according to NMR and surface 
tension results was in the range of 3-6 mM. Therefore HPMC/NaTC aggregation is expected 
to be limited in blank FaSSIF media. The similar sizes obtained from the samples of HPMC 
in buffer pH 6.5 and in blank FaSSIF suggest that the low NaTC concentration may be the 
cause of the limited aggregation between HPMC and NaTC in blank FaSSIF. 
As shown in Figure 5.4 the presence of piroxicam slightly changed the 
autocorrelation function of the DLS results. For the spray dried formulation dissolved in 
blank FaSSIF an increase in aggregate size was obtained in the bigger population of 
aggregates (333±59 d.nm), suggesting a possible role of the polymer aggregates in the drug 
solubilisation via drug encapsulation. The smaller population yielded a size of 44±5 d.nm. 
 
Figure 5.5: DLS normalised autocorrelation function and size distribution by intensity of spray 
dried HPMC in buffer, spray dried HPMC in blank FeSSIF and spray dried HPMC:piroxicam 
2:1 solid dispersion in blank FeSSIF (n=3). 
 
As seen in Figure 5.5, DLS results obtained for spray dried HPMC at pH 5 were 
similar to the one obtained at pH 6.5, indicating a bimodal distribution of aggregates. 
Nevertheless, the size of the slower (and therefore bigger in size) population is bigger in the 
media with pH 5 than in the media with pH 6.5. The sizes of the aggregate populations 
obtained for HPMC at pH 5 are 42±8 and 341±39 d.nm. The two buffers have different 
osmolarity (buffer pH 5 270 mOsmol/Kg, buffer pH 5 670 mOsmol/Kg) and, as mentioned 
in Chapter 4 (Section 4.3.1.3), salts can influence polymer aggregation via salting-in and 
salting-out effect. 267 Therefore the different size obtained for the bigger population of 
aggregates might be due to the different osmolarity of the phosphate and acetate buffer 
employed which can influence the hydration of the polymeric chains and the hydration 
sphere of polymeric aggregates. 
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In Blank FeSSIF the scattering curve of HPMC/blank FeSSIF sample shows 
different relaxation times compared to HPMC in buffer pH 5. In particular the second 
population of aggregates decreased in size to 221±26 d.nm, while the smaller population was 
constant in size yielding a diameter of 40.9±10 nm. As shown in Figure 5.5 in the presence 
of drug the smaller population of polymer aggregates did not change in size, while the 
bigger one increased in size to 423±70 d.nm. Both NMR and surface tension experiments 
(Chapter 4) indicated the occurrence of HPMC/NaTC aggregation in blank FeSSIF. DLS 
data showed the presence of a population of particles with consistently smaller size. This 
population is likely to be mainly composed of dissolved polymers and/or polymeric 
aggregates. The bigger population size change in the presence of NaTC, suggested the 
possible formation of NaTC/HPMC aggregates, which are likely to be structurally more 
retained and therefore smaller than the polymeric ones. The size increase of the 
HPMC/NaTC aggregates for the spray dried formulation sample is likely to be due to the 
drug encapsulation in the aggregates. This is in agreement with what shown by NMR 
spectrum of spray dried formulation sample (refer to Chapter 4, Section 4.3.4) that suggested 
a possible drug solubilisation via NaTC and/or NaTC/HPMC aggregates. 
 
Figure 5.6: DLS normalised autocorrelation functions and size distributions by intensity of 
spray dried HPMC:piroxicam 2:1 solid dispersion in FaSSIF and FeSSIF (n=3). 
 
In order to evaluate the impact of lecithin on HPMC-NaTC aggregation, DLS 
analysis was performed also on spray dried samples dissolved in FaSSIF and FeSSIF. Figure 
5.6 shows DLS results obtained for the two samples. It can be seen that the size distributions 
changed completely for both samples compared to the ones obtained in blank FaSSIF and 
blank FeSSIF, indicating a significant influence of lecithin on the aggregation. A very broad 
peak was obtained for spray dried formulation in FaSSIF containing lecithin. As reported in 
Section 5.3.1 FaSSIF itself yielded a population of aggregates having a diameter of 258±13 
d.nm. In the presence of the spray dried formulation much broader peak was obtained, with 
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an average size of 330±73 d.nm, suggesting the formation of possible new species in 
solution that lead to a much more polydisperse size distribution. This resulting solution 
possibly contained different populations of aggregates that could not be distinguished in the 
scattering pattern (due to possible overlaying). For spray dried HPMC:piroxicam 
formulation dissolved in FeSSIF two populations of aggregates were present, as shown by 
Figure 5.6. This is in agreement with the bimodality of FeSSIF medium aggregates 
distribution, but a significant increase in size was observed for both populations of the 
aggregates. The increase in size of aggregates in HPMC:piroxicam 2:1 in FeSSIF and 
FaSSIF compared to media without lecithin, suggests the possible formation of new species 
in solution. The size increase may also indicate the possible drug molecules encapsulation in 
the aggregates, which might cause their swelling and subsequently increase in size. 
Literature data previously reported HPMC ability to associate with anionic 
surfactant. 280 Furthermore NMR and interfacial tension data provided consistent indications 
of formation of HPMC/NaTC aggregation (refer to Chapter 4). Therefore obtained DLS data 
suggest that HPMC and NaTC are likely to interact in the simulated intestinal fluids 
employed in this study, in particular in blank FeSSIF due to the higher NaTC concentration. 
Nevertheless, due to the complexity of the systems analysed and the possible presence of 
different species in solution, a detailed description of the scattering aggregates composition 
could not be accurately obtained by only relying on DLS data. Therefore further studies, 
described in the next part of this Chapter, were performed in order to better clarify the 
solution phase composition of the different samples and the aggregates features. The particle 
sizes of different HPMC samples measured by DLS are summarised in Table 5.1. 
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Table 5.1: Summary of PVP and PVP/NaTC aggregates in different dissolution media 
Sample SIZE (d.mn) population 1 SIZE (d.mn) population 2 
Spray dried HPMC buffer 
pH 6.5 
40±9 231±45 
Spray dried HPMC blank 
FaSSIF 
48±5 238±20 
Spray dried formulation 
HPMC:Pir 2:1 blank FaSSIF 
44±5 333±59 
Spray dried formulation 
HPMC:Pir 2:1 FaSSIF 
330±73 - 
Spray dried HPMC buffer 
pH 5 
42±8 341±39 
Spray dried HPMC blank 
FeSSIF 
40±9 221±26 
Spray dried formulation 
HPMC:Pir 2:1 blank FeSSIF 
52±10 423±70 
Spray dried formulation 
HPMC:Pir 2:1 FeSSIF 
58±9 448±30 
 
5.3.3. DLS characterisation of PVP-NaTC complexes  
As for HPMC based spray dried formulations, DLS was used to study the interaction 
between PVP and NaTC in the different dissolution media employed in this study. PVP on 
its own was firstly analysed in buffer, without the presence of NaTC, in order to investigate 
the possible aggregation behaviour of PVP alone.  
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Figure 5.7: DLS normalised autocorrelation function and size distribution by intensity of spray 
dried PVP in buffer, spray dried PVP in blank FeSSIF and spray dried PVP:piroxicam 2:1 
solid dispersion in blank FeSSIF (n=3). 
 
As shown in Figure 5.7 PVP on its own (concentration 0.27 mg/ml) yielded an 
averaged size (intensity weighed) of 25±4 d.nm. The size distribution plot also shows the 
presence of a not well-defined small peak that indicates the presence of aggregates with 
smaller size. However since the peak is not defined, only one size was obtained by CONTIN 
analysis. In the presence of NaTC two populations of aggregates were indicated by DLS 
results. Two relaxation times can be clearly seen in the scattering curve (light blue curve 
shown in the scattering graph in Figure 5.7), corresponding to two populations having a 
diameter of 18±0.4 nm and 323± 41 nm, respectively. Therefore this indicates that the 
presence of NaTC has an impact on the PVP association, leading to the formation of a 
second population of aggregates, which, considering the low NaTC concentration is likely to 
be composed by a low number of PVP/NaTC aggregates. The CAC value of PVP/NaTC 
system in buffer pH 6.5 was measured to be approximately 3 mM (refer to Sections 4.3.1.3 
and 4.4.2 of Chapter 4). Therefore in blank FaSSIF, NaTC concentration corresponds to the 
onset of the polymer and surfactant aggregation and only a small number of PVP/NaTC 
complexes can be present in solution. In the presence of piroxicam no size change was 
observed for the smaller population, which kept constant in size as 18±2 d.nm. The 
population of aggregates with bigger size slightly decreased in size in the presence of drug, 
as shown by size distribution of the spray dried PVP:piroxicam formulation in blank FaSSIF 
in Figure 5.7. As for HPMC:piroxicam spray dried formulation in blank FaSSIF, no 
indication of drug encapsulation in the aggregates was obtained. This suggests that 
piroxicam significant increase in solubility shown by steady state solubility studies (Section 
3.3.2, Chapter 3) in blank FaSSIF, is likely to be due mainly to the solution pH, which 
favours piroxicam solubilisation. Piroxicam solubilisation might also be favoured by the 
surface tension reduction which eases the wetting of the drug particle surface and 
subsequently dissolution caused by the presence of polymer and surfactant, rather than to the 
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drug encapsulation in NaTC micelles and/or NaTC/polymer aggregates, which are likely to 
be present in a very low number. 
 
Figure 5.8: DLS normalised autocorrelation function and size distribution by intensity of spray 
dried PVP in buffer, spray dried PVP in blank FeSSIF and spray dried PVP:piroxicam 2:1 
solid dispersion in blank FeSSIF (n=3). 
 
DLS data for PVP in buffer pH 5 are very similar to the ones obtained for the 
polymer in buffer pH 6.5. The scattering curve in Figure 5.8 indicates the presence of only 
one relaxation time, related to aggregates having a size of 19±3 d.nm. In blank FeSSIF 
bimodal distribution was obtained. The smaller population was characterized by a size of 
19±0.8 d.nm, which corresponds to the PVP aggregates in buffer pH 5. This result suggests 
that such population in blank FeSSIF is likely to be composed only of the PVP aggregates. 
The bigger population has a size of 188±34 d.nm, and may possibly be composed of 
PVP/NaTC aggregates, as PVP/NaTC aggregation was shown to occur in blank FeSSIF by 
both NMR and interfacial tension data (Sections 4.3.1.3 and 4.4.2, Chapter 4).  
 
 
 
Figure 5.9: DLS normalised autocorrelation functions and size distributions by intensity of 
spray dried PVP:piroxicam 2:1 solid dispersion in FaSSIF and FeSSIF (n=3).                 
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As for HPMC based solid dispersions, the impact of lecithin on PVP/NaTC 
association was also investigated. The results shown in Figure 5.9 confirmed the formation 
of a monodispersed population of aggregates having a size of 273±9 d.nm in FaSSIF. This 
size is close to the size obtained for FaSSIF medium (258 ±13 d.nm), indicating that no 
significant change in the solution phase composition occurred. Therefore, the solution is 
likely to be mainly composed of lecithin vesicles, and no aggregation with PVP took place. 
The slight increase in size might be an indication of piroxicam encapsulation by lecithin 
vesicles, which have already be shown to play a role in poorly water-soluble drugs 
solubilisation. 281 For PVP:piroxicam spray dried formulation dissolved in FeSSIF, a 
bimodal distribution was obtained, yielding aggregates of 177±15 and 656±48 d.nm in size 
(as summarised in Table 5.2), respectively.  Obtained size for spray dried PVP:piroxicam in 
FeSSIF are bigger for both populations compared to the sizes obtained FeSSIF medium itself 
(133±14 and 552±39 d.nm). The swelling of the aggregates can possibly be attributed to 
both associations with PVP and drug encapsulation. Considering the complexity of the 
sample, from DLS data it is not possible to further clarify the solution composition. 
However the occurrence of aggregation indicated by NMR and interfacial tension data 
(Sections 4.3.1.3 and 4.4.2, Chapter 4) and the increased piroxicam solubility in blank 
FeSSIF in the presence of PVP suggest the possible formation of new species in solution and 
their possible involvement in the drug solubilisation. The particle size PVP and PVP/NaTC 
aggregates in the different dissolution media measured by DLS are summarized in Table 5.2. 
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Table 5.2: Summary of PVP and PVP/NaTC aggregates in different dissolution media 
Sample SIZE (d.mn) population 1 SIZE (d.mn) population 2 
Spray dried PVP buffer pH 
6.5 
25±4 - 
Spray dried PVP blank 
FaSSIF 
18±0.4 323±41 
Spray dried formulation 
PVP:Pir 2:1 blank FaSSIF 
18±2 333±59 
Spray dried formulation 
PVP:Pir 2:1 FaSSIF 
- 273±9 
Spray dried PVP buffer pH 
5 
19±3 - 
Spray dried PVP blank 
FeSSIF 
19±0.8 188±34 
Spray dried formulation 
PVP:Pir 2:1 blank FeSSIF 
20±6 216±18 
Spray dried formulation 
PVP:Pir 2:1 FeSSIF 
177±15 656±48 
 
5.3.3. Impact of polymer weight ratio on polymer-bile salts aggregation  
One of the factor that can possible impact polymer/surfactant aggregation is the 
polymer:surfactant ratio. In order to investigate the impact of polymer weight ratio in 
solution on the HPMC/NaTC complexation in blank FaSSIF and FeSSIF, DLS analysis was 
performed on HPMC:piroxicam spray dried solid dispersions having polymer:weight ratios 
of 4:1 and 9:1. The obtained results in blank FaSSIF are shown in Figure 5.10. 
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Figure 5.10: DLS normalised autocorrelation functions and size distributions by intensity of 
spray dried HPMC:piroxicam solid dispersion with different HPMC:piroxicam ratios in blank 
FaSSIF (n=3). 
 
It can be seen that the presence of higher HPMC concentration led to the formation 
of slightly bigger aggregates, for both populations present in solution, but did not impact 
significantly on the scattering curves and sizes distributions of the aggregates. This result 
indicates that higher concentration of polymer did not lead to a significant change of the 
solution composition, but only caused an increase in size of the aggregates.  
 
Figure 5.11: DLS normalised autocorrelation functions and size distributions by intensity of 
spray dried HPMC:piroxicam solid dispersion with different HPMC:piroxicam ratios in blank 
FeSSIF (n=3). 
 
Figure 5.11 shows the comparison between DLS data obtained from spray dried 
HPMC:piroxicam solid dispersion 2:1, 4:1, and 9:1 in blank FeSSIF. Results clearly show a 
change in the size distribution from polymer:drug ratio 2:1 to 4:1. For the HPMC:piroxicam 
4:1 sample, the two populations are closer in size as shown by the size distribution in Figure 
5.11. Nevertheless the distribution of aggregates is still bimodal and the obtained sizes, 
90±10 and 377±14 d.nm are close to the ones obtained for the sample with 
HPMC:piroxicam ratio of 2:1. Similarly to results obtained in blank FaSSIF, these data 
indicate minor influence of polymer weight ratio on HPMC and or HPMC/NaTC aggregates 
features.  
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The role of polymer weight ratio in solid dispersions has widely been studied and 
different studies reported that the presence of higher polymer weight ratios normally 
facilitates drug solubilisation. This study proved that the use of different polymer weight 
ratios might also influence the formation of colloidal species, such as polymer and/or 
polymer/surfactant aggregates in the intestinal fluids, which may play a role in poorly water-
soluble drugs dissolution and solubilisation. 
 
Table 5.3: Summary of HPMC/NaTC aggregates from HPMC:piroxicam spray dried 
formulations 2:1, 4:1 and 9:1 in blank FaSSIF and blank FeSSIF 
 
Sample SIZE (d.mn) population 1 SIZE (d.mn) population 2 
Spray dried formulation 
HPMC:Pir 2:1 FaSSIF 
44±5 333±59 
Spray dried formulation 
HPMC:Pir 4:1 FaSSIF 
46±9 333±59 
Spray dried formulation 
HPMC:Pir 9:1 FaSSIF 
53±3 414±58 
Spray dried formulation 
HPMC:Pir 2:1 FeSSIF 
58±9 448±30 
Spray dried formulation 
HPMC:Pir 4:1 FeSSIF 
90±10 377±14 
Spray dried formulation 
HPMC:Pir 9:1 FeSSIF 
60±0.6 503±21 
 
 
5.3.4 Nanosight characterisation of polymer-NaTC complexes 
To further characterize HPMC and PVP aggregation behaviour with NaTC in 
simulated intestinal fluids, Nanosight analysis was also performed. The rational of using 
Nanosight as an additional complimentary characterisation technique is due to the 
advantages of this techquie being able to direct visualise and study both mono-dispersed and 
poly-dispersed colloidal systems. Figure 5.12 a, b and c show the Nanosight images of spray 
HPMC in buffer 6.5, spray dried HPMC in blank FaSSIF and spray dried HPMC:piroxicam 
2:1formulation .  
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Figure 5.12: Nanosight images of spray dried HPMC in buffer pH 6.5 (a), spray dried HPMC in 
blank FaSSIF (b) and spray dried HPMC:piroxicam 2:1 in blank FaSSIF (c); Nanosight sizes 
distribution of samples a,b and c (d). 
 
It can be seen that a limited number of aggregates was imaged for all the samples. 
This result is in agreement with DLS data that showed a weak scattering of HPMC samples 
in blank FaSSIF, which indicated the presence of a low number of aggregates. Spray dried 
HPMC in buffer pH 6.5 yielded a broad peak including sizes between 100 and 300 d.nm. 
Therefore Nanosight results confirmed the possible bimodal distribution for HPMC 
aggregates, as already shown by DLS analysis and as reported in literature.  150Considering 
the broadness of the peak, the obtained average size by the Nanosight software analysis is 
not expected to be reliable, but serves as an indicative estimation of the samples aggregates 
sizes.  
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Figure 5.13: Nanosight images of spray dried HPMC in buffer pH 5 (a), spray dried HPMC in 
blank FeSSIF (b) and spray dried HPMC:piroxicam 2:1 in blank FeSSIF (c); Nanosight sizes 
distribution of samples a,b and c (d). 
 
As shown in Figure 5.13 a limited number of aggregates was present also for HPMC 
in buffer pH 5, with a particle concentration slightly higher that 10^6 particle/ml. The size 
range (100-400 nm) is slightly bigger than the one obtained at pH 5, which is in agreement 
with the corresponding DLS results, suggesting again a possible impact of the ions species 
on the polymer chains aggregation and/or hydration. Differently from the results obtained 
for the HPMC sample in blank FaSSIF, in blank FeSSIF HPMC aggregates increase in 
concentration, as shown by Image b in Figure 5.13, and in size as shown by Figure 5.13 d. 
The increase in aggregates size and concentration can possibly prove the aggregation 
between HPMC and NaTC in blank FeSSIF, as already suggested by DLS results and 
indicated by NMR and interfacial tension data (refer to Chapter 4). The peak broadness is 
very high for the spray dried HPMC in blank FeSSIF, indicating a high polydispersity which 
suggests the presence of different aggregates species (and possibly aggregates with different 
particle sizes) in solution. As shown by Figure 5.13 c, in the presence of piroxicam a 
significant swelling in size of the aggregates was observed. Such result may be an indication 
of the drug encapsulation in HPMC, HPMC/NaTC aggregates and NaTC free micelles. The 
latest are possibly formed in solution considering that NaTC concentration reaches the 
system CMC*, as shown by NMR and interfacial tension data. From Figure 5.13 d it can be 
d 
Chapter 5  
 
 167 
seen that spray dried HPMC:piroxicam formulation in blank FeSSIF yielded a highly 
polydispersed population of aggregates, therefore it is not possible to obtain a defined size 
for this sample. 
 
Figure 5.14: Nanosight images of spray dried PVP in buffer pH 6.5 (a), spray dried PVP in 
blank FaSSIF (b) and spray dried PVP:piroxicam 2:1 in blank FaSSIF (c); Nanosight sizes 
distribution of samples a,b and c (d). 
 
Nanosight analysis was performed also for spray dried PVP and spray dried 
PVP:piroxicam 2:1 samples. As for spray dried HPMC, spray dried PVP only yielded an 
extremly low number of aggregates in buffer pH 6.5. The particles concentration of the 
sample was 10^6 particles /ml (Figure 5.14 d) and increased up to 2*10^6 particles /ml in 
blank FaSSIF. The sizes of the aggregates obtained by the Nanosight software are not 
reliable due to the low number of aggregates tracked. Nevertheless it can be seen in Figure 
5.14 d that aggregates size distribution did not change significantly for spray dried PVP in 
blank FaSSIF, compared to the same sample in buffer. Therefore, as already seen for spray 
dried HPMC in blank FaSSIF, limited aggregation/association between PVP and NaTC 
occurred in blank FaSSIF. As previously discussed such effect is likely to be related to the 
low NaTC (3mM) concentration in the medium. As clearly shown by Figure 5.14 c, the 
number of scattering particles significantly increased for the spray dried PVP:piroxicam 2:1 
formulation, compared to the spray dried PVP. The particle concentration of the sample rose 
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up to 5*10^6 particles/ml and a broadening of the size distribution peak can also be 
observed, indicating the possible drug encapsulation by aggregates present in solution. 
 
Figure 5.15: Nanosight images of spray dried PVP in buffer pH 5 (a), spray dried PVP in blank 
FeSSIF (b) and spray dried HPMC:piroxicam 2:1 in blank PVP (c); Nanosight sizes distribution 
of samples a,b and c (d). 
An extremely low number of scattering aggregates can be seen also in Figure 5.15 a, 
indicating a very weak scattering by spray dried PVP in buffer pH 5, as seen in buffer pH 
6.5 (Figure 5.14 a). The particle concentration of PVP in pH 5 buffer was still around 10^6 
particles/ml, but a broader size distribution was observed, confirming the possible different 
polymer aggregations in the two buffers. In blank FeSSIF medium, the particle 
concentration increased up to 3*10^6 particles/ml, as a consequence of the higher NaTC 
concentration and the possible HPMC/NaTC aggregation. As shown in Figure 5.15 d, a 
bimodal distribution was obtained for spray dried PVP in blank FeSSIF, which is in good 
agreement with the corresponding DLS data. For the PVP sample in blank FaSSIF, the 
presence of drug resulted in the presence of larger aggregates and an increase in particle 
concentration. The particles concentration for the spray dried PVP:piroxicam formulation in 
blank FeSSIF was about 4*10^6 particles/ml and with an average size of about 150 d.nm. 
Nanosight data for all the samples analysed showed broad sizes distribution, indicating the 
formation of polydispersed aggregates. The high polydispersity may be an indication of the 
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formation of different species, such as polymer aggregates, polymer/NaTC complexes and 
free NaTC micelles, particularly in the case of the samples in blank FeSSIF. However, a 
detailed description of the solution phase composition for the different sample could not be 
obtained from Nanosight and DLS data.  
5.3.7 SESANS characterisation of solid dispersion in simulated intestinal fluids  
Spin-echo small angle neutron scattering (SESANS) is a neutron scattering 
technique that can be used to study structures with sizes from 20 nm to 20 µm. 282 
Considering polymer-NaTC aggregates sizes estimated by DLS and Nanosight analysis, 
SESANS is suitable for studying these aggregates and was employed to obtained structural 
information of HPMC-NaTC aggregates in different simulated intestinal fluids . 
As described in Chapter 2, in SESANS experiments a neutron beam is polarised 
through its passage via two precession regions, which apply to the beam an identical but 
opposite magnetic induction. The scattering of the neutron takes place between the two 
precession regions. Therefore for non-scattered neutrons the precession angle in front of the 
sample is completely compensated in the precession region located behind the sample, 
resulting in an identical beam polarisation after experiment completion. The polarised 
neutrons are scattered after the first precession region, the compensation of the precession 
angle in the second procession region is not complete, resulting in a depolarisation of the 
beam. 282 
Figure 5.16: Spin echo signal of blank FaSSIF, spray dried HPMC in blank FaSSIF (0.27 mg/ml) 
and spray dried formulation HPMC:piroxicam 2:1 in blank FaSSIF. 
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Figure 5.17: Spin echo signal of blank FeSSIF, spray dried HPMC in blank FeSSIF (0.27 mg/ml) 
and spray dried formulation HPMC:piroxicam 2:1 in blank FeSSIF. 
 
Figure 5.18: Spin echo length signal of spray dried formulation HPMC:piroxicam 2:1 in FaSSIF 
and FeSSIF as a function of normalised neutron beam polarisation. 
 
 As shown in Figures 5.16, 5.17, 5.18, no change on the neutron beam polarisation 
was obtained for all samples studied. Such results firstly suggest the absence of neutron 
scattering by the samples analysed. This may possibly be valid for the samples in blank 
FaSSIF, which were known to have a very low number of particles present by Nanosight 
experiments and a weak scattering by DLS analysis.  For the samples in blank FeSSIF, 
FaSSIF and FeSSIF the absence of neutron scattering is more difficult to explain as both 
Nanosight and DLS data showed the occurrence of strong light scattering by these samples. 
The lack of the neutron beam depolarisation may also be due to the high polydispersity of 
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the samples and to the possible more open-shape of the aggregates. It is well known that the 
formation of structure/shape of polymeric and micellar aggregates is a highly dynamic 
process, which can yield a weaker scattering in neutron experiments when studied in dilute 
regimes. It should also bear in mind that the ISIS off-Spec spectrometer was a brand new 
equipment and its optimisation was still on-going when our experiments were performed. In 
particular our experiment were the first set of experiments in aqueous solvents performed at 
the ISIS Off-spec facilities. Therefore further SESANS studies on similar samples might 
clarify the possible application of this brand new equipment for polymer/surfactant mixtures 
characterisation. 
In order to further confirm the results, the experiments were repeated using 
increased acquisition time and increased polymer concentration (data not shown). However 
no change on the results was obtained in both cases. To further investigate the samples, 
SANS experiments were performed. 
5.3.8 SANS characterisation of solid dispersion in simulated intestinal fluids  
SANS has been extensively employed for the study of polymer/surfactant 
aggregation.141,283,284 In this study, SANS was firstly performed on spray dried formulations 
PVP:piroxicam 2:1 and HPMC:piroxicam 2:1 in blank FaSSIF (Figure 5.19 and 5.20). Blank 
FaSSIF medium was also analysed, but no scattering was obtained (data not shown), 
suggesting the absence of NaTC micelles in such medium. This result is in agreement with 
both DLS and Nanosight data that did not shown any light scattering in blank FaSSIF 
(Sections 5.3.3 and 5.3.4). It can be seen in Figures 5.19 and 5.20 that the neutron scattering 
is still weak (low scattering intensity) in the presence of the spray-dried formulation. 
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Figure 5.19: Neutron Scattering intensity (cm-1) for spray dried HPMC:piroxicam 2:1 and for 
spray dried PVP:piroxicam 2:1 in blank FaSSIF, as a function of scattering vector Q (A-1). 
 
Due the low scattering obtained in blank FaSSIF, the fitting of the scattering curve 
was not successful. Therefore structural information could not be obtained for these samples. 
Slightly stronger scattering was obtained for the samples measured in FaSSIF. The presence 
of lecithin changed the scattering pattern completely as shown in Figure 5.20.  
Figure 5.20: Neutron Scattering intensity (cm-1) for FaSSIF, spray dried HPMC:piroxicam 2:1 
and for spray dried PVP:piroxicam 2:1 in FaSSIF, as a function of scattering vector Q (A-1). 
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In the presence of lecithin scattering intensity significantly increased. It can also be 
seen that in the low Q range scattering curve is very similar for FaSSIF and spray dried 
HPMC:piroxicam 2:1 and PVP:piroxicam 2:1. This indicates that the scattering pattern is 
dominated by the lecithin/NaTC aggregates and that the presence of the polymeric carrier 
did not significantly impact on the scattering pattern in the low Q range. In the high Q range 
the scattering pattern indicates the presence of larger aggregates for the samples containing 
spray dried HPMC:piroxicam 2:1 and PVP:piroxicam 2:1. This suggests the formation of 
new and/or larger structures that may result from the aggregation of the polymeric carriers 
and the aggregates present in FaSSIF. 
Bile salts/lecithin complexes have widely been characterized using SANS. Different 
fitting model have been applied to analyse the scattering data and obtain structural 
information about the aggregates. Some of the proposed models in literature were cylinders 
and vesicles, 285 flexible ellipsoid cylinders 215 and wormlike micelles. 214,286  
In this study the scattering curves of FaSSIF medium, spray dried HPMC:piroxicam 
2:1 in FaSSIF and PVP:piroxicam 2:1 in FaSSIF were fitted using a elliptical cylinder model.  
The fitting results are shown in Figure 5.21 and obtained size parameters are summarised in 
Table 5.4. 
 
Figure 5.21: Neutron Scattering intensity (cm-1) for FaSSIF, spray dried HPMC:piroxicam 2:1 
and for spray dried PVP:piroxicam 2:1 in FaSSIF, as a function of scattering vector Q (A-1), 
fitted using an elliptical cylindrical model. 
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Table 5.4: Size parameters obtained for FaSSIF, spray dried HPMC:piroxicam 2:1 and spray 
dried PVP:piroxicam 2:1 in FaSSIF by neutron scattering curves fitting (Elliptical Cylindrical 
model). 
Fitting 
Parameters 
FaSSIF 
Spray dried 
HPMC:piroxicam 2:1 
FaSSIF 
Spray dried 
PVP:piroxicam 2:1 
FaSSIF 
Length [Å] 401.35±4.26 492.36±6.3929 458.39±5.19 
R minor [Å] 16.78±0.26 16.964±0.24866 13.864±0.24 
R ratio 23,91±1.87 27.092±1.1689 75.928±2.05 
 
As shown in Table 5.4, the obtained results indicate the presence of elliptical 
cylinder having similar sizes in the three samples studied. Slight swelling of the aggregates 
was obtained in the presence of the spray dried formulation, with lengths of 458.39±5.19 Å 
and 492.36±6.39 Å for spray dried PVP:piroxicam 2:1 formulation and spray dried 
HPMC:piroxicam formulation, respectively, compared to FaSSIF on its own that yielded a 
length of 401.35±4.26 Å. The minor radius value was similar for all the three samples, 
indicating that the presence of the polymeric carrier mainly impacted on the length of the 
cylinders. The SANS measured cylinder length values are close to the hydrodynamic 
diameter values obtained by DLS analysis for the smaller population of aggregates (Section 
5.2.3).  From Figure 5.21 it can be seen that the last part of the scattering curve is not well 
fitted. This may be due to the presence of bigger and/or polydispersed aggregates which 
make the fitting more challenging.  The similar scattering pattern obtained with and without 
the presence of the spray dried formulations, suggest that the scattering pattern is mainly 
attributed by the NaTC/lecithin aggregates and that the presence of spray dried formulation 
mainly led to a slight swelling of such aggregates. Considering that the NaTC/lecithin 
interaction is mainly driven by hydrophobic forces, 287 interaction is likely to be stronger 
between NaTC and lecithin than NaTC and lecithin with the hydrophilic polymeric carriers. 
Nevertheless the formation of polymer/NaTC and polymer/lecithin complexes cannot be 
excluded, but no evidence is provided by the SANS data in this study. 
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Figure 5.22: Neutron Scattering intensity (cm-1) for FaSSIF, spray dried HPMC:piroxicam 2:1 
and for spray dried PVP:piroxicam 2:1 in FaSSIF, as a function of scattering vector Q (A-1). 
 
SANS experiments were also performed in blank FeSSIF and the results are shown 
in Figure 5.22. It can be seen that, in agreement with light scattering data, higher scattering 
intensity was obtained compared to samples in blank FaSSIF, as a consequence of the higher 
NaTC concentration (15 mM). The fitting of the curves was unsuccessful and this is likely to 
be due to the high polydispersity of the samples, which was clearly shown by the Nanosight 
data, in particular for HPMC based solid dispersion in blank FeSSIF. 
SANS was also used to study FeSSIF and spray dried HPMC:2:1 and spray dried 
PVP:piroxicam 2:1 in FeSSIF. As shown in Figure 5.23, the scattering pattern changed 
completely compared to samples in blank FeSSIF (Figure 5.22), indicating a remarkable 
impact of the presence of lecithin on the aggregation behaviour in solution. In terms of 
scattering curve fitting, similar to the samples in blank FeSSIF, the fitting was unsuccessful 
due to the high polydispersity of the aggregates as indicated by DLS and Nanosight results. 
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Figure 5.23: Neutron Scattering intensity (cm-1) for FeSSIF, spray dried HPMC:piroxicam 2:1 
and for spray dried PVP:piroxicam 2:1 in FeSSIF, as a function of scattering vector Q (A-1). 
 
The SANS data clearly indicate that the absence of signal in SESANS 
measurements is not to be related to the absence of the polarised neutron beam scattering by 
the samples studied. The only samples showed extremely weak scattering are the samples in 
blank FaSSIF, while the other samples analysed by SANS showed the occurrence of neutron 
scattering. Therefore the absence of signal in SESANS experiments was likely caused by the 
samples polydispersity. Accurate measurement using SANS is extremely challanging in the 
case of polydispersed samples. Therefore neutron scattering experiments are possibly 
unsuitable for the systems analysed in this study. Therefore more direct visualisation 
method, such as cryo-TEM was used to further study these complex colloidal systems. 
5.3.9 Cryo-TEM characterisation of polymer-bile salts aggregates 
 To further investigate HPMC/NaTC and NaTC/lecithin aggregates shape and size 
cryo-TEM was performed on spray dried HPMC:piroxicam 2:1 in blank FeSSIF, FeSSIF 
and spray dried HPMC:piroxicam 2:1 in FeSSIF. Due the low number of aggregates present 
in blank FaSSIF and FaSSIF, the contrast analyses using cryo-TEM was likely to be 
unsuccessful, thus the samples in such media were not analysed. 
Figure 5.24 and 5.25 show cryo-TEM images of spray dried solid dispersion 
HPMC:piroxicam 2:1 in blank FeSSIF. The image in Figure 5.24 shows the presence of 
globular aggregates having a size of about 50 d.nm. Aggregates imaged are consistent with 
the size obtained for the smaller population of the bimodal distribution yielded by DLS 
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analysis on the same sample. Considering the CAC and CMC* values obtained by NMR and 
interfacial tension measurements for such system, the presence of free NaTC micelles should 
be limited, as NaTC concentration in blank FeSSIF correspond to its CMC* value. Therefore 
the globular aggregates imaged by cryo-TEM technique are likely to be the NaTC/HPMC 
aggregates. In Figure 5.25 the arrow indicates the presence of elongated structures of about 
200 d.nm with low contrast. The nature of such elongated structure is not clear and may be 
associated with HPMC aggregates. Cryo-TEM images confirm the presence of two different 
aggregates in solution, which explained the bimodal distribution shown by DLS 
measurements and the broad size distribution peak obtained with Nanosight measurements.  
It should be bear in mind that the analysis was performed after 48-72 hours from sample 
preparation (due to the delivery time required from UK to Sweden and possibly with 
temperature fluctuation during this period). Therefore sample aging may affect the solution 
composition and subsequently the cryo-TEM aggregates imaging. 
 
Figure 5.24: Cryo-TEM images of spray dried formulation HPMC:Piroxicam 2:1 in Blank 
FeSSIF. Presence of globular aggregates of about 50 nm in size (a). Bar=200nm 
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Figure 5.25: Cryo-TEM images of spray dried formulation HPMC:Piroxicam 2:1 in Blank 
FeSSIF. The arrow indicates the presence of elongated structures (b). Bar=200nm 
 
Cryo-TEM analysis was also performed on FeSSIF and the obtained image is shown 
in Figure 5.26. The image shows the presence of globular small micelles with a size of about 
5 nm. This result is not in agreement with DLS analysis that showed the presence of two 
populations of aggregates of 133±14 and 552±39 d.nm. As previously mentioned cryo-TEM 
analysis could not be performed on fresh samples, but was instead carried out on samples 
aged for 48-72 hours. Literature data reported possible size and shape changes of 
NaTC/Lecithin aggregates over time. 285 Therefore the inconsistency between cryo-TEM and 
DLS results might be caused by the samples aging. 
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Figure 5.26: Cryo-TEM images FeSSIF. The image shows the presence of globular aggregates of 
about 5 nm in size (a). Bar=200nm 
 
Spray dried HPMC:piroxicam 2:1 solid dispersion in FeSSIF was also analysed and 
the cryo-TEM image is reported in Figure 5.27. It can be seen that the aggregates are very 
similar to the ones imaged for FeSSIF alone, confirming that there are mainly NaTC/lecithin 
aggregates present. For these samples Cryo-TEM results are in disagreement with DLS, 
which showed the presence of much bigger aggregates with a bimodal distribution. As for 
FeSSIF it is likely that the sample aging affected the aggregates features. 
Lecithin-bile salts aggregation has been extensively described in literature. 277,288 
Mazer et al proposed a  “mixed disk” model for the structure of bile salt-lecithin mixed 
micelles, while a rod-like morphology of the aggregates based on SANS data was described 
by Hjelm et al. More recently bile salt-lecithin micelles were found to be flexible rods, 
having different sizes between 5 to 300 nm depending on the micelles composition. 215 
Kloefer et al also reported cryo-TEM analysis for instant FaSSIF and FeSSIF (obtained from 
redissolution of freeze dried FaSSIF and FeSSIF media), but the different preparation 
procedure and the different aging of the aggregates do not allow a direction comparison of 
our results with the existing literature. Further cryo-TEM studies on fresh samples are 
needed to help accurately image the aggregate studied in this study.  
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Figure 5.27: Cryo-TEM images of spray dried formulation HPMC:Piroxicam 2:1 in Blank 
FeSSIF. Presence of globular aggregates of about 50 nm in size (a). Presence of elongated 
structures (b). Bar=200m 
 
5.4 Discussion on studied solution phase composition  
Data obtained in this Chapter provided more detailed indicative information on the 
solution phase composition of the different samples analysed. Based on the DLS, Nanosight, 
and neutron scattering results, a model about the possible aggregation between the polymeric 
carriers employed and NaTC in blank FaSSIF is shown in Figure 5.28. 
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Figure 5.28: Schematic representation of solution phase composition and NaTC/polymeric 
carrier features in spray dried solid dispersions dissolved in blank FaSSIF. 
 
DLS analysis for spray dried HPMC:piroxicam 2:1 solid dispersion in blank FaSSIF 
yielded a bimodal distribution of sizes. As described in this Chapter, in blank FaSSIF no free 
NaTC micelles are formed and NaTC/HPMC aggregation is limited by the low NaTC 
concentration. Therefore, the two populations indicated by DLS, may be composed by 
polymer aggregates. NaTC monomers and drug molecules do not scatter, therefore the light 
scattering signal can only be attributed to the polymer aggregates and possibly free chains. 
Drug solubilisation is likely to be facilitated by the reduced surface tension caused by the 
HPMC presence, by the increase of the drug molecules wettability and possibly via their 
encapsulation in the polymeric aggregates.  
A bimodal distribution was also obtained for the sample of spray dried 
PVP:piroxicam 2:1 solid dispersion in blank FaSSIF, with smaller sizes for the first 
population, in agreement with the smaller size obtained in buffer for spray dried PVP in 
buffer pH5. 
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Figure 5.29: Schematic representation of solution phase composition and NaTC/polymeric 
carrier features in spray dried solid dispersions dissolved in blank FeSSIF. 
 
In blank FeSSIF the possible presence of polymeric carrier/NaTC aggregation 
yielded different sizes distribution compared to blank FaSSIF. SANS, SESANS and 
Nanosight data indicated high polydispersity for spray dried formulations in blank FeSSIF, 
suggesting the formation of different species in solution. Based on DLS and Nanosight data 
the solution phase composition was speculated and illustrated in Figure 5.29. As indicated 
by NMR and interfacial tension measurements in Chapter 4, NaTC/HPMC aggregation 
occurred in blank FeSSIF. DLS results indicated the formation of two populations of 
aggregates having sizes of 58±9 and 448±30 d.nm. The smaller population of aggregates is 
likely to be composed of HPMC aggregates, as the size of the population is very close to the 
one obtained for spray HPMC in buffer pH5. The bigger population of aggregates is likely 
composed by HPMC/NaTC aggregates. Solubility studies described in Chapter 3 (Section 
3.3.2) showed piroxicam apparent solubility increase in blank FeSSIF. The increased 
solubility may be partially contributed to the drug encapsulation in the aggregates of 
NaTC/HPMC, as well as in HPMC aggregates. For PVP based spray dried formulation in 
blank FeSSIF, a bimodal distribution was also obtained. Therefore, also in this case the 
smaller population may be mainly composed of PVP aggregates, while the bigger one may 
be a result of the complexation between NaTC micelles and PVP. For PVP/NaTC system the 
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CMC* value could not be clearly assigned, therefore the formation of free NaTC micelles 
cannot be excluded and as possible solution composition is illustrated in Figure 5.29, also 
free NaTC micelles may be present in solution. Three different aggregates, PVP and 
PVP/NaTC aggregates and free NaTC micelles, may be involved in the drug solubilisation 
for the spray dried PVP:piroxicam solid dispersion. 
 
Figure 5.30: Schematic representation of solution phase composition and NaTC/polymeric 
carrier features in spray dried solid dispersions dissolved in FaSSIF. 
 
The samples in FaSSIF yielded completely different scattering pattern compared to 
the samples in blank FaSSIF, for both light and neutron experiments. This indicated the 
impact of lecithin on the aggregation in solution and the possible formation of new species. 
SANS data analysis indicated that the scattering pattern is mainly attributed to the scattering 
of lecithin vesicles. As previously discussed in this Chapter (Section 5.3.1) at low NaTC 
concentration, the bile salt is mainly in its monomeric form, but its concentration is not high 
enough to lead to lecithin vesicles dissolution by surfactants, bile salts in particular, which 
leads to the formation of mixed micelles.  278 Therefore, as represented in Figure 5.30, 
elliptic cylindrical lecithin vesicles are possibly present in solution, for both spray dried PVP 
and HPMC based formulation in FaSSIF. The high solubility of piroxicam in FaSSIF 
highlighted by apparent solubility studies (refer to Chapter 3, Section 3.3.2) may be 
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attributed to piroxicam solubilisation via lecithin vesicles. Considering DLS results obtained 
for spray dried formulation in the presence of polymer, polymeric aggregates and free 
polymeric chains that may contribute to the overall scattering, as illustrated in Figure 5.30. 
HPMC and PVP aggregates could also contribute to the drug solubilisation, as well as the 
reduction in the overall system surface tension. 
 
Figure 5.31: Schematic representation of solution phase composition and NaTC/polymeric 
carrier features in spray dried solid dispersions dissolved in FaSSIF. 
 
In FeSSIF medium, high polydispersity was indicated by SANS analysis for which 
the data fitting was not possible. Also DLS data indicated the presence of large aggregates 
for both spray dried formulations. A bimodal size distribution was obtained for both HPMC 
and PVP based spray dried formulation in FeSSIF. The solution phase composition can be 
speculated as the smaller population being mainly composed by polymeric aggregates. This 
was suggested by DLS results performed on spray dried HPMC:piroxicam samples having 
different drug:polymer ratios (Section. 5.3.3). The increase in polymer weight ratio led to the 
increase in size of the smaller population of aggregates. Such result indicated that the 
smaller population of aggregates was mainly composed of polymeric complexes. The high 
NaTC concentration in FeSSIF could lead to the lecithin vesicles dissolution, resulting in the 
formation of NaTC/lecithin mixed micelles. The possible structure of such mixed colloidal 
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system is speculated in Figure 5.31, being the co-existence of lecithin, NaTC monomers, and 
possibly polymeric chains. Drug solubilisation may be attributed to both polymeric 
aggregates and NaTC/lecithin mixed micelles. 
5.5 Conclusions 
In this Chapter NaTC/HPMC and NaTC/PVP complexes were characterised by the 
use of light scattering techniques including DLS and Nanosight, neutron scattering 
techniques including SANS and SESANS, and cryo-TEM. All data obtained indicated the 
occurrence of polymeric carriers/NaTC interaction in blank FeSSIF, while very limited 
aggregation was find to occur in blank FaSSIF. Therefore different drug solubilisation 
mechanism was speculated for spray dried formulations dissolved in the two media. 
Polymeric aggregates in blank FaSSIF are likely to play a major role in the drug 
solubilisation, while a possible involvement of NaTC/polymer aggregates may occur in 
blank FeSSIF. PVP and HPMC formulations yielded similar results, being with bigger 
aggregates formed in the case of spray dried HPMC based solid dispersions. 
Lecithin vesicles were found to dominate the light and neutron scattering patterns in 
FaSSIF, suggesting the possible role of such vesicles in the drug solubilisation. In FeSSIF 
polymeric aggregates and mixed NaTC/lecithin aggregates were possibly formed, despite 
cryo-TEM result, which indicated the presence of very small micelles. Analysis conducted 
by neutron and light scattering techniques on such complex systems is proven to be very 
challenging. It can be concluded that the solution composition of spray dried solid dispersion 
in simulated intestinal media is extremely complex, due to the presence of many components 
and the possible occurrence of interaction between them. Nevertheless consistency between 
NMR and Interfacial tension data was obtained. The possible role of the different aggregates 
in piroxicam solubilisation was further investigated by cellular absorption studies and the 
results are described in Chapter 6. 
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Chapter 6. Assessment of the potential effects of polymer/NaTC 
complexes on poorly water-soluble drugs absorption in the intestinal 
tract  
6.1 Introduction 
Effective drug dissolution is essential for proper drug absorption and realising the 
pharmacological effect after oral administration. 289 In this study the uses of solid dispersion 
formulations were proven to lead to an increase of drug solubilisation of three model poorly 
water-soluble drugs, in particular in the simulating intestinal fluids (Chapter 3). The study of 
the possible interactions between the polymeric carriers employed and the components in the 
simulated intestinal fluids (Chapters 4 and 5) suggested the possible formation of polymeric 
carrier/NaTC and polymeric carries/NaTC/lecithin aggregates that may play a role in the 
model drug solubilisation. In theory, the increase in solubility obtained for the model drug 
piroxicam (a BSC class II drug) should potentially lead to an increase in its intestinal 
absorption compared to crystalline form of the model drug. In order to further gain insights 
into the effect of these aggregates on the in-vitro absorption of the drugs, cellular drug 
absorption and transport assessment were performed using Caco-2 cells as the model cell 
line. 
Caco-2 cells culture model has been widely used in drug discovery and development 
studies. 290 The Caco-2 cell monolayers have been used as an in vitro cell model to identify 
drug absorption problems and possibly predict drugs absorption in-vivo after oral 
administration in the early stage drug development. 291,292 In literature, Caco-2 cells model 
has been recognised as a good predictive tool to investigate oral absorption for drugs 
passively transported via the transcellular route, such as piroxicam.  In these studies, the use 
of bio-relevant media in Caco-2 transport and absorption studies has been remarked as an 
important factor to obtain reliable prediction of drugs absorption in the intestinal tract. 293,294. 
Bile salts are known to have a cytotoxic detergent effect that can cause cell 
membrane damage. Therefore, in this study in order to find the suitable condition to perform 
Caco-2 cell experiments using blank FaSSIF, blank FeSSIF, FaSSIF and FeSSIF, 
cytotoxicity studies were performed in the first instance. Absorption and transport studies 
were also carried out using Caco-2 cells monolayer to investigate the impact of solid 
dispersion formulation and the bio-relevant media on the drug absorption by the Caco-2 cell 
monolayer. 
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6.2 Materials 
75 cm2 flasks, cells scrapers, 6 and 96-well plates were purchased from Greiner bio-
one. All the reagents employed were purchased from Sigma-Aldrich unless differently stated.  
 
6.3 Experimental methods 
6.3.1 Cell Culture 
Growth and maintenance of cultured cells were carried out in an Envair Class II 
model safety cabinet with laminar flow hood using aseptic technique to ensure sterility of 
cells and growth media. All glassware were sterilised by double high pressure and 
temperature autoclave. All consumables were packaged pre-sterilised or sterilised by 
autoclave prior to use. All water was of Milli-Q grade and was double distilled using a 
Millipore filtration unit (Millipore, Massachusetts, USA) and was sterilised using an 
autoclave. All media and solutions were pre-warmed at 37 ºC in a water bath. 
 
6.3.2 Clonal Caco-2/TC7 Cells 
Caco-2/TC7 cells were obtained from Dr M. Rousset (U178 INSERM, Villejuif, 
France), and were cultured between passages 49 and 59. Cells were grown in 75 cm2 flasks 
and maintained in Dulbecco Modified Eagle’s Medium (DMEM) with 1 % non-essential 
amino acids, 1 % L-glutamine, 100 IU/ML penicillin and 100 µg/ml streptomycin, and 
supplemented with 20 % (v/v) heat inactivated foetal calf serum. Cells were maintained in a 
Napco 4530 water-jacketed CO2 incubator at 37 ºC with 5 % CO2 and 95 % air. Cell seeding 
was assessed by light microscope and was undertaken at 80 % confluency (approximately a 
week after seeding). All media and solutions were pre-warmed to 37 ºC in a water bath. The 
cells were washed three times with phosphate buffered saline solution (PBS). A solution 
containing 0.05 % trypsin and 0.2 % ethylenediaminetetraacetate (EDTA) was added to the 
cells (2 ml per dish or flask) and excess removed before the flask was incubated at 37 ºC 
until the cells became detached from the flask. The remaining trypsin was neutralised by 
dilution using 10ml of DMEM. Flasks were seeded at 2-4 × 104 cells per cm2. All media 
was changed every other day. Cells were re-seeded once 80% of confluency was reached 
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6.3.3 Solution samples preparation for cells studies  
Samples for cytotoxicity, absorption and transport studies were prepared employing sterile 
glassware. All the sample solutions were prepared in safety cabinet with laminar flow hood 
using aseptic technique, to reduce the risk of samples contamination. Accurately weighed 
piroxicam and spray dried HPMC:piroxicam 4:1 solid dispersion were dissolved in the 
different media and incubated at 37 ºC for 1 hour. Spray dried samples were freshly prepared 
after thorough spray dryer cleaning. Instrument cleaning was performed by spray drying a 
mixture of ethanol and water and drying the instrument at 130 ºC prior to spray-drying 
formulation samples.  
 
6.3.4 Cytotoxicity studies 
Cells were cultured in 96-well tissue culture plates at culture conditions described in 
Section 6.3.2 in 200 µl per well. Once 80 % confluency was reached (approximately 3 
weeks), cells were washed twice using pre-warmed sterile PBS.  Subsequently 200 µl of test 
solution samples were added and the cells were placed in the incubator (Napco 4530 water 
jacketed CO2 incubator at 37 ºC with 5 % CO2 and 95 % air) for two hours. Cytotoxicity test 
was run after two hours as the duration of the later absorption and transport experiments was 
both two hours. 
6.3.4.1 Lactate dehydrogenase (LDH) cytotoxicity test 
LDH test is a routinely used cytotoxicity test based on the colorimetric 
determination of LDH released from lysed cells. In this study apical release of LDH enzyme 
was determined using a colorimetric kit following a previously reported method. 295 
After two hours of incubation, 100 µl of apical medium was transferred into a clean 
plate. 50 µl of substrate reagent were added to the samples and a 30-minute of reaction 
period was allowed at room temperature and the plates were protected from light. After 30 
minutes 50 µl of stopping solution were added. Absorbance was measured at 492 nm. 
(Hitachi spectrophotometer, Hitachi High Technologies America, Schaumburg, USA) LDH 
content was calculated as % of the total LDH content measured by inducing total cell lysing 
with 0.1% Triton X-100.   
6.3.4.2 Cyto-Tox Glo™ test 
Another cell viability assay employed in this study was the Cyto-Tox Glo™ test. 
This assay uses a luminogenic peptide, the (alanyl-alanyl-phenylalanyl-aminoluciferin) 
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AAF-Glo™ substrate, to measure the activity of protease released by the dead cells. The 
AAF-Glo™ substrate cannot cross the membrane of living cells.  The assay exploits 
thermostable luciferase (Ultra-Glo™ Recombinant Luciferase), which uses AAF-Glo™ 
substrate to generate a luminescent signal. By the use of the Lysis Reagent provided in the 
assay kit, the luminescent signal associated with the total number of cells in each well can 
also be obtained. This allows the viability calculation by subtracting the luminescent signal 
obtained for lysed cell from total luminescence of the samples. 
100 µl of apical media were transferred into a clean opaque well. 50 µl of the assay 
reagents were added to each well. The samples were incubated for 30 minutes at room 
temperature. After 30 minutes luminescence was measured using a FLUOstar OPTIMA 
microplate reader (BMG LABTECH GMBH, Ortenberg, Germany). Meanwhile 100 µl of 
lysing buffer were added to the original plate and left in oscillation for 10-15 minutes. 100 µl 
of apical media were then withdrawn from the original plate containing the lysing buffer and 
transferred to the opaque plate containing apical media added with assay reagents. 
Luminescence was measured again after 15 minutes of oscillation. 
 
6.3.5 Drug uptake studies 
Cells were grown in 6-well plates until 21 days post confluency. Before performing 
uptake study confluent cells were washed twice using sterile PBS and aspirated as described 
in Section 6.3.1. After washing, the cells were treated with 2 ml of the solution sample and 
placed in the incubator for 2 hours. For each sample 5 replicates were studied. 1 ml of apical 
media was withdrawn from each well. Cells were then washed twice using sterile PBS and 
scraped after addition of 400 µl of sterile water. Apical media and scraped cells were 
collected in sterile eppendorf and frozen after addition of 25 µl of ethanol and 25µl acetic 
acid for each eppendorf (sample frozen ≈ 1 ml). Samples were later analysed using HPLC 
analysis. Data analysis was performed by dividing piroxicam (µg) detected in the cells lysate 
by the total amount (µg) of drug detected (lysed cells+apical media content). Absorbed 
piroxicam was expressed as % of total drug load. 
 
6.3.6 Transport studies 
Caco-2/TC7 cells were seeded at 2-4 x 104 cells per cm2 on Transwell 
polycarbonate filters (Greiner bio-one, Stonehouse, UK) with growth surface of 4.5 cm2 (6 
well format). Monolayer integrity was assessed using transepithelial electrical resistance 
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(TEER), and those wells showing values higher than 180 ohms per cm2 were aspirated of 
media from both apical and basolateral compartments and washed three times with 
phosphate buffered saline (PBS). Phenol red free DMEM was added to the lateral side (1 ml). 
1 ml of test sample solution was added to the apical side. Control and treatment cells were 
incubated at 37 ºC, for 2 hours. After 2 hours 400 µl of apical and lateral media were 
withdrawn and the sample was frozen at -20 ºC after addition of methanol and acetic acid 
(10% of final volume for both). The samples were later analysed by HPLC analysis. 
 6.3.6.1. Evaluation of monolayer integrity: Transepithelial electrical resistance 
measurements (TEER) 
TEER of 6-well Transwells monolayers was routinely measured before changing 
cell culture media. A Millicell-ERS volt ohmmeter (Millipore corporation, Massachusetts) 
was used to take the measurements as per the supplied instructions. TEER was expressed as 
Ω.cm2 (or mohms.cm2) and was calculated by subtracting the reading of the resistance of the 
supporting filter and multiplying obtained result by the surface area of the monolayer 
(4.5 cm2).  TEER measurements were performed before each transport experiment to ensure 
adequate monolayer integrity. The monolayers with TEER readings below the minimum 
level were discarded (below 180 ohms per cm2).  
 
6.3.7 HPLC analysis of cells absorption and transport samples 
Samples collected from absorption and transport studies were firstly defrosted and 
sonicated for 10 minutes using a sonication bath. Samples were subsequently vortexed and 
centrifuged at 15000 rpm for 15 minutes. Supernatant was used for HPLC analysis. In this 
study, HPLC analysis was carried out in reverse phase with a Perkin Elmer (Whaltam, 
Massachussets, USA) high performance liquid chromatography having a Serier 200 isocratic 
pump, equipped with a Series 600 link interface and a Series 200 UV-VIS detector. TC-
NAV (Perkin Elmer, Whaltam, Massachussets, USA) software was used to collect, integrate 
and analyse the chromatographic data. UV detection was carried out at 314 nm. A C18 150 x 
4.6mm column Supelco Li-Chrospher, RP18 Sum was used. For the analysis, the mobile 
phase consisted of HPLC grade acetonitrile (MeCN)-phosphate buffer (40:60 v/v) adjusted 
to pH 3 with phosphoric acid, at an injection volume of 10 μL and a flow rate of 1 mL min-1. 
The retention time of piroxicam was approximately 5.2 minutes with this system. Linearity 
between absorbance and concentration was tested using external standards at various 
concentrations and the response was linear with a correlation coefficient r2 = 0.99595 (data 
shown in appendix), over the whole range of used concentrations. A standard stock solution 
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of piroxicam (0.7 mg/ml) in the mobile phase and a series of diluitions with concentration 
between 0.28 to 0.0007 mg/ml were prepared. Each sample was prepared in triplicate and 
analysed three times. 
 
6.4 Results and discussion 
6.4.1 Cell viability  
Cytotoxicity studies were performed in order to identify the non-cytotoxic condition 
for the later absorption and transport studies, with particular regards to the suitable 
concentrations of agents, such as bile salts, should be used in the bio-relevant media. 
Previous studies reported FaSSIF to be compatible with Caco-2 cells, while FeSSIF was 
cytotoxic. 294 For this reason the cytotoxicities of the solutions containing piroxicam, HPMC, 
buffers pH 5 and pH 6.5, lecithin and NaTC with different concentrations were evaluated.   
 
Table 6.1: LDH assay cytotoxicity results expressed as % of lysed cells (n=6) 
Sample Averaged cytotoxicity (%) Standard deviation (%) 
Buffer pH 6.5 3.88 2.29 
Buffer pH 5 21.42 19.35 
NaTC 15mM in DMEM 51.77 9.38 
NaTC 3mM in DMEM 40.10 12.62 
Spray dried HPMC (0.5 
mg/ml) in DMEM 
-0.11 2.03 
 
As summarised in Table 6.1, the buffer pH 6.5 is slightly cytotoxic, as 3.88±2.29% 
cell died in two hours. The buffer pH 5 was even more cytotoxic and 21.42±19.25% of cells 
death was achieved in two hours. The higher cytotoxicity of acetate buffer is likely to be 
caused by its lower pH and higher osmolality (670mOsmol/kg) in comparison to phosphate 
buffer at pH 6.5 (270mOsmol/kg). Strong cytotoxicity was obtained for all NaTC solutions 
in DMEM, even at the lower concentration employed (3mM), confirming the cytotoxicity of 
bile salts possibly via membrane damage as described in literature. 296 HPMC was 
compatible with Caco-2 cells as no cytotoxic effect was observed. This is in agreement with 
literature data. 297 
In order to obtain a time profile of the progression of NaTC cytotoxicity and 
evaluate the possibility of using NaTC solution for shorter experiments, LDH cytotoxicity 
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test was repeated for the lower NaTC concentration (3mM) and cells viability was measured 
at regular time intervals. The results are shown in Table 6.2. 
Table 6.2: LDH assay cytotoxicity results expressed as % of lysed cells (n=6) 
Sample Average cytotoxicity (%) Standard deviation (%) 
NaTC 3mM 15 minutes 25.30 2.76 
NaTC 3mM 30 minutes 32.07 2.32 
NaTC 3mM 60 minutes 32.23 9.05 
NaTC 3mM 120 minutes 53.36 11.73 
 
As shown by the results summarised in Table 6.2, 25.30±2.76% Caco-2 cells were 
already dead after 15 minutes exposure to NaTC 3mM in DMEM. Cytotoxicity reached the 
32.23±9.05 % in one hour and the 53.36±11.73% in two hours, indicating that the suitable 
NaTC concentration of Caco-2 cell experiments with NaTC concentration should be below 
3mM. 
Table 6.3: LDH assay cytotoxicity results expressed as % of lysed cells (n=6) 
Sample 
Average cytotoxicity 
(%) 
Standard deviation 
(%) 
NaTC 0.3mM in DMEM 0.07 2.76 
NaTC 0.6mM in DMEM 2.27 3.97 
Lecithin 0.75mM in DMEM 0.28 2.16 
FaSSIF 50.33 15.91 
Spray dried HPMC:Piroxicam 
4:1 in blank FaSSIF 
37.17 7.79 
Spray dried HPMC:Piroxicam 
4:1 in FaSSIF 
30.28 6.33 
 
Results reported in Table 6.3 show that at very low concentration NaTC was not 
significantly cytotoxic. Lecithin was also shown to be compatible with Caco-2 cells as no 
significant cytotoxicity was observed for the solutions with lecithin concentration of 
0.75mM which is the same concentration used in FaSSIF. On the contrary, FaSSIF itself was 
very cytotoxic, as 50% of Caco-2 cells death was observed after 2 hours of exposure to the 
media. Considering that lecithin was not toxic, such result can be attributed to NaTC (3mM) 
cell membrane damage. The high cytotoxicity obtained for FaSSIF is in disagreement with 
literature data, that reported compatibility of FaSSIF use in with Caco-2 cells experiments. 
293,294 Moreover Patel et al suggested that bile salts cytotoxicity could be reduced by the 
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presence of lecithin, as phospholipids have been shown to protect cellular membrane from 
bile-salts damage. 298,299 However, in this study no decrease in NaTC cytotoxicity was 
observed in the presence of lecithin. Interestingly, the decrease of NaTC cytotoxic was observed 
in the presence of spray dried formulation. As shown in Tables 6.2 and 6.3, obtained 
cytotoxicity for spray dried HPMC:piroxicam 4:1 solid dispersion in blank FaSSIF was 
37.17±7.79%, which is significantly lower than the cytotoxicity value obtained for NaTC 
3mM in DMEM. Such decrease may be a consequence of the NaTC/HPMC interaction, 
which has previously been suggested to occur by NMR, interfacial tension (refer Chapter 4) 
and light scattering (Chapter 5) data in this study. The aggregation of NaTC with HPMC 
would decrease the amount of free NaTC which can interact with membrane lipids and cause 
the cellular membrane damage. 
 
Table 6.4: CYTO-TOX GLO™ assay cytotoxicity results expressed as % of lysed cells (n=6) 
Sample 
Averaged cytotoxicity 
(%) 
Standard deviation 
(%) 
Piroxicam 0.4mg/ml in DMEM 
(Ethanol 2%) 
3.69 0.95 
NaTC 1mM in DMEM 11.61 7.05 
NaTC 1.5mM in DMEM 21.41 3.86 
NaTC 2mM in DMEM 36.17 6.98 
Spray dried HPMC:Piroxicam 
4:1 in DMEM 
1.74 0.81 
Spray dried HPMC:Piroxicam 
4:1 in NaTC 1.5 mM DMEM 
10.78 7.24 
 
Further cytotoxicity studies were performed using Cyto-Tox Glo™ assay, with and 
without the presence of bovine serum, and the results are summarised in Tables 6.4 and 6.5. 
The cytotoxicity of piroxicam was reported in Table 6.4. At the used concentrations, the 
model drug showed very low cytotoxic effect on Caco-2 cells. For piroxicam solutions with 
increasing concentration of NaTC, significant cytotoxic effects on the cells monolayer were 
observed with 11.61±7.05, 21.41±3.86 and 36.17±6.98 % of cells death after two hours of 
treatment for the solutions containing NaTC 1, 1.5 and 2mM, respectively. The solution of 
spray dried HPMC:piroxicam 2:1 in DMEM was not cytotoxic. Interestingly, as already 
shown by LDH assay, the spray dried solid dispersion dissolved in NaTC 1.5mM (in DMEM) 
yielded a lower cytotoxicity value of 10.78±7.24 %. Therefore the cytotoxic effect of NaTC 
decreased of about 50 % in the presence of spray dried polymer, compared to the NaTC 
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1.5mM in DMEM without polymer. This result suggests again the possible occurrence of 
NaTC/HPMC interaction in the tested solution, which may play a protective role of cellular 
membrane from NaTC damage. It should be bear in mind that NMR and interfacial tension 
data indicated the occurrence of NaTC/HPMC aggregation for the samples with NaTC 
concentration above 3mM. But NMR and interfacial tension data were performed in acetate 
and phosphate buffers. DMEM used in the cell studies may affect the NaTC/HPMC 
aggregation and possibly change the CAC of the system. Therefore it is possible that CAC 
value was lowered in DMEM and consequently NaTC/HPMC interaction could take place at 
a lower NaTC concentration, such as 1.5mM. An investigation into the HPMC/NaTC 
aggregation in DMEM may help clarify this hypothesis. 
Table 6.5: CYTO-TOX GLO™ assay cytotoxicity results expressed as % of lysed cells (n=6). 
Assay was perfomed in DMEM added with foetal serum. 
Sample 
Averaged cytotoxicity 
(%) 
Standard deviation 
(%) 
NaTC1.5mM in DMEM+serum 13.46 4.77 
NaTC1.5mM in DMEM+serum 17.84 8.70 
Spray dried HPMC:Piroxicam 4:1 
in NaTC 1.5 mM DMEM+serum 
12.36 1.76 
Spray dried HPMC:Piroxicam 4:1 
in NaTC 3 mM DMEM+serum 
16.52 4.49 
Spray dried HPMC:Piroxicam 4:1 
in FaSSIF in  DMEM+serum 
10.66 1.84 
 
Table 6.5 shows cytotoxicity results obtained for samples in DMEM added with 
foetal serum. The presence of serum showed significant impact on the cytotoxicity results. 
For all tested samples, the cytotoxicity was lowered compared to the results obtained in 
DMEM without serum. Such result suggests that the cell death may at least partially be due 
to the absence of proper conditions for cell maintenance during cytotoxicity experiments. 
Another possible indication is the possible interaction between NaTC and serum components. 
However the presence of such complex mixture of proteins would have made HPLC analysis 
less reliable, in particular for the UV detection. Therefore despite the lower cytotoxicity 
shown by the cell viability experiments in the presence of serum, drug uptake and transport 
studies were performed without the addition serum. 
For transport and absorption studies the threshold of cytotoxicity was set as 25%. 
Therefore samples that yielded cytotoxicity values higher than 25% were not employed in 
Caco-2 cell monolayer experiments. In order to simplify media nomenclature NaTC 1.5mM 
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solutions at pH 5 and 6.5 were labelled as blank FeSSIF-2 and blank FaSSIF-2, respectively, 
while the same media in the presence of lecithin 0.75mM were labelled FeSSIF-2 and 
FaSSIF-2. These modified non-cytotoxic biorelevant media (with low NaTC concentration 
than FaSSIF and FeSSIF) were used in drug uptake and transport studies.   
 
6.4.2 Piroxicam uptake studies 
Piroxicam uptake studies using Caco-2 as model cell line were performed in order to 
evaluate the impact of polymers and the components in the biorelevant media used in this 
study on the passively drug absorption. 300 Firstly piroxicam uptake by Caco-2 in the media 
containing DMEM, acetate and phosphate buffers was assessed. The influence of NaTC on 
piroxicam absorption was investigated by studying the uptake of the drug solubilised in 
acetate and phosphate buffered NaTC 1.5mM solution. This concentration was chosen based 
on the cytotoxicity results. This NaTC concentration led to about 20% cell death, whereas 
higher concentration of NaTC led to much high cytotoxic effect on Caco-2 cells monolayers. 
The impact of spray drying formulation on the drug uptake was also investigated by 
performing absorption studies of spray dried HPMC:piroxicam 4:1 solid dispersions. Solid 
dispersions were solubilised in the acetate and phosphate buffers employed in steady state 
solubility and dissolution studies and in NaTC buffered solution with and without the 
presence of lecithin. The obtained results of above samples are shown in Figure 6.1. 
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Figure 6.1: Caco-2 cellular uptake studies results for piroxicam in different media. (n=5) 
 
It can be seen that 16.95±0.36 % of piroxicam in DMEM was absorbed by Caco-2 
cells at the end of 2 hours testing period. No significant change in the drug absorption % was 
obtained for piroxicam in acetate (pH 5) and phosphate (pH 6.5) buffers, which yielded 
18.17±0.31% and 18.74±0.84%, respectively. This result indicates that, despite the higher 
solubility of piroxicam in phosphate buffer shown by steady state solubility studies (Section 
3.3.2.1, Chapter 3), in vitro cellular drug absorption was not affected by the pH of the media. 
The presence of NaTC 1.5mM did not lead to significant absorption increase, indicating low 
cell damage and little role NaTC played in enhancing drug absorption by Caco-2 cells. 
19.22±0.35% and 18.06±0.85% of drug were absorbed from the buffer pH 5 piroxicam 
solution containing NaTC 1.5 mM and the buffer pH 6.5 piroxicam solution containing 
NaTC 1.5 mM, respectively. It is possible that NaTC solubilisation effect is not exerted at 
the concentration of 1.5 mM. Piroxicam absorption values obtained for spray dried 
formulation was 19.05±1.32% in buffer pH 6.5 and 22.38±3.31% in buffer pH 5. The solid 
dispersion formulation only showed slight impact on drug absorption and mainly for the 
samples in buffer pH5, despite the higher piroxicam solubility in phosphate buffer at pH 6.5. 
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Similar value of piroxicam absorption was obtained from spray dried HPMC:piroxicam 4:1 
solid dispersion in blank FaSSIF-2, from which 18.49±0.5% of piroxicam was absorbed by 
Caco-2 cells monolayer. Higher drug absorption (26.44±1.52%) was obtained for the spray 
dried formulation in blank FeSSIF-2. The presence of lecithin in the solution showed a 
significant impact on piroxicam absorption. Piroxicam absorption reached 28.87±1.72% and 
32.47±1.54%, when spray dried HPMC:piroxicam formulation was dissolved in FeSSIF-2 
and FaSSIF-2, respectively. This is in good agreement with steady state solubility results 
that showed the highest piroxicam solubilisation in FaSSIF, confirming the potential 
contribution of enhanced solubility on drug absorption. 
Uptake data are only partially in agreement with steady state solubility studies, 
suggesting that drug solubilisation is only one of the factors ruling drug absorption in the 
intestinal cells. The absorption values obtained from the spray dried formulation in buffer 
suggest that the formation of solid dispersion did not significantly facilitate the drug 
absorption. Solid-state analysis of spray dried formulation performed in Chapter 3 
highlighted that the physical state of piroxicam in HPMC based spray dried solid dispersion 
was mainly amorphous. In literature, it is commonly agreed that the amorphous state of 
drugs usually favours drug solubilisation and consequent absorption. 33 Despite the higher 
piroxicam dissolution rate obtained in blank FaSSIF and blank FeSSIF (refer to Chapter 3, 
section 3.3.9), the results of this study indicate that the physical state of piroxicam is not the 
main determinant for its intestinal absorption. Moreover, the use of modified biorelevant 
media did not cause a significant increase in the drug uptake by Caco-2 cells. Enhanced drug 
absorption was instead obtained when the spray dried HPMC:piroxicam 4:1 formulation was 
dissolved in modified biorelevant media FaSSIF-2 and FeSSIF-2. Such results confirm the 
importance of using simulated intestinal fluids media in Caco-2 cells models experiments, as 
already stated in literature. 293,301  
The results of the absorption studies support the hypothesis that the occurrence of 
polymeric carrier/bile salts aggregation may play a role in the absorption of poorly water-
soluble drugs in the GIT. The highest absorption of piroxicam was obtained when both 
polymeric carrier and simulated intestinal media were used in the tests. Lecithin resulted to 
be as well a key component of biorelevant media for improved piroxicam absorption, as well 
as for its solubilisation as shown in Chapter 3 (Section 3.3.2.1).  
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6.4.3 Piroxicam transport studies 
The attempts of quantitatively studying piroxicam transport across Caco-2 cell 
monolayer were unsuccessful. Almost no signal could be measured by HPLC analysis, 
indicating a limited transport of the drug across the Caco-2 cells monolayer. Further studies 
are needed in order to confirm the results and further investigate piroxicam transport across 
the intestinal membrane applying Caco-2 cells model. 
 
6.5 Conclusions 
The results reported in this chapter confirmed piroxicam, polymeric carrier and 
lecithin are non-cytotoxic for Caco-2 cells, while high cytotoxicity was associated with the 
presence of bile salts. Different NaTC concentrations were tested to identify a possible 
concentration compatible with Caco-2 cells and 1.5 mM gave acceptable cytotoxicity value 
(≈ 20 %).  Therefore biorelevant media were modified with reduced NaTC concentration for 
Caco-2 cells drug uptake and transport studies. Significant reduction of bile salts cytotoxic 
effect was obtained in the presence of HPMC. We speculate that this may be a consequence 
of HPMC/NaTC interaction, which reduces the interaction between NaTC and the cell 
membrane lipid and subsequently decreases the NaTC cytotoxicity. 
Absorption studies showed higher piroxicam absorption from spray dried 
HPMC:piroxicam 4:1 formulation in FeSSIF-2 and FaSSIF-2. Obtained data proved the 
importance of biorelevant media employment in Caco-2 cells studies and also supported the 
indication of a possible interaction occurrence between polymeric carrier and biorelevant 
media components which may facilitate drug uptake. 
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Chapter 7. Conclusions 
Solid dispersion technology represents one of the most researched formulation 
approaches for the delivery of poorly water-soluble drugs. 23,24,38,302 It can be argued that a 
general consensus has been reached about the ability of solid dispersion to increase the 
dissolution rate of drugs and potentially favour an improvement of their bioavailability. 303–
305 In order to overcome possible limitations related to the use of solid dispersions, many 
efforts have been made in the last decades to improve the physical stability of solid 
dispersions and their in vitro dissolution performance. 306–308 The importance of in vitro 
dissolution tests has been extensively emphasised and its potential as bioavailability 
predictive tool has arose from many studies. 20,67,208,289 Despite the high number of 
publications in the field of solid dispersions, the mechanism of how solid dispersion 
formulation can enhance the bioavailability of poorly soluble drugs, particularly in in human 
intestinal fluid, is still not fully understood. This study focused on the characterisation of the 
physico-chemical behaviour the polymeric carriers of solid dispersion formulations in 
simulated intestinal media, in order to provide new insights into the role of these polymers in 
the drug solubilisation and absorption processes. Particular remark was given to the possible 
role of bile salts/polymer aggregates in the solubilisation and subsequent absorption of 
poorly water-soluble drugs in the intestinal tract. 
 
7.1 Effects of drug physical state and dissolution media composition on 
the in vitro performance of solid dispersions  
In Chapter 3 solid-state characterisation revealed conversion of the model drug from 
crystalline to amorphous state in the spray dried solid dispersions, with partial crystallinity 
of the model drugs in the solid dispersions having high drug content (33%). The steady state 
solubility studies of the model drugs performed in different biorelevant media revealed 
dramatic effects of the simulated fluids compositions on the apparent solubilities of the 
drugs. The importance of mimicking the physiological conditions by the use biorelevant 
fluids in solubility and dissolution studies has previously been highlighted in literature. 
15,19,20 The results obtained in this study indicated remarkable impact of NaTC and lecithin 
on increasing the model drugs solubilisation, in both crystalline and amorphous forms. 
Highest apparent solubility values of the model drugs were obtained in FaSSIF and FeSSIF 
in the presence of the polymeric carriers. Such result suggested that both simulated fluids 
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components and polymeric carriers were possibly contributing to the drug solubilisation 
observed. This raised the question whether the effects were originating by the presences of 
the single components (bile salts, lecithin and polymeric carriers) or by an interaction 
between them. 
Dissolution studies performed in media with and without the addition of NaTC 
demonstrated the primary effect of this model bile salt in drug solubilisation, particularly for 
piroxicam and fenofibrate. The type of polymer and the physical state of the model drugs 
also showed clear impacts on the dissolution behaviour of the solid dispersions. For HPMC 
based solid dispersions, fastest dissolution profile was obtained after spray drying, indicating 
the impact of the drug physical state conversion from crystalline to amorphous on the drug 
dissolution rate for such system. Differently, fastest dissolution rate was obtained from 
PVP:drug physical mixtures compared to the spray dried solid dispersions. The reason 
behind this observation is still not well understood. However, similar results have been 
reported previously. 309 The concomitant presence of polymeric carrier and surfactant in the 
dissolution media yielded the fastest dissolution profiles, the involvement of different 
chemical entities in the drug solubilisation process.  
Chapter 3 provided strong evidences indicating the potential interactions between 
hydrophilic polymers and dissolution media compositions. This led to the proposal of the 
involvements of such interactions in drug solubilisation and dissolution processes. Therefore 
major focus of the next stage of study was directed to the investigation of polymeric carriers-
bile salts interaction.  
 
7.2 Polymer-bile salts interactions in simulated intestinal fluids 
Chapter 4 and 5 described the investigation of NaTC-polymer interactions and the 
characterisation of the resulting polymer/bile salts aggregates.  In particular NMR and 
interfacial tension studies reported in Chapter 4 focused on the characterisation of the 
possible polymer-NaTC interactions. The occurrence of NaTC-HPMC and NaTC-PVP 
aggregation was indicated in aqueous medium. Both NMR and interfacial tension results 
confirmed the important impact of salts on the surfactant-polymer aggregation, with a 
decrease in the CAC value for both systems, indicating possible facilitation of the 
occurrence of polymer-bile salts interactions by the presence of salts in the media. Obtained 
results indicated the occurrence of NaTC-HPMC and NaTC-PVP interactions in blank 
FeSSIF, suggesting during the dissolution of a PVP or HPMC based solid dispersion in 
blank FeSSIF, the formation of polymer-NaTC aggregates may occur. According to NMR 
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and interfacial tension data the presence of few free NaTC micelles is also possible. As 
CMC* (surfactant concentration value at which the formation of free micelles occurs in 
polymer/surfactant systems) resulted to be 15mM for both HPMC:NaTC and PVP:NaTC 
systems, both NaTC-polymer aggregates and NaTC micelles can be present in the blank 
FeSSIF media. Therefore different aggregates species may be involved in the solubilisation 
of the model drug.  
 For NMR and interfacial tensions studies performed in blank FaSSIF, the obtained 
results indicated the possible formation of only few NaTC-HPMC aggregates at low NaTC 
concentration, as CAC value of the system corresponded to NaTC concentration in the 
medium (3mM). No free NaTC micelles can be formed in blank FaSSIF, as NaTC 
concentration is well below CMC* of the system. Therefore the phase compositions of the 
solution of NaTC-PVP system in blank FaSSIF are likely to be mainly free NaTC molecules 
and free dissolved polymer. Considering the solution phase composition indicated by NMR 
and interfacial tension data, the increase in apparent solubility and dissolution rate of the 
model drugs obatained in blank FaSSIF, is likely to be mainly due to system surface tension 
reduction caused by NaTC monomer and to drug solubilisation through polymer aggregates. 
Therefore it is reasonable to predict that only a minor role was played by polymer/NaTC 
interaction in blank FaSSIF on drug solubilisation. 
As described in Chapter 5, with high NaTC concentration in blank FeSSIF, 
significant numbers of aggregates were detected, while very limited aggregation was find to 
occur in blank FaSSIF. Therefore size and shape of NaTC/polymer aggregates and NaTC 
micelles were further studied by different light and neutron scattering techniques and cryo-
TEM. Only minor role in the drug solubilisation can potentially be played by polymeric 
aggregates in blank FaSSIF, while a possible role of NaTC/polymer aggregates can be 
played in blank FeSSIF.DLS and Nanosight characterisations of PVP and HPMC based solid 
dispersion formulations solutions yielded similar results, with bigger aggregates formed in 
dissolved spray dried HPMC based solid dispersions in all the media employed. 
Lecithin vesicles were clearly detected by light and neutron scattering methods in 
FaSSIF. The significant drug solubilisation increase obtained for piroxicam showed by 
steady state solubility studies (reported in Chapter 3) might be related to lecithin vesicles 
possible role in the drug solubilisation. In FeSSIF polymer aggregates and mixed 
NaTC/lecithin aggregates were possibly formed. As for FaSSIF, in FeSSIF much higher 
apparent solubility values were obtained for model drugs, compared to simple buffered 
media. Therefore the influence of employed medium phase solution composition on the 
model drugs solubilisation was again highlighted. Nevertheless composition of the dissolved 
Chapter 7  
 
 202 
solution of spray dried solid dispersion in simulated intestinal media is extremely complex, 
due to the presence of many components and the possible occurrence of interaction between 
them. The complete clarification of each type of aggregate’s possible role in the drug 
solubilisation therefore could not be made, but the combination of dissolution, steady state 
solubility studies and colloidal characterisation of solid dispersion formulation in biorelevant 
media employed in this study strongly suggested a possible key role of solid dispersion 
carrier/ media components on the drug solubilisation. Based on literature data, the nature of 
interaction between the polymeric carriers employed and NaTC is likely to be hydrophobic. 
110 The nature of interaction was not the key point of this study, as it was mainly focused on 
the polymeric carriers/bile salts interaction and its possible drug solubilisation impact. 
Further studies might be useful to provide insights about the interaction driving forces.  
 
7.3 Possible effects of polymer-bile salts aggregation on drug uptake 
As discussed in Chapter 6, to investigate the effects of polymer-NaTC complexation 
on the drug absorption in the intestinal tract, Caco-2 cells were used to conduct the drug 
uptake studies. In order to understand the possible impact of biorelevant media components 
on the drug absorption by Caco-2 cells monolayer, media with increasing complexity were 
used. Model crystalline drug absorption resulted to be not influenced by the medium pH, and 
only slightly impacted by the presence of NaTC (which was 1.5mM in concentration to meet 
cell compatibility) and by the drug physical state. Indeed absorption studies performed on 
spray dried solid dispersion did not show significant drug uptake increase indicating minor 
role of drug amorphisation on drug absorption by Caco-2 cells. Moreover significant 
increase in the model drug absorption from spray dried HPMC:piroxicam 4:1 formulation 
was obtained for studies performed using FeSSIF-2 and FaSSIF-2 (modified media with 
NaTC concentration 1.5mM and lecithin concentration 0.75mM). Obtained data confirmed 
the importance of biorelevant media used in Caco-2 cells, which has increasingly been 
highlighted in literature.294,299,301,310,311 Furthermore performed Caco-2 cells uptake studies 
supported the indication of a possible interaction occurrence between polymeric carrier and 
bio-relevant media components and the possible role of such interactions in enhancing the 
drug uptake of poorly water soluble drug in the intestinal tract. The proposed possible 
working mechanism of how spray dried solid dispersion formulations containing piroxicam 
can increase the dissolution rate, the solubility in simulated intestinal fluids and drug uptake 
via Caco-2 cells model is schematically illustrated in Figure 7.1 
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. 
Figure 7.1: Schematic representation of the impact of polymer-NaTC complexation on the 
dissolution, solubilisation and intestinal uptake of model drug, piroxicam, delivered via spray 
dried solid dispersions. 
 
 
7.4 Final remarks and future perspectives 
This study highlighted the importance of molecular level investigation of the 
excipient-media interaction on understanding the dissolution and drug release behaviour of 
solid dispersion in bio-relevant conditions. The main aim of the project was to investigate 
whether interactions occurring between polymers used in solid dispersion preparation and 
intestinal fluids components may influence drug solubilisation and absorption in the intestine. 
Wide indication of polymer-bile salts interactions occurrence has been provided by different 
experiments and Caco-2 cells studies clearly showed a significant dependence of the drug 
uptake from the dissolution medium composition and drug formulation. Therefore it is 
possible to conclude that, in order to develop successful formulations of poorly water-
soluble drugs, proper prediction of the formulation behaviour in the intestine represents a 
key factor to have effective in vitro prediction of drug solubilisation and absorption and 
possibly achieve good in vitro/in vivo correlation. A proper prediction of molecular 
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behaviour of polymer in simulating media can potentially provide a useful guide for the 
study of new solid dispersions formulations. Fuller understanding of the behaviour of 
polymeric carriers in bio-relevant condition can be used to highlight limitations and 
advantages of each carrier in terms of drug solubilisation enhancement in a bio-relevant 
environment.  
This study provided new insights into the interactions of polymer and biorelevant 
surfactant post-dissolution of polymer based solid dispersions and the possible role of such  
interactions on the drug solubilisation and uptake. In order to confirm the findings of this 
study, the following further studies are required: 
1. The further investigation of physical and chemical properties of polymer on the 
interactions with bile salts, by the use of more pharmaceutical polymers employed in the 
preparation of solid dispersions.  
2. The study of polymeric carrier/bile salts interaction occurring in more updated simulating 
intestinal fluids, such as FaSSIF-2 and FeSSIF-2. These media are both prepared starting 
from maleate buffered solution, therefore their use might provide further information about 
the interaction occurrence between polymer and bile salts excluding the possible buffer 
species difference impact that might be present for FaSSIF and FeSSIF. 
3. The study of the polymeric carrier interaction with bile salts, other intestinal fluids 
components and possible combination of more components in other conditions, such as 
gastric fluids, more complex biorelavent media and human intestinal fluids.  
4. The study of polymeric carrier/GIT fluids components interaction impact, occurring in 
more complex media, on the drug transport across the intestinal media through Caco-2 cells. 
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Appendix 
Calibration curves 
In this appendix UV calibration curves of the model drugs employed in this project 
are reported (Figure i-ix). HPLC piroxicam calibration is also shown (Figure x). 
 
 
 
Figure i: UV piroxicam calibration curve buffer pH 6.5 
 
 
 
 
 
 
Figure ii: UV piroxicam calibration curve buffer pH 5 
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Figure iii: UV piroxicam calibration curve ethanol 
 
 
 
Figure iv: UV griseofulvin calibration curve buffer pH 5 
 
 
 
Figure v: UV griseofulvin calibration curve buffer pH 6.5 
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Figure vi: UV griseofulvin calibration curve ethanol 
 
 
 
     Figure vii: UV fenofibrate calibration curve buffer pH 5 
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     Figure viii: UV fenofibrate calibration curve buffer pH 6.5 
 
 
 
Figure ix: UV fenofibrate calibration curve ethanol 
 
 
 
 
Figure x: HPLC-UV piroxicam calibration curve mobile phase (CH3CN/phosphate buffer)
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Abstract 
 
Purpose 
To evaluate the role of polymer-surfactant interactions in drug solubilisation/stabilisation 
during the dissolution of spray-dried solid dispersions and their potential impact on in vivo 
drug solubilisation and absorption. 
Methods 
Dissolution/precipitation tests were performed on spray-dried HPMC-Etravirine solid 
dispersions to demonstrate the impact of different surfactants on the in vitro performance of 
the solid dispersions. Interactions between HPMC and bio-relevant and model anionic 
surfactants (bile salts and SDS respectively) were further characterised using surface tension 
measurements, fluorescence spectroscopy, DLS and SANS. 
Results 
Fast and complete dissolution was observed in media containing anionic surfactants with no 
drug recrystallisation within 4 h. The CMCs of bile salts and SDS were dramatically reduced 
to lower CACs in the presence of HPMC and Etravirine. The maximum increases of the 
apparent solubility of Etravirine were with the presence of HPMC and SDS/bile salts. The 
SANS and DLS results indicated the formation of HPMC-SDS/bile salts complexes which 
encapsulated/solubilised the drug. 
Conclusions 
This study has demonstrated the impact HPMC-anionic surfactant interactions have during 
the dissolution of non-ionic hydrophilic polymer based solid dispersions and has highlighted 
the potential relevance of this to a fuller understanding of drug solubilisation/stabilisation in 
vivo. 
